Form 8-K

8-K — LEGGETT & PLATT INC

Accession: 0001193125-26-151966

Filed: 2026-04-13

Period: 2026-04-13

CIK: 0000058492

SIC: 2510 (HOUSEHOLD FURNITURE)

Item: Entry into a Material Definitive Agreement

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — d38467d8k.htm (Primary)

EX-2.1 (d38467dex21.htm)

EX-99.1 (d38467dex991.htm)

EX-99.2 (d38467dex992.htm)

GRAPHIC (g38467ex99_2p10g1.jpg)

GRAPHIC (g38467ex99_2p11g1.jpg)

GRAPHIC (g38467ex99_2p12g1.jpg)

GRAPHIC (g38467ex99_2p13g1.jpg)

GRAPHIC (g38467ex99_2p14g1.jpg)

GRAPHIC (g38467ex99_2p15g1.jpg)

GRAPHIC (g38467ex99_2p16g1.jpg)

GRAPHIC (g38467ex99_2p17g1.jpg)

GRAPHIC (g38467ex99_2p18g1.jpg)

GRAPHIC (g38467ex99_2p19g1.jpg)

GRAPHIC (g38467ex99_2p1g1.jpg)

GRAPHIC (g38467ex99_2p20g1.jpg)

GRAPHIC (g38467ex99_2p21g1.jpg)

GRAPHIC (g38467ex99_2p22g1.jpg)

GRAPHIC (g38467ex99_2p23g1.jpg)

GRAPHIC (g38467ex99_2p24g1.jpg)

GRAPHIC (g38467ex99_2p25g1.jpg)

GRAPHIC (g38467ex99_2p26g1.jpg)

GRAPHIC (g38467ex99_2p2g1.jpg)

GRAPHIC (g38467ex99_2p3g1.jpg)

GRAPHIC (g38467ex99_2p4g1.jpg)

GRAPHIC (g38467ex99_2p5g1.jpg)

GRAPHIC (g38467ex99_2p6g1.jpg)

GRAPHIC (g38467ex99_2p7g1.jpg)

GRAPHIC (g38467ex99_2p8g1.jpg)

GRAPHIC (g38467ex99_2p9g1.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: d38467d8k.htm · Sequence: 1

8-K

LEGGETT & PLATT INC false 0000058492 0000058492 2026-04-13 2026-04-13

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): April 13, 2026

LEGGETT & PLATT, INCORPORATED

(Exact Name of Registrant as Specified in its Charter)

Missouri

001-07845

44-0324630

(State or other jurisdiction of

incorporation or organization)

(Commission

File Number)

(IRS Employer

Identification No.)

1 Leggett Road

Carthage, MO

64836

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code:

417-358-8131

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☒

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading

Symbol(s)

Name of Each Exchange on

which Registered

Common Stock, par value $.01 per share

LEG

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01

Entry into a Material Definitive Agreement.

On April 13, 2026, Somnigroup International Inc., a Delaware corporation (“Parent”), and Leggett & Platt, Incorporated, a Missouri corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among Parent, Sparrow Unity Corporation, a Missouri corporation and a direct, wholly owned subsidiary of Parent (“Merger Sub” and together with Parent, the “Parent Parties”), and the Company, pursuant to which, subject to the terms and conditions of the Merger Agreement, Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving the Merger as a direct, wholly owned subsidiary of Parent. All defined terms used in this summary of the Merger Agreement that are not otherwise defined herein have the meanings ascribed to such terms in the Merger Agreement. The Merger Agreement has been unanimously approved by the respective boards of directors of the Company (the “Company Board”) and the board of directors of Parent.

The Merger

Subject to the terms and conditions of the Merger Agreement, at the date and time the Merger becomes effective (the “Effective Time”), each share of common stock, par value $0.01 per share, of the Company (“Company common stock”) issued and outstanding immediately prior to the Effective Time (other than Company Cancelled Shares and Dissenting Shares, each as defined in the Merger Agreement) will be converted into and represent the right to receive 0.1455 (the “Exchange Ratio”) shares of common stock of Parent, $0.01 par value per share (“Parent common stock”) and, if applicable, cash in lieu of fractional shares (the “Merger Consideration”). The Exchange Ratio will be equitably adjusted to reflect any stock split, reverse stock split, subdivision, consolidation, combination or other reclassification of Company common stock or Parent common stock after the date of the Merger Agreement and prior to the Effective Time. It is expected that the Merger will qualify as a tax free reorganization for U.S. federal income tax purposes.

Treatment of Stock Options and Stock-Based Awards

Immediately prior to the Effective Time, all restrictions on outstanding Company restricted shares will lapse, and such shares will fully vest and be converted into the right to receive the Merger Consideration. As of the Effective Time, and as a result of the Merger:

•

Each option to acquire shares of Company common stock that is outstanding immediately prior to the Effective Time will be assumed by Parent and converted into an option to acquire shares of Parent common stock (“Parent option”), with the same terms and conditions that applied to the original option. Each Parent option will represent the right to receive a number of shares of Parent common stock equal to the number of shares of Company common stock subject to the original option multiplied by the Exchange Ratio, and will have an exercise price per share equal to the exercise price per share of the original option, divided by the Exchange Ratio.

•

Each restricted stock unit (“RSU”) award covering shares of Company common stock (“Company RSU award”) that is outstanding immediately prior to the Effective Time, other than a Company RSU award issued under the Company’s deferred compensation plans, will be assumed by Parent and converted into an RSU award covering shares of Parent common stock (“Parent RSU award”), with the same terms and conditions that applied to the original award. The number of shares of Parent common stock subject to each assumed RSU award will equal the number of shares of Company common stock subject to the Company RSU award, multiplied by the Exchange Ratio.

•

Each performance stock unit award covering shares of Company common stock (each, a “Company PSU award”) for which the performance period has not yet ended that is outstanding immediately prior to the Effective Time will be assumed by Parent and converted into a Parent RSU award, with the same terms and

conditions that applied to the original award, except that the Parent RSU award will not be subject to performance conditions. Performance will be deemed achieved at maximum, and the number of shares of Parent common stock subject to each Parent RSU award will equal 200% of the target number of shares of Company common stock subject to the Company PSU award, multiplied by the Exchange Ratio.

•

Each Company PSU award for which the performance period has ended that is outstanding immediately prior to the Effective Time will constitute the right to receive shares of Parent common stock equal to the number of shares of Company common stock earned based on actual performance during the performance period, multiplied by the Exchange Ratio.

•

Stock units that track Company common stock held in participant accounts under the Company’s deferred compensation plans will be converted into notional cash investments based on the average closing price of the Company common stock for the five trading days immediately prior to the closing date of the Merger. Such notional cash will be reinvested in one or more diversified investment options as determined by the Parent board, in accordance with the directions of affected participants.

Any Parent option or Parent RSU awards held by an individual who is not employed by or in service with the Company or its subsidiaries at the Effective Time will be settled solely in cash based on the closing price of Parent common stock on the applicable exercise or settlement date.

Conditions to the Merger

Completion of the Merger is subject to the satisfaction or waiver of certain conditions, including:

•

approval of the Merger Agreement by the Company’s shareholders;

•

absence of any law or order (exclusive of laws or orders issued under antitrust and competition laws or foreign investment laws, other than the Required Approvals) restraining, enjoining or otherwise prohibiting or making the Merger illegal (each, a “Legal Impediment”);

•

receipt of approvals under certain applicable antitrust and competition laws and foreign investment laws, including under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “Required Approvals”);

•

approval for listing the shares of Parent common stock issuable to the Company’s shareholders as Merger Consideration on the New York Stock Exchange (the “NYSE”);

•

the effectiveness of the registration statement on Form S-4 to be filed by Parent and the absence of any stop order or pending proceeding with respect thereto;

•

a customary “bringdown” of the Parent Parties’ and the Company’s representations and warranties;

•

compliance by the Parent Parties and the Company with the covenants in the Merger Agreement in all material respects; and

•

the absence of a material adverse effect on either Parent or the Company.

Representations, Warranties and Covenants

The Merger Agreement contains customary representations and warranties of the Parent Parties and the Company. The Merger Agreement also contains customary mutual pre-closing covenants, including the obligation of Parent and the Company to conduct their respective businesses in the ordinary course of business consistent with past practice and to refrain from taking certain specified actions without the consent of the other party.

The Company has agreed to customary non-solicitation obligations related to soliciting or engaging in any discussions or negotiations regarding competing proposals. Notwithstanding these non-solicitation obligations, prior to approval of the Merger Agreement by the Company’s shareholders and under certain specified circumstances, the Company Board may change its recommendation of the transaction and terminate the Merger Agreement to accept a competing transaction that the Company Board determines is superior to the Merger (a “Superior Proposal”).

If the Company has received a Superior Proposal and the Company Board determines in good faith, after consultation with its outside counsel, that the failure to take such action would be inconsistent with its fiduciary duties to the Company’s stockholders, then the Company Board may (i) effect a Change of Board Recommendation (as defined in the Merger Agreement) with respect to such Superior Proposal or fail to include the Company Board Recommendation in the Proxy Statement/Prospectus (as defined in the Merger Agreement) or (ii) terminate the Merger Agreement, subject to payment of the termination fee described below to Parent. Prior to taking such actions, the Company must provide Parent with at least four business days’ notice (the “Notice Period”) of the Company’s intention to take such action, which notice must specify the material terms and conditions of the Acquisition Proposal (as defined in the Merger Agreement) and a copy of the available proposed transaction agreement to be entered into in respect of such Acquisition Proposal. To the extent Parent desires to negotiate, the Company is required to engage in good faith negotiations with Parent during the Notice Period regarding any adjustments to the terms and conditions of the Merger Agreement proposed in writing by Parent. In the event of any material modifications to an Acquisition Proposal that has triggered a Notice Period, the Company is required to deliver a new written notice to Parent at which point the Notice Period shall be the longer of the remaining period of the prior Notice Period and two business days with respect to such revised Superior Proposal from the date of such new notice. Subject to similar provisions and requirements in the Merger Agreement, including a four-business day notice period, the Company Board may also effect a Change of Board Recommendation with respect to an Intervening Event (as defined in the Merger Agreement).

Termination Provisions

The Merger Agreement contains provisions granting Parent and the Company the right to terminate the Merger Agreement under specified circumstances, including:

•

by mutual consent of Parent and the Company;

•

if the Merger is not completed by January 13, 2027, or as this date is automatically extended at certain times up until April 13, 2028 if all the conditions to the Merger Agreement are satisfied other than receipt of the Required Approvals (the “Outside Date”);

•

if a Legal Impediment permanently restrains, enjoins or prohibits the completion of the Merger;

•

if the Company fails to obtain approval of the Merger Agreement by the Company’s shareholders;

•

if the Company Board (a) changes or withdraws its recommendation that the Company’s shareholders approve the Merger Agreement, (b) enters into a definitive agreement with another party that submitted a Superior Proposal and (c) pays Parent the Company Termination Fee (as defined below); or

•

if the other party breaches its representations, warranties, agreements or covenants contained in the Merger Agreement so that the conditions to the Merger would not be satisfied and has failed to cure the breach within a specified time period.

If the Merger Agreement is terminated due to a failure to complete the Merger by the Outside Date as result of failing to obtain the Required Approvals or pursuant to a Legal Impediment related to the Required Approvals, Parent will be required to pay the Company $80,000,000. Furthermore, Parent and the Company have agreed to extend the material terms of their existing supply agreement for up to two years, upon the termination of the Merger Agreement under certain specified circumstances.

Subject to the terms and conditions of the Merger Agreement, if, prior to receiving approval of the Merger Agreement by the Company’s shareholders, the Merger Agreement is terminated due to the Company Board changing its recommendation in connection with the Merger and the Company enters into, a definitive agreement with respect to a Superior Proposal, the Company will be required to pay Parent $64,000,000 (the “Company Termination Fee”). In

addition, if the Merger Agreement is terminated due to failing to complete the Merger by the Outside Date, the Company’s failure to obtain shareholder approval or the Company’s breach of its representations, warranties or covenants contained in the Merger Agreement, a competing proposal was publicly announced prior to the Company’s shareholder meeting and within 12 months following such termination, the Company enters into a material definitive agreement with respect to, or consummates, an Acquisition Proposal, the Company will be required to pay Parent the Company Termination Fee.

The Merger Agreement is attached hereto as Exhibit 2.1 and is incorporated herein by reference. The foregoing description does not purport to be complete and is subject to and qualified in its entirety by reference to the Merger Agreement.

The Merger Agreement has been included to provide security holders and investors with information regarding its terms. It is not intended to provide any other factual information about Parent, the Company or any other person. The representations, warranties and covenants contained in the Merger Agreement were made solely for purposes of the Merger Agreement and as of specific dates, were solely for the benefit of the parties to the Merger Agreement, may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures made for the purposes of allocating contractual risk between the parties to the Merger Agreement instead of establishing these matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to security holders. Security holders and investors are not third-party beneficiaries under the Merger Agreement and should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Parent Parties or the Company. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in Parent’s or the Company’s public disclosures.

Following the Effective Time, the shares of Company common stock will be delisted from the NYSE and deregistered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

Item 7.01

Regulation FD Disclosure.

On April 13, 2026, Parent and the Company announced that they had entered into the Merger Agreement. A copy of the joint press release is attached hereto as Exhibit 99.1 and incorporated by reference herein. In addition, on April 13, 2026, Parent and the Company released a joint investor presentation. A copy of the joint investor presentation is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

The information in this Item 7.01 (including Exhibits 99.1 and 99.2) is being furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the Exchange Act or otherwise subject to liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth in such filing.

FORWARD-LOOKING STATEMENTS

This communication contains statements that may be characterized as “forward-looking” within the meaning of the federal securities laws. Such statements might include information concerning one or more of Parent’s and the Company’s plans, guidance, objectives, goals, strategies, and other information that is not historical information. When used in this communication, the words “will,” “targets,” “expects,” “anticipates,” “plans,” “proposed,” “intends,” “outlook,” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements include, without limitation, statements relating to Parent’s expectations regarding the impact of the proposed transaction on Parent’s brands, products, customer base, results of operations, or financial position, its share repurchases, adjusted EPS, net leverage, operating cash flow, net income, future performance, cost and run-rate synergies, funding sources, expected capital structure, the financial impact of the Company’s existing long-term debt, ability to deleverage after the proposed transaction, the expected timing and likelihood of completion of the proposed transaction, the integration of the Company with Parent’s business and personnel and Parent’s and the Company’s post-acquisition financial reporting. Any forward-looking statements contained herein are based upon current expectations and beliefs and various assumptions. There can be no assurance that these expectations or beliefs will prove correct.

Numerous factors, many of which are beyond Parent’s and the Company’s control, could cause actual results to differ materially from any that may be expressed herein as forward-looking statements. These potential risks include risks associated with the Company’s ongoing operations; the ability to obtain the requisite Company shareholder approval; the risk that Parent or the Company may be unable to obtain governmental and regulatory approvals required for the proposed transaction (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the proposed transaction); the risk that an event, change or other circumstance could give rise to the termination of the proposed transaction; the risk of delays in completing the proposed transaction; the ability to successfully integrate the Company into Parent’s operations and realize synergies from the proposed transaction and the expected run-rate of such synergies; the possibility that the expected benefits of the acquisition are not realized when expected or at all; the risk that any announcement relating to the proposed transaction could have adverse effects on the market price of Parent common stock or Company common stock; the risk of litigation related to the proposed transaction; the diversion of management time from ongoing business operations and opportunities as a result of the proposed transaction; the risk of adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction; general economic, financial and industry conditions, particularly conditions relating to the financial performance and related credit issues present in the retail sector, as well as consumer confidence and the availability of consumer financing; the impact of the macroeconomic environment in both the U.S. and internationally on Parent and the Company; uncertainties arising from national and global events; industry competition; the effects of consolidation of retailers on revenues and costs; consumer acceptance and changes in demand for Parent’s and the Company’s products; and other risks inherent in Parent’s and the Company’s businesses.

All such factors are difficult to predict, are beyond Parent’s and the Company’s control, and are subject to additional risks and uncertainties, including those detailed in Parent’s annual report on Form 10-K for the year ended December 31, 2025 and those detailed in the Company’s annual report on Form 10-K for the year ended December 31, 2025. These risks, as well as other risks related to the proposed transaction, will be included in the Form S-4 and proxy statement/prospectus (each as defined below) that Parent and the Company intend to file with the United States Securities and Exchange Commission (the “SEC”) in connection with the proposed transaction. There may be other factors that may cause Parent’s and the Company’s actual results to differ materially from the forward-looking statements. Neither Parent nor the Company undertakes any obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.

NO OFFER OR SOLICITATION

This communication is not intended to be, and shall not constitute, an offer to sell, buy or exchange or the solicitation of an offer to sell, buy or exchange any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

IMPORTANT ADDITIONAL INFORMATION AND WHERE TO FIND IT

In connection with the proposed transaction, Parent intends to file with the SEC a registration statement on Form S-4 (the “Form S-4”) that will include a proxy statement of the Company and that will also constitute a prospectus of Parent with respect to the shares of Parent common stock to be issued in the proposed transaction (the “proxy statement/prospectus”). The definitive proxy statement/prospectus (if and when available) will be filed with the SEC by, and mailed to shareholders of, the Company. Each of Parent and the Company may also file other relevant documents with the SEC regarding the proposed transaction.

This communication is not a substitute for the Form S-4, the proxy statement/prospectus or any other document that Parent or the Company may file with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS OF PARENT AND THE COMPANY ARE URGED TO READ THE FORM S-4, THE PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, CAREFULLY IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain

copies of these documents (if and when available), as well as other filings containing information about Parent and the Company, free of charge on the SEC’s website at www.sec.gov. Copies of the documents filed with, or furnished to, the SEC by Parent will be available free of charge on Parent’s website at https://somnigroup.com/investor-resources/financials/sec-filings/default.aspx. Copies of the documents filed with, or furnished to, the SEC by the Company will be available free of charge on the Company’s website at https://leggett.gcs-web.com/financials/sec-filings. The information included on, or accessible through, Parent’s or the Company’s website is not incorporated by reference into this communication.

PARTICIPANTS IN THE SOLICITATION

Parent, the Company and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies with respect to the proposed transaction under the rules of the SEC. You can find information about Parent’s executive officers and directors in Parent’s definitive proxy statement filed with the SEC on March 31, 2026, under the section entitled “Proposal No. 1 — Election of Directors - Executive Officers,” “Proposal No. 1 — Election of Directors - Nominees to Board of Directors,” “Stock Ownership – Stock Ownership of Certain Beneficial Owners and Directors and Executive Officers,” “Executive Compensation and Related Information - Compensation of Executive Officers” and “Director Compensation.” You can find information about the Company’s executive officers and directors in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, under the section entitled “Supplemental Item: Information About our Executive Officers” and “Directors, Executive Officers and Corporate Governance,” and in the Company’s definitive proxy statement filed with the SEC on April 7, 2026, under the sections entitled “Corporate Governance and Board Matters — Director Compensation,” “Proposals to be Voted On at the Annual Meeting — Proposal One: Election of Directors,” “Executive Compensation and Related Matters — Compensation Discussion & Analysis” and “Security Ownership — Security Ownership of Directors and Executive Officers.” Additional information regarding the interests of the participants in the solicitation of proxies will be included in the Form S-4, the proxy statement/prospectus and other relevant materials to be filed with the SEC if and when they become available. You should read the Form S-4 and the proxy statement/prospectus carefully when available before making any voting or investment decisions. You may obtain free copies of these documents using the sources indicated above.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

Exhibit

No.

Description

2.1*

Merger Agreement, dated as of April 13, 2026, by and among Somnigroup International Inc., Sparrow Unity Corporation and Leggett & Platt, Incorporated.

99.1

Joint Press Release, dated as of April 13, 2026

99.2

Joint Investor Presentation, dated as of April 13, 2026

104

Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish supplemental copies of any of the omitted schedules and exhibits upon request by the SEC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEGGETT & PLATT, INCORPORATED

Date: April 13, 2026

By:

/s/ Jennifer J. Davis

Name:

Jennifer J. Davis

Title:

Executive Vice President – General Counsel

EX-2.1

Filename: d38467dex21.htm · Sequence: 2

EX-2.1

Exhibit 2.1

Execution Version

AGREEMENT AND PLAN OF MERGER

AND AMONG

SOMNIGROUP INTERNATIONAL INC.,

SPARROW UNITY CORPORATION,

AND

LEGGETT & PLATT, INCORPORATED

DATED AS OF APRIL 13, 2026

TABLE OF CONTENTS

Page

ARTICLE 1

THE MERGER

1.1

The Merger

1.2

Closing and Effective Time of the Merger

ARTICLE 2

CONVERSION OF SECURITIES IN THE MERGER

2.1

Conversion of Securities

2.2

Payment for Securities; Surrender of Certificates

2.3

Dissenting Shares

2.4

Distributions with Respect to Unexchanged Shares

2.5

Fractional Shares

2.6

Further Assurances

2.7

Treatment of Company Equity Awards

2.8

Withholding Rights

2.9

Tax Treatment

2.10

FIRPTA Certificate

ARTICLE 3

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

3.1

Organization and Qualification; Subsidiaries

3.2

Capitalization

3.3

Authority

3.4

No Conflict

3.5

Required Filings and Consents

3.6

Compliance With Law

3.7

SEC Filings; Financial Statements

3.8

Absence of Certain Changes or Events

3.9

Employee Benefit Plans

3.10

Labor and Other Employment Matters

3.11

Contracts

3.12

Customers and Suppliers

3.13

Permits

3.14

Litigation

3.15

Environmental Matters

3.16

Intellectual Property

3.17

Data Privacy and Security

3.18

Tax Matters

3.19

Real Property; Title to Assets

3.20

Anti-Corruption

3.21

International Trade

3.22

Opinion of Financial Advisor

3.23

Information Supplied

3.24

State Takeover Statutes

3.25

Related Party Transactions

3.26

Insurance

3.27

Brokers

3.28

Joint Ventures

3.29

No Other Representations or Warranties

ARTICLE 4

REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

4.1

Organization and Qualification; Subsidiaries

4.2

Capitalization

4.3

Authority

4.4

No Conflict

4.5

Required Filings and Consents

4.6

Compliance With Law

4.7

SEC Filings; Financial Statements

4.8

Absence of Certain Changes or Events

4.9

Litigation

4.10

Information Supplied

4.11

State Takeover Statutes

4.12

Adequacy of Funds

4.13

Intended Tax Treatment

4.14

Brokers

4.15

No Other Representations or Warranties

ARTICLE 5

CONDUCT OF THE PARTIES

5.1

Conduct of Business by the Company Pending the Closing

5.2

Conduct of Business by Parent Pending the Closing

ARTICLE 6

ADDITIONAL COVENANTS OF THE PARTIES

6.1

Proxy Statement/Prospectus and Registration Statement; Company Shareholders Meeting

6.2

Access to Information; Confidentiality

6.3

Non-Solicitation

6.4

Appropriate Action; Consents; Filings

6.5

Stockholder Litigation

6.6

Public Announcements

6.7

Employee Benefit Matters

6.8

Indemnification of Directors and Officers

6.9

Section 16 Matters

6.10

Takeover Statutes

6.11

Existing Indebtedness

6.12

Dividends

6.13

Parent Written Consent

6.14

Certain Merger Sub Matters

6.15

Delisting and Deregistration

6.16

Stock Exchange Listing

6.17

Financing Cooperation

6.18

Resignation of Directors

ARTICLE 7

CONDITIONS TO CONSUMMATION OF THE MERGER

7.1

Conditions to Obligations of Each Party Under This Agreement

7.2

Additional Conditions to Obligations of the Parent Parties

7.3

Additional Conditions to Obligations of the Company

ARTICLE 8

TERMINATION, AMENDMENT AND WAIVER

8.1

Termination

8.2

Effect of Termination

8.3

Company Termination Fee

8.4

Parent Termination Fee

ARTICLE 9

GENERAL PROVISIONS

9.1

Non-Survival of Representations and Warranties

9.2

Fees and Expenses

9.3

Notices

9.4

Certain Definitions

9.5

Terms Defined Elsewhere

9.6

Headings

9.7

Entire Agreement

9.8

Assignment

9.9

Severability

100

9.10

No Third Party Beneficiaries

100

9.11

Mutual Drafting; Interpretation

100

9.12

Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury

101

9.13

Counterparts

102

9.14

Specific Performance

103

9.15

Modification or Amendment

103

9.16

Extension; Waiver

104

iii

Exhibit A

Form of Articles of Merger

Exhibit B-1

Form of Parent Parties Tax Representation Letter

Exhibit B-2

Form of Company Tax Representation Letter

Exhibit B-3

Alternative Form of Parent Parties Tax Representation Letter

Exhibit B-4

Alternative Form of Company Tax Representation Letter

AGREEMENT AND PLAN OF MERGER

This AGREEMENT AND PLAN OF MERGER, dated as of April 13, 2026 (this “Agreement”), is by and among Somnigroup

International Inc., a Delaware corporation (“Parent”), Sparrow Unity Corporation, a Missouri corporation and a direct, wholly owned Subsidiary of Parent (“Merger Sub” and together with Parent, the

“Parent Parties”), and Leggett & Platt, Incorporated, a Missouri corporation (the “Company”). All capitalized terms used in this Agreement shall have the meanings assigned to such terms in

Section 9.4 or as otherwise defined elsewhere in this Agreement unless the context clearly indicates otherwise.

RECITALS

A. The parties

intend that, on the terms and subject to the conditions set forth in this Agreement, Merger Sub be merged with and into the Company (the “Merger”), with the Company continuing as the surviving corporation in the Merger (the

“Surviving Corporation”) and as a direct, wholly owned Subsidiary of Parent in accordance with the applicable provisions of the General and Business Corporation Law of Missouri, as amended (the “GBCLM”);

B. In connection with the Merger, on the terms and subject to the conditions set forth in this Agreement, each share of common stock, par

value $0.01 per share, of the Company (“Company Common Stock”) issued and outstanding immediately prior to the Effective Time (other than any Company Cancelled Shares and Dissenting Shares) shall be converted automatically into

the right to receive the Merger Consideration;

C. The Board of Directors of the Company (the “Company Board”) has

unanimously, upon the terms and subject to the conditions set forth herein, (i) determined that the transactions contemplated by this Agreement, including the Merger, are advisable, fair to and in the best interests of the Company and its

shareholders, (ii) approved, adopted and declared advisable this Agreement and the transactions contemplated hereby, including the Merger, in accordance with the GBCLM, (iii) directed that this Agreement be submitted to the Company’s

shareholders for their adoption, and (iv) determined to recommend that the Company’s shareholders adopt and approve this Agreement and approve the Merger (collectively, the “Company Board Recommendation”);

D. The Board of Directors of Merger Sub has, upon the terms and subject to the conditions set forth herein, (i) determined that the

transactions contemplated by this Agreement, including the Merger, are advisable, fair to and in the best interests of Merger Sub and its sole stockholder, (ii) approved, adopted and declared advisable this Agreement and the transactions

contemplated hereby, (iii) directed that this Agreement be submitted for consideration by Merger Sub’s sole stockholder, and (iv) determined to recommend that the sole stockholder of Merger Sub adopt and approve this Agreement and

approve the Merger;

E. The Board of Directors of Parent (the “Parent Board”) has unanimously, upon the terms and

subject to the conditions set forth herein, (i) determined that the transactions contemplated by this Agreement, including the Merger, are advisable, fair to and in the best interests of Parent and its stockholders, and (ii) approved,

adopted and declared advisable this Agreement and the transactions contemplated hereby, including the Merger;

F. Concurrently with the execution and delivery of this Agreement, Parent and the Company

are entering into the Supply Agreement Amendment; and

G. For U.S. federal income tax purposes, the Company, Parent and Merger Sub intend

that (i) the Merger will qualify as a “reorganization” within the meaning of Section 368(a) of the Code and (ii) this Agreement will constitute a “plan of reorganization” within the meaning of Sections 1.368-2(g) and 1.368-3(a) of the Treasury Regulations with respect to the Merger.

AGREEMENT

NOW,

THEREFORE, in consideration of the foregoing, and the covenants, premises, representations and warranties and agreements contained in this Agreement and for other good and valuable consideration, the receipt and adequacy of which are hereby

acknowledged, and intending to be legally bound, the parties agree as follows:

Article 1

THE MERGER

1.1 The

Merger. Upon the terms and subject to the satisfaction or waiver of the conditions set forth in this Agreement and in accordance with the applicable provisions of the GBCLM:

(a) At the Effective Time, Merger Sub shall merge with and into the Company, the separate corporate existence of Merger Sub shall cease, and

the Company shall continue as the Surviving Corporation. As a result of the Merger, the Surviving Corporation shall become a direct wholly owned Subsidiary of Parent. The Merger shall have the effects set forth in this Agreement and the applicable

provisions of the GBCLM. Without limiting the generality of the foregoing, from and after the Effective Time, all of the property, rights, privileges, immunities, powers and franchises of the Company and Merger Sub shall vest in the Surviving

Corporation, and all of the debts, liabilities and duties of the Company and Merger Sub shall become the debts, liabilities and duties of the Surviving Corporation.

(b) In connection with the Merger and prior to the Effective Time, Parent shall take all corporate action necessary to authorize and reserve

for issuance a sufficient number of shares of common stock, par value $0.01 per share, of Parent (“Parent Common Stock”) to permit the issuance of shares of Parent Common Stock to the holders of shares of Company Common Stock as

of the Effective Time, subject to and in accordance with the terms of this Agreement.

and without any action by the Company, Parent, Merger Sub or any other Person, the articles of incorporation and the bylaws of the Surviving Corporation shall be amended to be identical to the articles of incorporation and bylaws of Merger Sub

(except that the name of the Surviving Corporation shall not be changed), as in effect immediately prior to the Effective Time.

(d) The directors of Merger Sub serving in such positions immediately prior to the

Effective Time shall become, as of the Effective Time, the directors of the Surviving Corporation, each to hold office in accordance with the articles of incorporation and bylaws of the Surviving Corporation until their respective successors have

been duly elected, designated or qualified, or until their earlier death, resignation or removal in accordance with the articles of incorporation and bylaws of the Surviving Corporation. The officers of the Company serving in such positions

immediately prior to the Effective Time shall become, effective as of the Effective Time, the officers of the Surviving Corporation, each until their respective successors have been duly elected, designated or qualified, or until their earlier

death, resignation or removal in accordance with the articles of incorporation and bylaws of the Surviving Corporation.

1.2 Closing

and Effective Time of the Merger.

(a) The closing of the Merger (the “Closing”) shall

take place remotely by electronic exchange of executed documents at 9:00 a.m., Eastern Time, as soon as practicable (and, in any event, within three (3) Business Days) after satisfaction or, to the extent permitted hereunder, waiver of all of

the applicable conditions set forth in Article 7 (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the fulfillment or waiver of those conditions at the Closing), or at such other time and

place as the parties shall agree in writing. The date and time at which the Closing occurs is referred to herein as the “Closing Date”.

(b) On the Closing Date, Parent, Merger Sub and the Company shall cause the articles of merger in the form attached hereto as Exhibit

A (subject to such changes as may be mutually agreed to by Parent and the Company, the “Articles of Merger”) to be executed and filed with the Missouri Secretary of State in accordance with the relevant provisions of the GBCLM

and shall make all other filings or recordings required under the GBCLM. The Merger shall become effective at the time the Articles of Merger have been duly filed with the Missouri Secretary of State, or at such later date and time as is agreed upon

by the parties and specified in the Articles of Merger in accordance with the GBCLM (such time as the Merger becomes effective, the “Effective Time”).

Article 2

CONVERSION OF

SECURITIES IN THE MERGER

2.1 Conversion of Securities.

(a) At the Effective Time, by virtue of the Merger and without any action on the part of the Company, Parent, Merger Sub or the holders of

any capital stock of the Company, Parent, or Merger Sub:

(i) Subject to Sections 2.1(b) (Adjustments), 2.2

(Payment for Securities, Surrender of Certificates) and 2.5 (Fractional Shares), each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than Company Cancelled Shares and

Dissenting Shares) shall be automatically converted into the right to receive a number of fully paid and nonassessable shares of Parent Common Stock equal to the Exchange Ratio (the total amount of shares of Parent Common Stock to be issued in the

Merger with respect to each such share of Company Common Stock, the “Merger Consideration”).

(ii) All shares of Company Common Stock (other than any Company Cancelled Shares and

Dissenting Shares) shall cease to be outstanding and shall be automatically cancelled and shall cease to exist and, as of the Effective Time, each holder of record of shares of Company Common Stock shall cease to have any rights with respect

thereto, except the right to receive the Merger Consideration in accordance with Section 2.1(a)(i) and Section 2.2, plus any Fractional Shares Cash Amount to which such holder is entitled in

accordance with Section 2.5.

(iii) All shares of Company Common Stock held, directly or indirectly, by

(x) the Company (as treasury shares or otherwise), (y) any Company Subsidiary or (z) Parent or any Parent Subsidiary, in each case, immediately prior to the Effective Time (collectively, the “Company Cancelled Shares”),

shall be automatically cancelled and shall cease to exist, and no consideration or payment shall be owed or delivered in exchange therefor.

(iv) Each share of common stock, par value $0.001 per share, of Merger Sub issued and outstanding immediately prior to the Effective Time

shall be automatically converted into one fully paid and nonassessable share of common stock of the Surviving Corporation and shall constitute the only outstanding shares of capital stock of the Surviving Corporation.

(b) If, at any time during the period between the date of this Agreement and the Effective Time, Parent or the Company should split, reverse

split, subdivide, consolidate, combine or otherwise reclassify the Parent Common Stock or the Company Common Stock, as applicable, or pay a stock dividend or other stock distribution (with a record date during such period) in the Parent Common Stock

or the Company Common Stock, as applicable, or otherwise change the Parent Common Stock or the Company Common Stock, as applicable, into any other securities, or make any other such stock dividend or stock distribution (with a record date during

such period) in capital stock of Parent or the Company in respect of the Parent Common Stock or the Company Common Stock, as applicable, then any number or amount contained herein which is based upon the price or the number or fraction of shares of

Parent Common Stock or Company Common Stock, as applicable, including the Exchange Ratio, shall be equitably adjusted to provide to Parent, Merger Sub and the holders of shares of Company Common Stock or Company Equity Awards the same economic

effect as contemplated by this Agreement prior to such split, combination, stock dividend or other stock distribution or change; provided that nothing in this Section 2.1(b) shall be construed to permit Parent or the

Company to take any action with respect to its securities that is prohibited by the terms of this Agreement.

2.2 Payment for

Securities; Surrender of Certificates.

(a) Exchange Agent. At or prior to the Effective Time, Parent shall designate a

reputable bank or trust company to act as the exchange agent (the identity and terms of designation and appointment of which shall be reasonably acceptable to the Company) for purposes of effecting the payment of the aggregate Merger Consideration

in connection with the Merger (the “Exchange Agent”). At the Effective Time, Parent shall deposit, or cause to be deposited, with the Exchange Agent an amount of uncertificated, book-entry shares representing the number of shares

of Parent Common Stock sufficient to deliver the aggregate Merger Consideration, in each case, to which holders of Company Common Stock shall be entitled at the Effective Time pursuant to Section 2.1(a)(i) and

Section 2.5, as applicable. The Exchange Agent shall not be entitled to vote or exercise any rights of ownership with respect to the Parent Common

Stock held by it from time to time hereunder. Following the Effective Time, Parent shall pay, or shall cause to be paid to the Exchange Agent, from time to time, as needed, cash sufficient to pay

the aggregate dividends and other distributions, if any, pursuant to Section 2.4. In the event such deposited funds or shares are insufficient to make the payments contemplated pursuant to

Section 2.1(a)(i) and Section 2.4, as applicable, Parent shall promptly deposit, or cause to be deposited, with the Exchange Agent such additional funds or shares, as applicable, to ensure that the

Exchange Agent has sufficient funds or shares, as applicable, to make such payments. Earnings from any investment by the Exchange Agent (to be made solely at Parent’s direction) of the cash deposited by Parent with the Exchange Agent shall be

the sole and exclusive property of Parent. No part of such earnings shall accrue to the benefit of holders of Company Common Stock and no losses shall alter Parent’s obligation to cause the Exchange Agent to pay the aggregate Merger

Consideration and the Fractional Shares Cash Amount in accordance with Section 2.2(b).

(b) Procedures for

Surrender; Treatment of Certificates and Book Entry Shares.

(i) Company Certificated Shares. As soon as practicable after the

Effective Time (and in no event later than five (5) Business Days after the Effective Time), Parent shall instruct the Exchange Agent to mail to each Person that was a holder of record of shares of Company Common Stock represented by a

certificate (if any) (“Company Certificated Shares”) immediately prior to the Effective Time, which shares of Company Common Stock are entitled to the Merger Consideration: (A) a letter of transmittal, which shall specify

that delivery shall be effected, and risk of loss and title to the Company Certificated Shares shall pass, only upon delivery of the Company Certificated Shares to the Exchange Agent, and shall otherwise be in such form as Parent, the Company and

the Exchange Agent shall reasonably agree prior to the Closing Date; and (B) instructions for effecting the surrender of the Company Certificated Shares (or affidavits of loss in lieu of the Company Certificated Shares as provided in

Section 2.2(e)) in exchange for payment of the Merger Consideration and any Fractional Shares Cash Amount that such holder is entitled to receive pursuant to Section 2.1(a)(i) and

Section 2.5. Upon surrender of any Company Certificated Shares (or affidavit of loss in lieu of the Company Certificated Shares as provided in Section 2.2(e)) to the Exchange Agent or to such other

agent or agents as may be appointed by Parent, and upon delivery of a letter of transmittal, duly executed and in proper form, with respect to such Company Certificated Shares, the holder of such Company Certificated Shares shall be entitled to

receive, and Parent shall instruct the Exchange Agent to pay and deliver, as promptly as practicable after such surrender, (I) in the case of the Merger Consideration, credit in the stock ledger and other appropriate books and records of

Parent, for the number of shares of Parent Common Stock into which such Company Certificated Shares have been converted pursuant to Section 2.1(a)(i) and (II) in the case of any Fractional Shares Cash Amount, a cash

payment in the amount of any Fractional Shares Cash Amount that such holder has the right to receive pursuant to Section 2.5, as applicable, together with any dividends or other distributions to which the holder of such

Company Certificated Shares becomes entitled, if any, with respect to such Company Certificated Shares, in accordance with Section 2.4, and any Company Certificated Shares so surrendered shall forthwith be cancelled. If

payment of the Merger Consideration or any Fractional Shares Cash Amount is to be made to a Person other than the Person in whose name any surrendered Company Certificated Shares are registered, it shall be a condition precedent of payment that the

Company Certificated Shares so surrendered shall be properly endorsed or shall be otherwise in proper form for transfer as determined by Parent, and the Person requesting such

payment shall have paid (or caused to be paid) any transfer and other similar Taxes required by reason of the payment of the Merger Consideration and any Fractional Shares Cash Amount to a Person

other than the registered holder of the Company Certificated Shares so surrendered and shall have established to the satisfaction of the Surviving Corporation and Parent that such Taxes either have been paid or are not required to be paid. No

interest will be paid or accrued on any amount payable upon due surrender of the Company Certificated Shares. Until surrendered as contemplated hereby, each Company Certificated Share shall be deemed at any time after the Effective Time to represent

only the right to receive the Merger Consideration and the Fractional Shares Cash Amount as contemplated by this Agreement, except for Company Certificated Shares representing Dissenting Shares or Company Cancelled Shares.

(ii) Company Book-Entry Shares. Notwithstanding anything to the contrary contained in this Agreement, no holder of shares of Company

Common Stock held in book-entry form (“Company Book-Entry Shares”) shall be required to deliver a certificate evidencing such Company Book-Entry Shares or, in the case of holders of Company Book-Entry Shares held through The

Depository Trust Company, an executed letter of transmittal, to the Exchange Agent, to receive the Merger Consideration and any Fractional Shares Cash Amount that such holder is entitled to receive pursuant to

Section 2.1(a)(i) and Section 2.5. In lieu thereof, each holder of record of one or more Company Book-Entry Shares held through The Depository Trust Company, whose shares of Company Common Stock

were converted into the right to receive the Merger Consideration and any Fractional Shares Cash Amount shall automatically, upon the Effective Time, be entitled to receive, and Parent shall instruct the Exchange Agent to pay and deliver as promptly

as practicable after the Effective Time, (A) in the case of the Merger Consideration, credit in the stock ledger and other appropriate books and records of Parent for the number of shares of Parent Common Stock into which such Company

Book-Entry Shares have been converted pursuant to Section 2.1(a)(i) and (B) in the case of the Fractional Shares Cash Amount, a cash payment in the amount of any Fractional Shares Cash Amount that such holder has the

right to receive pursuant to Section 2.5, as applicable, together with any dividends or other distributions, to which the holder of such Company Book-Entry Shares becomes entitled, if any, with respect to such Company

Book-Entry Shares in accordance with Section 2.4, and any Company Book-Entry Shares shall forthwith be cancelled. As soon as practicable after the Effective Time (and in no event later than five (5) Business Days after

the Effective Time), Parent shall instruct the Exchange Agent to mail to each Person that was, immediately prior to the Effective Time, a holder of record of Company Book-Entry Shares not held through The Depository Trust Company: (I) a letter

of transmittal, which shall be in such form as Parent, the Company and the Exchange Agent shall reasonably agree; and (II) instructions for returning such letter of transmittal in exchange for the Merger Consideration and the Fractional Shares

Cash Amount. Upon delivery of such letter of transmittal, duly executed and in proper form, with respect to such Company Book-Entry Shares, the holder of such Company Book-Entry Shares shall be entitled to receive, and Parent shall instruct the

Exchange Agent to pay and deliver as promptly as practicable after such delivery, (A) in the case of the Merger Consideration, credit in the stock ledger and other appropriate books and records of Parent for the number of shares of Parent

Common Stock into which such Company Book-Entry Shares have been converted pursuant to Section 2.1(a)(i) and (B) in the case of the Fractional Shares Cash Amount, a cash payment in the amount of any Fractional Shares

Cash Amount that such holder has the right to receive pursuant to Section 2.5, as applicable, together with any dividends or other distributions, if any, to which such holder of Company Book-Entry Shares becomes entitled,

if any, with respect to such

Company Book-Entry Shares in accordance with Section 2.4, and any Company Book-Entry Shares shall forthwith be cancelled. Payment of the Merger Consideration and the

Fractional Shares Cash Amount with respect to Company Book-Entry Shares, shall only be made to the Person in whose name such Company Book-Entry Shares are registered. No interest will be paid or accrued on any amount payable upon due surrender of

Company Book-Entry Shares. Until paid or surrendered as contemplated hereby, each Company Book-Entry Share shall be deemed at any time after the Effective Time to represent only the right to receive the Merger Consideration and the Fractional Shares

Cash Amount, in each case, as contemplated by this Agreement, except for Company Book-Entry Shares representing Dissenting Shares or Company Cancelled Shares.

(c) Transfer Books; No Further Ownership Rights in Shares. The shares of Parent Common Stock issued upon conversion of shares

of Company Common Stock pursuant to and in accordance with Section 2.1(a)(i) and Section 2.2, together with any Fractional Shares Cash Amount paid in accordance with

Section 2.5 and any dividends or other distributions paid, if any, in accordance with Section 2.4, shall be deemed to have been delivered in full satisfaction of all rights pertaining to such

shares of Company Common Stock. From and after the Effective Time, (i) all holders of Company Common Stock as of immediately prior to the Effective Time shall cease to have any rights as shareholders of the Company other than the right to

receive the Merger Consideration into which such shares of Company Common Stock have been converted pursuant to Section 2.1(a)(i) (together with any dividends or other distributions to which the former holders of such

shares of Company Common Stock become entitled, if any, in accordance with Section 2.4) and the Fractional Shares Cash Amount to which such holders are entitled to receive in accordance with

Section 2.5, and (ii) the stock transfer books of the Company shall be closed and there shall be no further registration of transfers of shares of Company Common Stock thereafter on the records of the Company.

(d) Termination of Fund; Abandoned Property; No Liability. Any portion of the funds (including any interest or earnings received with

respect thereto) made available to the Exchange Agent that remains unclaimed by the holders of Company Common Stock on the first anniversary of the Effective Time shall be returned to Parent upon demand, and any such holder of Company Common Stock

who has not complied with Section 2.2(b) prior to such time shall thereafter look only to Parent (subject to abandoned property, escheat or other similar Laws) for delivery of the Merger Consideration and any Fractional

Shares Cash Amount and any dividends or other distributions, if any, to which such holders are entitled in accordance with Section 2.4 in respect of such holder’s shares of Company Common Stock. Any Merger

Consideration or Fractional Shares Cash Amount remaining unclaimed by the holders of Company Common Stock immediately prior to such time as such amounts would otherwise escheat to, or become property of, any Governmental Entity shall, to the extent

permitted by applicable Law, become the property of Parent, free and clear of any claim or interest of any Person previously entitled thereto immediately prior to such time on which any payment in respect hereof would escheat to or become the

property of any Governmental Entity pursuant to any applicable abandoned property, escheat or similar Laws. Notwithstanding the foregoing, none of Parent, the Company, the Exchange Agent, or their respective affiliates or any other Person will be

liable to any holder of Company Common Stock for Merger Consideration (or any dividends or other distributions, if any, payable or issuable in connection therewith in accordance with Section 2.4) or any Fractional Shares

Cash Amount delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law.

(e) Lost, Stolen or Destroyed Certificates. In the event that any Company

Certificated Shares shall have been lost, stolen or destroyed, the Exchange Agent shall issue in exchange for such lost, stolen or destroyed Company Certificated Shares, upon the making of an affidavit, in customary form reasonably acceptable to

Parent, of that fact by the holder thereof, the Merger Consideration payable in respect thereof pursuant to Section 2.1(a)(i) (together with any dividends or other distributions to which such holder is entitled, if any, in

accordance with Section 2.4) and any Fractional Shares Cash Amount to which the holder is entitled pursuant to Section 2.5; provided, that Parent may, in its reasonable discretion and as a

condition precedent to the payment of such Merger Consideration (and any dividends or other distributions payable or issuable in connection therewith, if any, in accordance with Section 2.4) or any Fractional Shares Cash

Amount to which the holder is entitled pursuant to Section 2.5, require the owner of such lost, stolen or destroyed Company Certificated Shares to deliver a bond in a reasonable sum as it may reasonably direct as indemnity

against any claim that may be made against Parent, the Surviving Corporation or the Exchange Agent with respect to the Company Certificated Shares alleged to have been lost, stolen or destroyed.

2.3 Dissenting Shares. Notwithstanding anything in this Agreement to the contrary, any shares of Company Common Stock

outstanding immediately prior to the Effective Time and held by a shareholder who has not voted in favor of the Merger or consented thereto in writing and who is entitled to demand, and who properly demands payment of the fair value of such shares

(“Dissenting Shares”), pursuant to, and who otherwise complies in all respects with the provisions of Section 351.455 of the GBCLM shall not be converted into the right to receive the Merger Consideration, unless and until

such holder fails to perfect or effectively withdraws or loses the right to appraisal under the GBCLM. If, after the Effective Time, any such holder fails to perfect, withdraws or loses such right to appraisal, such holder’s shares shall be

treated as if they had been converted as of the Effective Time into a right to receive the Merger Consideration in accordance with Section 2.1(a)(i) without any interest thereon, and will no longer be a Dissenting Share.

The Company shall give Parent prompt notice of any demands for appraisal for any Dissenting Share, any attempted withdrawals of such demands and any other notice given or instrument served relating to the exercise of dissenters’ rights granted

under the GBCLM. Parent shall have the right to participate in all negotiations and proceedings relating thereto, except as otherwise required by applicable Law. The parties agree that the Company shall be responsible to pay solely out of its own

funds any obligations with respect to appraisal demands; provided, however, that the Company shall not make any payment with respect to, or settle or offer to settle, any appraisal demands without Parent’s prior written consent

in its sole discretion and the parties acknowledge and agree that any such settlement shall be paid from the funds of the Company.

2.4

Distributions with Respect to Unexchanged Shares. No dividends or other distributions declared or made with respect to shares of Parent Common Stock with a record date after the Effective Time shall be paid to the holder of any Company Common

Stock converted into the right to receive the Merger Consideration pursuant to Section 2.1(a)(i) until such holder shall have complied with the provisions of Section 2.2(b). Subject to escheat, Tax

or other applicable Law, following the surrender of any such Company Common Stock in accordance with Section 2.2(b), such holder shall be entitled to receive any such dividends or distributions, without interest, with a

record date after the Effective Time which theretofore had become payable with respect to the Parent Common Stock exchangeable for such Company Common Stock pursuant to Section 2.1(a)(i) (after giving effect to any required

Tax withholdings as provided in Section 2.8).

2.5 Fractional Shares. Notwithstanding anything in this Agreement to the contrary, no

fractional shares of Parent Common Stock shall be issued upon the conversion of shares of Company Common Stock pursuant to Section 2.1(a)(i) or in exchange for Company Certificated Shares or Company Book-Entry Shares or

otherwise, and such fractional share interests shall not entitle the owner thereof to vote or to any other rights of a stockholder of Parent. As promptly as practicable following the Effective Time, the Exchange Agent shall determine the excess of

(i) the number of whole shares of Parent Common Stock delivered to the Exchange Agent by Parent for issuance to holders of Company Certificated Shares or Book-Entry Shares over (ii) the aggregate number of whole shares of Parent Common

Stock to be distributed to holders of Company Certificated Shares or Book-Entry Shares (such excess being herein referred to as the “Excess Shares”). As promptly as practicable after the Effective Time, the Exchange Agent, as

agent for such holders of Company Certificated Shares or Book-Entry Shares, shall sell the Excess Shares at then prevailing prices on the NYSE, all in the manner provided herein. The sale of the Excess Shares by the Exchange Agent shall be executed

on the NYSE and shall be executed in round lots to the extent practicable. Until the proceeds of any such sale or sales have been distributed to the holders of Company Certificated Shares or Book-Entry Shares, the Exchange Agent shall hold such

proceeds in trust for such holders. The Exchange Agent shall determine the portion of such proceeds to which each holder of Company Certificated Shares or Book-Entry Shares shall be entitled, if any, by multiplying the amount of the aggregate

proceeds by a fraction, the numerator of which is the amount of the fractional share interest to which such holder of Company Certificated Shares or Book-Entry Shares is entitled (after taking into account all Company Certificated Shares or

Book-Entry Shares then held by such holder) and the denominator of which is the aggregate amount of fractional share interests to which all holders of Company Certificated Shares or Book-Entry Shares are entitled (such cash amount with respect to

each such holder, the “Fractional Shares Cash Amount”). As soon as practicable after the determination of the amount of the Fractional Shares Cash Amount, if any, to be paid to holders of Company Certificated Shares or Book-Entry

Shares with respect to any fractional share interests, the Exchange Agent shall promptly pay the Fractional Shares Cash Amount due to each such holder subject to and in accordance with this Section 2.5. The parties agree

that the payment of the Fractional Shares Cash Amount in lieu of fractional share interests pursuant to this Section 2.5 is not separately bargained-for consideration but merely

represents a mechanical rounding off for purposes of avoiding the expense and inconvenience to Parent that would otherwise be caused by the issuance of fractional shares of Parent Common Stock.

2.6 Further Assurances. From and after the Effective Time, the respective officers of Parent and the Surviving Corporation, as

applicable, shall be authorized to execute and deliver, in the name and on behalf of the Company or any Parent Party, any deeds, bills of sale, assignments or assurances and to take and do, in the name and on behalf of the Company or any Parent

Party, any other actions and things to vest, perfect or confirm of record or otherwise in the Surviving Corporation any and all right, title and interest in, to and under any of the rights, properties or assets acquired or to be acquired by the

Surviving Corporation, as applicable, as a result of, or in connection with, the Merger.

2.7 Treatment of Company Equity Awards.

(a) Treatment of Company Options. As of the Effective Time, by virtue of the Merger and without any action on the part of the Company,

Parent, Merger Sub or the holders thereof, each Company Option that is outstanding and unexercised immediately prior to the Effective Time, whether or not then vested or exercisable, shall be assumed by Parent and shall be converted into an option

to acquire shares of Parent Common Stock or the cash equivalent thereof in accordance with this Section 2.7(a). Each such Company Option as so assumed and converted (after such conversion, an “Assumed

Option”) shall continue to have, and shall be subject to, the same terms and conditions as applied to the Company Option immediately prior to the Effective Time (which, for the avoidance of doubt, includes any forfeiture terms and

exercisability terms applicable to such Company Option) except that, as of the Effective Time, (i) each such Assumed Option shall constitute an option to acquire that number of whole shares of Parent Common Stock (rounded down to the nearest

whole share) equal to the product of (A) the number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time multiplied by (B) the Exchange Ratio, at an exercise price per share of Parent

Common Stock (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (I) the exercise price per share of Company Common Stock of such Company Option by (II) the Exchange Ratio and (ii) with respect to an

Assumed Option that is held by an individual who is not employed by or in service with the Company or a Company Subsidiary immediately prior to the Effective Time, such Company Option shall be exercisable solely in cash (and not shares of Parent

Common Stock), with the amount of cash payable upon exercise of such Company Option calculated by reference to the closing price of the shares of Parent Common Stock that would otherwise be issued on the applicable exercise date, minus the exercise

price. Notwithstanding the generality of the foregoing, the exercise price and number of shares of Parent Common Stock subject to an Assumed Option shall be determined in a manner consistent with the requirements of Section 409A of the Code

and, with respect to an Assumed Option converted from a Company Option that is intended to qualify as an incentive stock option within the meaning of Section 422 of the Code, consistent with the requirements of Section 422 of the Code.

(b) Treatment of Company RSU Awards. As of the Effective Time, by virtue of the Merger and without any action on the part of the

Company, Parent, Merger Sub or holders thereof, each Company RSU Award that is outstanding immediately prior to the Effective Time, other than a Company RSU Award issued pursuant to a Deferred Compensation Plan, shall be assumed by Parent and shall

be converted into a restricted stock unit award to receive shares of Parent Common Stock or the cash equivalent thereof (an “Assumed RSU Award”) in accordance with this Section 2.7(b). Each such Assumed

RSU Award shall continue to have, and shall be subject to, the same terms and conditions as applied to the Company RSU Award immediately prior to the Effective Time (which, for the avoidance of doubt, includes any accelerated vesting protections,

forfeiture terms, settlement terms (including cash settlement) and terms relating to dividend equivalent rights applicable to such Company RSU Award) except that, as of the Effective Time, (i) each such Assumed RSU Award shall constitute the

right to receive that number of whole shares of Parent Common Stock (rounded up or down to the nearest whole share) equal to the product of (A) the number of shares of Company Common Stock subject to such Company RSU Award immediately prior to

the Effective Time multiplied by (B) the Exchange Ratio and (ii) with respect to an Assumed RSU Award held by an individual who is not employed by or in service with the Company or a Company Subsidiary immediately prior to the Effective

Time, such Assumed RSU Award shall be settled solely in cash (rather than shares of Parent Common Stock), in an amount calculated based on the closing price of the shares of Parent Common Stock that would otherwise be issued on the applicable

settlement date.

(i) As of the Effective Time, by virtue of the Merger and without any action on the part of the Company, Parent, Merger Sub or holders

thereof, each Company PSU Award for which the performance periods have not yet ended as of the Effective Time that is outstanding immediately prior to the Effective Time shall be assumed by Parent and shall be converted into a restricted stock unit

award to receive shares of Parent Common Stock or the cash equivalent thereof (an “Assumed PSU Award”) in accordance with this Section 2.7(c). Each such Assumed PSU Award shall continue to have, and shall

be subject to, the same terms and conditions as applied to the Company PSU Award immediately prior to the Effective Time (which, for the avoidance of doubt, includes any accelerated vesting protections, forfeiture terms and settlement terms

(including cash settlement) and terms relating to dividend equivalent rights applicable to such Company PSU Award, but does not include any performance based vesting conditions, which shall be deemed achieved as of the Effective Time at maximum

performance levels) except that, as of the Effective Time, (A) each such Assumed PSU Award for which the performance periods have not yet ended as of the Effective Time shall constitute the right to receive that number of whole shares of Parent

Common Stock (rounded up or down to the nearest whole share) equal to the product of (I) 200% of the target number of shares of Company Common Stock subject to such Company PSU Award immediately prior to the Effective Time multiplied by

(II) the Exchange Ratio and (B) with respect to an Assumed PSU Award held by an individual who is not employed by or in service with the Company or a Company Subsidiary immediately prior to the Effective Time, such Assumed PSU Award shall

be settled solely in cash (rather than shares of Parent Common Stock), in an amount calculated based on the closing price of the shares of Parent Common Stock that would otherwise be issued on the applicable settlement date).

(ii) As of the Effective Time, by virtue of the Merger and without any action on the part of the Company, Parent, Merger Sub or holders

thereof, each Company PSU Award for which the performance periods have ended as of the Effective Time that is outstanding immediately prior to the Effective Time, shall constitute the right to receive (subject to any applicable withholding or other

Taxes, or other amounts required by applicable Law to be withheld, which shall be remitted by the Company) that number of whole shares of Parent Common Stock (rounded up or down to the nearest whole share) equal to the product of (i) the number

of shares of Company Common Stock subject to such Company PSU Award immediately prior to the Effective Time calculated based on actual performance multiplied by (ii) the Exchange Ratio. The Company shall, acting in good faith, determine the

level of actual performance achieved with respect to each Company PSU Award for which the applicable performance period has ended as of the Effective Time.

(d) Treatment of Company Restricted Shares. Immediately prior to the Effective Time and without any action on the part of the Company,

Parent, Merger Sub or holders thereof, any restrictions on any Company Restricted Shares shall lapse and such Company Restricted Shares shall fully vest (subject to any applicable withholding or other Taxes, or other amounts required by applicable

Law to be withheld, which shall be remitted by the Company). Each Company Restricted Share will thereafter be treated as shares of Company Common Stock in accordance with Section 2.1. Notwithstanding the foregoing and

subject to Section 2.7(f), the Merger Consideration payable pursuant to this Section 2.7(d) shall be made by Parent or the Exchange Agent as soon as commercially practicable following the Effective

Time.

(e) Company DSP. Prior to the Effective Time, the Company shall take all actions

with respect to the Company DSP that are necessary or desirable to (i) provide that (A) no new enrollment period will be commenced following the date of this Agreement under the Company DSP, (B) there will be no increase in the amount

of participants’ payroll deduction elections under the Company DSP or any contributions other than previously elected payroll deductions during the current enrollment period from those in effect as of the date of this Agreement, (C) no

individuals shall commence participation in the Company DSP during the period from the date of this Agreement through the Effective Time and (D) each participant election made pursuant to the Company DSP shall be fully exercised no later than

ten Business Days prior to the Effective Time (“Final Exercise Date”) (with any accumulated employee contributions as of the Final Exercise Date not used to purchase Company Common Stock in accordance with the terms and conditions

of the Company DSP refunded by the Company to such employee as promptly as practicable following the Final Exercise Date (without interest)), and (ii) terminate the Company DSP as of effective immediately prior to the Effective Time. The

Company shall provide timely notice to participants of the Company DSP of the setting of the Final Exercise Date and the termination of the Company DSP in accordance with the terms of the Company DSP. Shares of Company Common Stock purchased

pursuant to the foregoing shall be treated the same as all other shares of Company Common Stock in accordance with Section 2.1.

(f) Treatment of Deferred Compensation Plans; Section 409A. As of the Effective Time, by virtue of the Merger and

without any action on the part of the Company, Parent, Merger Sub or any participant in the Company’s 2005 Executive Stock Unit Program (the “ESUP”) or the Company’s Deferred Compensation Programs (together with the

ESUP, the “Deferred Compensation Plans”), each Company RSU Award issued pursuant to a Deferred Compensation Plan (representing notional investments in Company Common Stock in participant accounts under the Deferred Compensation

Plans) shall be converted into notional investments in cash based on a price per share of Company Common Stock equal to the average closing price per share of Company Common Stock for the five (5) trading days immediately prior to the Closing

Date, and such notional cash shall be deemed reinvested in one or more “Diversified Investments” (as defined in the ESUP, except references to the 401(k) Plan shall mean the 401(k) Plan of the Parent and references to the Investment

Committee shall mean the Parent Board (or a committee selected by the Parent Board)) as determined by the Parent Board (or a committee selected by the Parent Board), in accordance with the directions of affected participants in the Deferred

Compensation Plans communicated to Parent prior to the Effective Time, and such accounts shall be distributed to each participant pursuant to the participant’s applicable distribution election and the terms of the applicable Deferred

Compensation Plan, as in effect immediately prior to the Effective Time, in order to comply with Section 409A of the Code. Prior to the Effective Time, the Company shall, and shall cause each applicable Company Subsidiary, to take all necessary

action to implement the provisions of this Section 2.7(f). Parent shall assume all the obligations of the Company under the Deferred Compensation Plans. In addition, and notwithstanding anything to the contrary contained in

this Agreement, to the extent that any payment in respect of any Company Equity Award constitutes “nonqualified deferred compensation” subject to Section 409A of the Code, any payment contemplated hereby with respect to such award

shall be made on the applicable settlement date for such Company Equity Award in accordance with the applicable award’s terms to the extent required in order to comply with Section 409A of the Code.

(g) Company Equity Plan. The Company shall take all necessary action, to the extent

permissible under Section 409A of the Code, to settle, prior to the Effective Time, any Company RSU Award or Company PSU Award that is vested but not yet settled as of immediately prior to the Effective Time. At the Effective Time, parties

shall take all necessary action for the treatment of the Company Equity Awards as contemplated under this Section 2.7; provided, however, that no such action taken shall be required to be irrevocable until

immediately prior to the Effective Time. Parent shall assume all the obligations of the Company under the Company Equity Plan and each outstanding Company Option, Company RSU Award and Company PSU Award and the agreements evidencing the grants

thereof (as modified by this Section 2.7), and the number and kind of shares available for issuance under the Company Equity Plan shall be adjusted to reflect shares of Parent Common Stock in accordance with the provisions

of the Company Equity Plan. Parent shall reserve for future issuance a number of shares of Parent Common Stock at least equal to the number of shares of Company Common Stock that will be subject to Assumed Options, Assumed RSU Awards and Assumed PSU

Awards as a result of the actions contemplated by this Section 2.7. Not later than ten (10) Business Days following the Closing Date, Parent shall file one or more registration statements under the Securities Act on

Form S-8 or Form S-3 (or other applicable form) with respect to the Parent Common Stock subject to such Assumed Options, Assumed RSU Awards and Assumed PSU Awards and

shall, in each case, to the extent they are eligible to be registered on Form S-8 or Form S-3 (or other applicable form) and Parent shall use commercially reasonable

efforts to cause such registration statement or registration statements to become effective under the Securities Act and maintain the effectiveness of such registration statement or registration statements (and maintain the current status of the

prospectus or prospectuses contained therein) for so long as such Assumed Options, Assumed RSU Awards and Assumed PSU Awards remain outstanding.

2.8 Withholding Rights. Each of Parent, Merger Sub, the Surviving Corporation and the Exchange Agent shall be entitled to deduct

and withhold from any amounts otherwise payable pursuant to this Agreement, such amounts, if any, as are required to be deducted and withheld with respect to the making of such payment under the Code or any provision of applicable Law. Parent shall

be entitled to request any necessary Tax forms in order to effectuate such withholding, including Form W-9 or the appropriate series of Form W-8, as applicable, or any

similar information, from the payee. Parent shall use commercially reasonable efforts to notify the payee of its intention to deduct or withhold prior to any such deduction or withholding (other than in respect of any withholding arising as a result

of the Company’s failure to provide the certificate described in Section 2.10 or in respect of any amounts properly treated as compensation for applicable Tax purposes) and the parties shall cooperate in good faith

with each other to minimize any such deduction and withholding of any Taxes; provided that Parent shall not be required to delay such deduction or withholding to the extent that such delay is reasonably expected to cause Parent to be subject

to material audit, fines or penalties or create a materially increased risk of exposure to the foregoing. To the extent that amounts are so deducted and withheld and remitted by the deducting and withholding party to the applicable Governmental

Entity as required by applicable Law, such amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and withholding was made.

2.9 Tax Treatment.

(a) Each of Parent, Merger Sub and the Company intends that the Merger will qualify as a “reorganization” within the meaning of

Section 368(a) of the Code (the “Intended Tax Treatment”), and shall, and shall cause its respective affiliates to, use its reasonable best efforts to cause the Merger to so qualify and shall not take any action (or fail to

take any action), or cause or permit any action to be taken (or to be omitted), if such action, failure, or omission could be reasonably expected to prevent, preclude or impede either (i) the Merger from so qualifying or (ii) the tax

counsel for the Company (or, if such tax counsel is unable or unwilling to issue the Company Tax Opinion, another nationally recognized tax counsel reasonably acceptable to the Company and Parent, the “Company Tax Counsel”) from

providing the tax opinions issued in accordance with Section2.9(e). Each of the parties will notify the other parties promptly after becoming aware of any reason to believe that the Merger may not qualify as a

“reorganization” within the meaning of Section 368(a) of the Code.

(b) The parties adopt this Agreement as a

“plan of reorganization” within the meaning of Treasury Regulations Sections 1.368-2(g) and 1.368-3(a).

(c) None of the parties nor any of their affiliates shall take any position for U.S. federal income tax purposes (and applicable state, local

and non-U.S. Tax purposes) on any applicable Tax Return or in any applicable Tax contest or audit or in any communication (whether written or unwritten) with any applicable Governmental Entity inconsistent

with the Intended Tax Treatment unless required by a “determination” as defined in Section 1313 of the Code (or any similar provision of state, local or non-U.S. Law); provided, that

nothing in this Section 2.9(c) shall require a party to appeal such a determination.

(d) Each of the parties

shall use reasonable best efforts in connection with the issuance of the Company Tax Opinion at the Closing and any tax opinions in connection with the preparation, filing and delivery of the Proxy Statement/Prospectus or the Registration Statement

with respect to the qualification of the Merger for the Intended Tax Treatment. In connection with any such tax opinions, upon the request of Company Tax Counsel, or tax counsel for Parent (“Parent Tax Counsel”), as applicable,

officers of each Parent Party and the Company shall use their reasonable best efforts to deliver to Company Tax Counsel and Parent Tax Counsel, as applicable, duly executed certificates or letters (which, subject to

Section 2.9(e), shall be substantially in the form of Exhibit B-1 and Exhibit B-2), dated as of the necessary date for the

relevant tax opinions, signed by such officers of each Parent Party or the Company, as applicable, and containing customary assumptions, representations, warranties and covenants. If the tax counsel for the Company is unable or unwilling to issue

the Company Tax Opinion, the Company shall use its reasonable best efforts to engage another Company Tax Counsel that is able and willing to issue the Company Tax Opinion.

(e) Subject to Section 2.9(d), in the event that either Parent or

the Company determines that it is reasonably likely that the condition set forth in Section 7.3(e) (Company Tax Opinion) would not be satisfied at Closing, then, the parties shall, at the request of Parent or the

Company, use reasonable best efforts to amend the terms of this Agreement solely to consummate the transactions contemplated by this Agreement in a manner consistent with Revenue Ruling 2001-46, 2001-2 C.B. 321 in order to effect an integrated transaction within the meaning therein. In the event that the Agreement is amended in accordance with this Section 2.9(e), then upon the

request of Company Tax Counsel in connection with the Company Tax Opinion, officers of each Parent Party and the Company shall use their reasonable best efforts to deliver to Company Tax Counsel duly executed certificates or letters (which shall be

substantially in the form of Exhibit B-3 and Exhibit B-4), dated as of the Closing Date, signed by such officers of each Parent Party or the Company, as

applicable, and containing customary assumptions, representations, warranties and covenants.

(f) Any transfer, documentary, sales, use,

stamp, registration and other such Taxes, and all conveyance fees, recording charges and other fees and charges (including any penalties and interest) incurred in connection with consummation of the transactions contemplated by this Agreement

(“Transfer Taxes”), shall be borne by Parent; provided, that notwithstanding the foregoing, any Transfer Taxes for which holders of Company Stock or Company Equity Awards are solely liable under any provision of state Law

shall be borne by such holder.

2.10 FIRPTA Certificate. Prior to the Closing, the Company shall deliver to Parent a certification,

dated as of the Closing Date, that the shares of Company Stock are not United States real property interests as defined in Section 897(c) of the Code, together with a notice to the IRS, in accordance with Treasury Regulations under

Sections 897 and 1445 of the Code. If Parent does not receive the certification and notice described above, the sole recourse of Parent, Merger Sub, the Surviving Corporation and the Exchange Agent shall be to withhold from the payments to be

made pursuant to this Agreement any required withholding Tax under Section 1445 of the Code in accordance with Section 2.8.

Article 3

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

Except (a) as set forth in the disclosure schedule delivered by the Company to Parent (the “Company Disclosure

Schedule”) concurrent with the execution of this Agreement (with specific reference to the representations and warranties in this Article 3 to which the information in such schedule relates; provided, that, disclosure in the

Company Disclosure Schedule as to a specific representation or warranty shall qualify one or more other sections of this Agreement to the extent (notwithstanding the absence of a specific cross reference) it is reasonably apparent on its face that

such disclosure relates to such other sections); provided, further, that nothing in the Company Disclosure Schedule is intended to broaden the scope of any representation, warranty, covenant or agreement of the Company or any Company

Subsidiary made herein and no reference to or disclosure of any item or other matter in the Company Disclosure Schedule shall be construed as an admission or indication that (i) such item or other matter is material, (ii) such item or

other matter is required to be referred to in the Company Disclosure Schedule, (iii) any breach or violation of applicable Laws or any contract, agreement, arrangement or understanding to which Company or any Company Subsidiary is a party

exists or has actually occurred, or (iv) such item or other matter constitutes an admission to any third party, and no reference to or disclosure of any item or other matter in the Company Disclosure Schedule shall give rise to any claim or

benefit to any Person who is not a party to this Agreement, and (b)

as otherwise disclosed or identified in the Company SEC Documents filed, furnished, amended or supplemented at least two (2) Business Days prior to the date hereof (other than any

forward-looking disclosures contained in the “Forward Looking Statements” and “Risk Factors” sections of the Company SEC Documents and any other disclosures included in the Company SEC Documents to the extent they are

primarily predictive, cautionary or forward-looking in nature, but including any historical or factual matters disclosed in such sections), the Company hereby represents and warrants to Parent and Merger Sub as follows:

3.1 Organization and Qualification; Subsidiaries.

(a) The Company is a corporation duly organized, validly existing and in good standing under the Laws of Missouri. The Company has the

requisite corporate power and authority to own, lease and operate its properties, rights and assets and to carry on its business as it is now being conducted in all material respects.

(b) The Company is duly qualified to do business and is in good standing in each jurisdiction in which the nature of the business conducted

by it or the character or location of the properties, rights and assets owned or leased by it makes such licensing or qualification necessary, except where the failure to be so qualified or in good standing has not had and would not reasonably be

expected to have, individually or in the aggregate, a Company Material Adverse Effect.

do business and is in good standing in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties, rights and assets owned or leased by it makes such licensing or qualification necessary,

except where the failure to be so qualified or in good standing has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

(d) The Company has made available or caused to be made available to Parent true and complete copies of (i) any amendments to the

Amended and Restated Articles of Incorporation of the Company (as amended to date, the “Company Charter”) not filed prior to the date hereof with the SEC, (ii) any amendments to the Bylaws of the Company (as amended to date,

the “Company Bylaws”) not filed prior to the date hereof with the SEC and (iii) the certificates of incorporation and bylaws, or equivalent organizational or governing documents, and all amendments to such documents, of

each material Company Subsidiary. The Company Bylaws and the Company Charter, are in full force and effect and neither the Company nor any of the Company Subsidiaries is in violation of any of the provisions of their organizational documents in any

material respect. The certificates of incorporation and bylaws, or equivalent organizational or governing documents, and all amendments to such documents, of each material Company Subsidiary are in full force and effect.

(e) Section 3.1(e) of the Company Disclosure Schedule sets forth a true and complete list of the Company

Subsidiaries, together with the jurisdiction of organization or incorporation, as the case may be, of each Company Subsidiary. Each Company Subsidiary is a corporation or other legal entity duly organized validly existing and in good standing (with

respect to jurisdictions which recognize such concept) under the Laws of the jurisdiction of its

incorporation or organization and has the requisite organizational power and authority to own, lease and operate its properties, rights and assets and to carry on its business as it is now being

conducted, except where failure to be so duly organized and in good standing has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. The Company owns, beneficially and of record,

directly or indirectly, all Equity Interests of the Company Subsidiaries free and clear of any Liens other than Permitted Liens, except where the failure to own such interest free and clear of any Liens (other than Permitted Liens) is not and would

not reasonably be expected to be material to the Company and the Company Subsidiaries taken as a whole. Except for the capital stock of the Company Subsidiaries, the Company does not own, directly or indirectly, any Equity Interests in any other

Person. All of the Equity Interests of the Company Subsidiaries have been duly authorized and validly issued and are fully paid, non-assessable and free of preemptive rights and have been issued in compliance

in all material respects with all applicable securities Laws.

3.2 Capitalization.

(a) The authorized capital stock of the Company consists of (i) 600,000,000 shares of Company Common Stock, of which, as of the close of

business on April 9, 2026 (the “Company Capitalization Date”), there were 136,402,847 shares of Company Common Stock issued and outstanding and (ii) 100,000,000 shares of preferred stock, without par value, of the

Company (“Company Preferred Stock” and together with the Company Common Stock, the “Company Stock”). As of the Company Capitalization Date, no shares of Company Preferred Stock are issued and outstanding. As of

the Company Capitalization Date, 62,396,696 shares of Company Common Stock were held by the Company as treasury shares. No Company Subsidiary owns any shares of Company Stock or has any option or warrant to purchase shares of any Company Stock or

any other Equity Interest in the Company. All of the outstanding shares of Company Stock have been duly authorized and validly issued and are fully paid, non-assessable and free of preemptive rights and have

been issued in compliance with all applicable securities Laws.

(b) As of the close of business on the Company Capitalization Date, the

Company has no shares of Company Stock subject to or reserved for issuance, except for (i) 279,342 shares of Company Common Stock subject to outstanding Company Options under the Company Equity Plan, (ii) 2,210,769 shares of Company Common

Stock subject to outstanding Company RSU Awards under the Company Equity Plan (which excludes outstanding Company RSU Awards with respect to 48,301 shares of Company Common Stock that will be settled in cash), (iii) 1,325,846 at target and

2,651,692 at maximum shares of Company Common Stock subject to outstanding Company PSU Awards under the Company Equity Plan (assuming that, for purposes of any such Company PSU Awards, the applicable performance metrics have been achieved at target

and maximum performance levels) (which excludes outstanding Company PSU Awards with respect to 1,342,723 shares of Company Common Stock at target and 2,685,446 shares of Company Common Stock at maximum that will be settled in cash, assuming that,

for purposes of any such cash-settled Company PSU Awards, the applicable performance metrics have been achieved at target and maximum performance levels), (iv) 103,998 outstanding Company Restricted Shares, (v) 3,318,613 outstanding stock units

that are part of Company Deferred Compensation Plans under the Company Equity Plan, and (vi) 4,154,407 shares of Company Common Stock reserved for future issuance under the Company Equity Plan for awards not yet granted.

upon issuance prior to the Effective Time on the terms and conditions specified in the instruments pursuant to which they are issuable, shall be duly authorized, validly issued, fully paid, non-assessable and

free of preemptive rights. Section 3.2(c) of the Company Disclosure Schedule sets forth the following information with respect to each outstanding Company Equity Award as of the close of business on the Company

Capitalization Date: (1) the name (or employee identification number) of the holder thereof; (2) the number of shares of Company Common Stock issuable thereunder (assuming that for purposes of any such Company PSU Awards the applicable

performance goals are achieved at target and maximum performance levels); (3) the grant date; (4) the expiration date (if any); (5) the exercise price (if any); (6) the vesting schedule and the extent to which such Company Equity

Award is vested and/or exercisable; and (7) with respect to a Company Option, whether such Company Option is intended to constitute an “incentive stock option” within the meaning of Section 422 of the Code.

(d) All Company Equity Awards have been properly reported and registered in accordance with, and otherwise have been issued in compliance

with, all applicable Laws in all material respects, including with respect to securities Laws and the withholding and payment of any applicable Taxes and social insurance contributions, and have been issued in compliance with all the terms and

conditions of any applicable Company Benefit Plan in all material respects.

(e) Except for Equity Interests set forth in Section

3.2(b), there are no outstanding Equity Interests or other options, phantom equity, warrants or other rights, relating to or based on the value of any Equity Interests of the Company or the Company Subsidiaries or obligating the Company or the

Company Subsidiaries to issue, acquire or sell any Equity Interests of the Company or any Company Subsidiary. From the close of business on the Company Capitalization Date until the date hereof, the Company has not issued any Company Stock or other

Equity Interests other than Company Common Stock issued upon the exercise or settlement of Company Equity Awards outstanding as of the close of business on the Company Capitalization Date in accordance with their terms.

(f) Except with respect to the Company Equity Awards, there are no outstanding obligations of the Company or the Company Subsidiaries

(i) restricting the transfer of, (ii) affecting the voting rights of, (iii) requiring the repurchase, redemption or disposition of, or containing any right of first refusal with respect to, (iv) requiring the registration for

sale of or (v) granting any preemptive or anti-dilutive rights with respect to, any Company Stock or other Equity Interests of the Company or the Company Subsidiaries.

3.3 Authority. The Company has all necessary power and authority to execute and deliver this Agreement, to perform its obligations

hereunder and to consummate the transactions contemplated hereby, including the Merger. The execution and delivery of this Agreement by the Company and the consummation by the Company of the transactions contemplated hereby, including the Merger,

have been duly and validly authorized by all necessary corporate action, and no other corporate proceedings on the part of the Company and, except for

affirmative vote of the holders of two-thirds of the outstanding shares of Company Common Stock entitled to vote thereon in favor of the adoption of this Agreement (the “Required Company

Vote”), no shareholder votes are necessary to adopt this Agreement or to consummate the transactions contemplated hereby. The Company has duly and validly executed and delivered this Agreement and, assuming due and valid authorization,

execution and delivery by the Parent Parties, this Agreement constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms, except such enforcement may be limited by applicable bankruptcy, insolvency,

reorganization, moratorium, fraudulent conveyance or other similar Laws from time to time in effect relating to creditors’ rights and remedies generally, by general equitable principles or by the discretion of any Governmental Entity before

which any Proceeding seeking enforcement may be brought (collectively, the “Enforceability Limitations”). The Company Board has duly adopted the Company Board Recommendation, and as of the date of this Agreement, the Company Board

Recommendation has not been withdrawn, modified or amended in any respect.

3.4 No Conflict. Subject to receipt of the Required

Company Vote, none of the execution, delivery or performance of this Agreement by the Company, the consummation by the Company of the Merger or any other transaction contemplated by this Agreement will (with or without notice or lapse of time, or

both): (a) conflict with, breach or violate any provision of the Company Charter or the Company Bylaws; (b) assuming that all consents, approvals, authorizations and permits described in Section 3.5 have been

obtained and all filings and notifications described in Section 3.5 have been made and any waiting periods thereunder have terminated or expired, conflict with or violate, or give any Person the right to challenge the

Merger or any of the other transactions contemplated by this Agreement or to exercise any remedy or obtain any relief under, any Law applicable to the Company or any Company Subsidiary or any of their respective properties, rights or assets; or

(c) require any consent or approval under, violate, conflict with, result in any breach of (with or without the lapse of time, the giving of notice or both) or any loss of any benefit under, or constitute a change of control or default under,

or result in termination or give to others any right of termination, vesting, amendment, modification, acceleration or cancellation of, or result in the creation of a Lien (other than Permitted Liens) upon any of the respective properties, rights or

assets of the Company or any Company Subsidiary pursuant to any Company Material Contract or any Company Permit to which the Company or any Company Subsidiary is a party, except, with respect to clauses (b) and (c), for any

such conflicts, violations, consents, breaches, losses, changes of control, defaults, rights, other occurrences or Liens which would not, individually or in the aggregate, reasonably be expected to (i) have a Company Material Adverse Effect or

(ii) prevent, materially delay or materially impair the ability of the Company to perform its obligations under this Agreement or to consummate the Merger.

3.5 Required Filings and Consents. Assuming the accuracy of the representations and warranties of the Parent Parties in

Section 4.5, none of the execution, delivery or performance of this Agreement by the Company, including the consummation by the Company of the Merger or any other transaction contemplated by this Agreement will require

(with or without notice or lapse of time, or both) any consent, approval, authorization or permit of, or filing or registration with or notification to, any Governmental Entity, other than (a) the filing of the Articles of Merger as required by

the GBCLM, (b) compliance with any applicable requirements of any Competition Laws, (c) compliance with the applicable requirements of the Exchange Act, Securities Act and any other applicable U.S. state or federal securities Laws,

(d) filings with the SEC as may be required by the Company in connection with this Agreement and the transactions

contemplated hereby and (e) where the failure to obtain such consents, approvals, authorizations or permits of, or to make such filings, registrations with or notifications to any

Governmental Entity would not reasonably be expected to (i) have, individually or in the aggregate, a Company Material Adverse Effect or (ii) prevent, materially delay or materially impair the ability of the Company to perform its

obligations under this Agreement or to consummate the Merger.

3.6 Compliance With Law. Neither the Company nor any Company

Subsidiary is, or since January 1, 2023, has been in conflict with, default under or violation of any Law applicable to the Company or any Company Subsidiary or by which any property, rights or asset of the Company or any Company Subsidiary is

bound or affected, except for any conflicts, defaults or violations that have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Neither the Company nor any Company Subsidiary

has received since January 1, 2023 any written notice or, to the Knowledge of the Company, other communication from any Governmental Entity regarding any actual, alleged, potential or possible violation of, or failure to comply with, any Law,

except for any violations or failures to comply that have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. No investigation by any Governmental Entity with respect to the

Company or any Company Subsidiary is pending, nor has any Governmental Entity indicated to the Company an intention to conduct any such investigation, except for such investigations, the outcomes of which if determined adversely to the Company or

any Company Subsidiary have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

3.7 SEC Filings; Financial Statements.

(a) The Company has filed or furnished all reports, schedules, forms, statements, registration statements, prospectuses and other documents

required to be filed or furnished by the Company with the SEC under the Securities Act or the Exchange Act since January 1, 2023 (the “Company SEC Documents”). No Company Subsidiary is required to make any filings with the

SEC.

(b) As of its respective filing date, and, if amended, as of the date of the last amendment prior to the date hereof, each Company

SEC Document complied in all material respects with the requirements of the Exchange Act, the Securities Act or the Sarbanes-Oxley Act, as the case may be, and the rules and regulations of the SEC promulgated thereunder applicable to such Company

SEC Document and did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made,

not misleading. As of the date of this Agreement, there are no unresolved comments issued by the staff of the SEC with respect to any of the Company SEC Documents. As of the date of this Agreement, to the Knowledge of the Company, none of the

Company SEC Documents is the subject of any ongoing review by the SEC.

Documents (including, in each case, any notes or schedules thereto) (the “Company Financial Statements”) fairly present, in all material respects, the consolidated financial condition and the consolidated results of operations,

cash flows and changes in shareholders’ equity of the Company and the Company Subsidiaries (on a consolidated basis) as of the respective dates of and for the periods referred to in the Company Financial Statements, and were prepared in

accordance with GAAP applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto), subject, in the case of any interim unaudited Company Financial Statements, to normal

year-end adjustments and the absence of notes and other presentation items that will not be material in effect or amount to the Company and the Company Subsidiaries, taken as a whole. No financial statements

of any Person other than the Company and the Company Subsidiaries are required by GAAP to be included in the consolidated financial statements of the Company.

(d) The Company has established and maintains disclosure controls and procedures and internal control over financial reporting (as such terms

are defined in paragraphs (e) and (f), respectively, of Rule 13a-15 and paragraph (e) of Rule 15d-15 under the Exchange Act) as required by Rules 13a-15 and 15d-15 under the Exchange Act. The Company’s disclosure controls and procedures are designed to ensure that all material information (both

financial and non-financial) required to be disclosed by the Company in the reports that it files or furnishes under the Exchange Act is recorded, processed, summarized and reported within the time periods

specified in the rules and forms of the SEC, and that such material information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding required disclosure and to make the certifications

required pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act. The Company’s management has completed an assessment of the effectiveness of the Company’s disclosure controls and procedures and, to the extent required by

applicable Law, presented in any applicable Company SEC Document that is a report on Form 10-K or Form 10-Q, or any amendment thereto, its conclusions about the

effectiveness of the disclosure controls and procedures as of the end of the period covered by such report or amendment based on such evaluation. Since January 1, 2023, to the Knowledge of the Company, the Company has not had: (i) any

significant deficiency or material weakness in the design or operation of its internal control over financial reporting that is reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial

information; or (ii) any fraud, whether or not material, that involves management or any other employee (or former employee) who has (or has had) a significant role in the Company’s internal control over financial reporting.

3.8 Absence of Certain Changes or Events. Since January 1, 2026 through the date hereof:

(a) Except for the discussion and negotiation of this Agreement, the Company and the Company Subsidiaries have conducted their respective

businesses in all material respects in the ordinary course of business consistent with past practice.

(b) None of the Company or the

Company Subsidiaries have taken any action, or authorized, approved, committed, agreed or offered to take any action, that if taken after the date hereof and prior to the Closing would have required Parent’s consent under Sections

5.1(b)(i), 5.1(b)(iii), 5.1(b)(v), 5.1(b)(vi), 5.1(b)(vii), 5.1(b)(viii), 5.1(b)(xiii), 5.1(b)(xvi) and 5.1(b)(xxii).

reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

3.9 Employee Benefit

Plans.

(a) Section 3.9(a) of the Company Disclosure Schedule sets forth a list of each material Company

Benefit Plan as of the date hereof, excluding (i) any Company Benefit Plan that is an employment offer letter or individual independent contractor or consultant agreement that (x) does not materially differ from the applicable form set

forth on Section 3.9(a) of the Company Disclosure Schedule, provided that any such form applicable to employees outside the U.S. shall be identified by jurisdiction and (y) does not provide for (A) any

change in control, retention or other payments or benefits that could be triggered solely by the consummation of the transactions contemplated hereby, or (B) severance payments or benefits (other than statutory payments or benefits under

applicable Laws) and (z) can be terminated without further payment, liability or obligation (other than as required by applicable Laws) and (ii) any individual award agreement evidencing Company Equity Awards that is on a form that does

not materially differ from the applicable form set forth on Section 3.9(a) of the Company Disclosure Schedule. With respect to each Company Benefit Plan scheduled on Section 3.9(a) of the Company

Disclosure Schedule, to the extent applicable, the Company and the Company Subsidiaries have either delivered or made available to Parent prior to the execution of this Agreement true, correct and complete copies of: (i) all plan documents and

all amendments thereto, and all related trust, insurance, or other funding documents, and in the case of unwritten Company Benefit Plans, written descriptions thereof, (ii) the most recent determination letters, rulings, opinion letters,

information letters or advisory opinions issued by the IRS or the United States Department of Labor, (iii) the most recently filed annual return/report (Form 5500) and accompanying schedules and attachments thereto, (iv) the most

recently prepared actuarial report and financial statements, (v) the most recent prospectus or summary plan descriptions and any material modifications thereto, (vi) all nondiscrimination and compliance testing reports for the most

recently completed plan year and (vii) all material non-routine correspondence to and from any Governmental Entity within the last three (3) years.

(b) Each Company Benefit Plan has been established, administered and maintained in all respects in accordance with its terms and all

applicable Laws, including ERISA and the Code, except as, individually or in the aggregate, would not reasonably be expected to have a Company Material Adverse Effect. With respect to each Company Benefit Plan that is intended to be qualified under

Section 401(a) of the Code, such Company Benefit Plan has received a determination from the IRS that such Company Benefit Plan is so qualified (or if it is a prototype plan, it has a favorable opinion letter, or if it is a volume submitter

plan, it has a favorable advisory letter), and, to the Knowledge of the Company, nothing has occurred that has or would reasonably be expected to adversely affect or cause the loss of the qualification of such Company Benefit Plan.

their respective ERISA Affiliates sponsors, maintains, contributes to, has any obligation to contribute to, or otherwise has any liability or obligation (whether direct or contingent) under or with respect to: (i) a Multiemployer Plan;

(ii) a “multiple employer plan” within the meaning of Section 210 of ERISA or Section 413(c) of the Code; (iii) a “multiple employer welfare arrangement” within the meaning of Section 3(40) of ERISA;

or (iv) a “defined benefit plan” (as defined in Section 3(35) of ERISA whether or not subject thereto) or any other pension plan that is subject to Section 302 or Title IV of ERISA or Section 412 or 430 of the Code.

None of the Company or any of the Company Subsidiaries has any current or contingent liability or obligation as a consequence of being considered a single employer with any other Person under Section 414 or Section 4001 of ERISA of the

Code during the past six (6) years.

(d) None of the Company and Company Subsidiaries, nor, to the Knowledge of the Company, any

fiduciary, has engaged in any “prohibited transaction” (as defined in Section 4975 of the Code or Section 406 of ERISA) which would reasonably be expected to subject any of the Company Benefit Plans or their related trusts, the

Company or any of the Company Subsidiaries to any material Taxes or penalty imposed under Section 4975 of the Code or Section 502 of ERISA.

(e) No Company Benefit Plan provides, and neither the Company nor any of the Company Subsidiaries sponsors, maintains, contributes to or is

required to contribute to or has any liability with respect to any post-retirement welfare benefits, other than (i) health care continuation coverage required by Section 4980B of the Code (“COBRA”), Section 601 et

seq. of ERISA, or other applicable Law (for which the covered individual pays the full cost of coverage) (ii) coverage through the end of the calendar month in which a termination of employment occurs or (iii) pursuant to an applicable

agreement, plan or policy requiring the Company or any Company Subsidiary to pay or subsidize COBRA premiums for a terminated employee following the employee’s termination of employment.

(f) No claims, actions, causes of action, suits, litigations, proceedings, arbitrations, mediations, interferences, audits, assessments,

hearings or other legal proceedings (including Proceedings but excluding routine claims for benefits) are pending or, to the Knowledge of the Company, threatened with respect to any Company Benefit Plan that would reasonably be expected to have a

Company Material Adverse Effect.

(g) None of the execution, delivery or performance of this Agreement by the Company or the consummation

by the Company of the transactions contemplated hereby could (alone or in conjunction with any other event) (i) accelerate the time of payment, vesting, exercisability, or funding of any payment, right or other benefit to any current or former

employee, individual independent contractor, officer or director of the Company or any of the Company Subsidiaries under any Company Benefit Plan or entitle any such individuals to any payment or benefit thereunder, (ii) increase the amount or

value of any compensation or benefits payable under any Company Benefit Plan (including loan forgiveness), (iii) require any contributions under any Company Benefit Plan or cause the Company or any Company Subsidiary to transfer or set aside any

assets to fund any Company Benefit Plan or related trust, or (iv) result in the payment of any “excess parachute payments” within the meaning of Section 280G of the Code.

(h) Except as, individually or in the aggregate, would not reasonably be expected to have a Company Material Adverse Effect, all required

premiums for, or contributions required to be made to, each Company Benefit Plan have been timely made in accordance with the terms of the applicable Company Benefit Plan and applicable Law.

(i) Except as, individually or in the aggregate, would not reasonably be expected to have a

Company Material Adverse Effect, each Company Benefit Plan, and any award thereunder, that is or forms part of a “nonqualified deferred compensation plan” within the meaning of Section 409A of the Code has been operated and

maintained in all respects with all applicable requirements of Sections 409A of the Code. Neither the Company nor any of the Company Subsidiaries maintains any obligations to gross-up or reimburse any

individual for any Tax or related interest or penalties incurred by such individual, including under Sections 409A or 4999 of the Code or otherwise.

(j) Except as, individually or in the aggregate, would not reasonably be expected to have a Company Material Adverse Effect, with respect to

each Company Benefit Plan that is subject to the Laws of a jurisdiction other than the United States (whether or not United States law also applies) (a “Non-U.S. Company Benefit Plan”): (i)

all employer and employee contributions to each Non-U.S. Company Benefit Plan required by Law or by the terms of such Non-U.S. Company Benefit Plan have been timely

made, or, if applicable, accrued in accordance with normal accounting practices, (ii) each Non-U.S. Company Benefit Plan required to be registered has been registered and has been maintained in good

standing with applicable regulatory authorities, and (iii) there are no unfunded or underfunded liabilities with respect to any Non-U.S. Company Benefit Plan. No

Non-U.S. Company Benefit Plan is a defined benefit plan (as defined in ERISA, whether or not subject to ERISA).

3.10 Labor and Other Employment Matters.

(a) Section 3.10(a) of the Company Disclosure Schedule sets forth all Collective Bargaining Agreements to which the

Company or any Company Subsidiary is a party or bound. Neither the Company nor any of the Company Subsidiaries will incur any notice, consultation or consent obligations under any Collective Bargaining Agreements in connection with the execution of

this Agreement or the consummation of the transactions contemplated hereby. Neither the execution of this Agreement nor the consummation of the transactions contemplated hereby will result in a breach or violation of any Collective Bargaining

Agreement.

(b) As of the date hereof, to the Knowledge of the Company, there are no and for the past three (3) years have been no

material union organizing activities or demands of any union for recognition or certification pending or threatened against the Company or any Company Subsidiary. There is no, and for the past three (3) years has been no, material labor strike,

material labor dispute, material slowdown or concerted work stoppage pending or, to the Knowledge of the Company, threatened against or affecting the Company or any Company Subsidiary.

(c) The Company and the Company Subsidiaries are and for the past three (3) years have been in compliance with all applicable Laws

respecting labor, employment and employment practices including, without limitation, all Laws respecting terms and conditions of employment, hiring, worker classification, health and safety, wage payment, wages and hours, child labor, immigration

and work authorizations, employment harassment and discrimination, disability rights or benefits, equal opportunity, plant closures and layoffs (including the WARN Act), affirmative action, workers’ compensation, labor relations, discipline,

termination, social welfare obligations and unemployment insurance, except for noncompliance as has not had and

would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. For the past three (3) years, the Company and the Company Subsidiaries have

been in compliance with all applicable Law governing the work authorization of U.S. employees in accordance with the requirements of: the U.S. Immigration Reform and Control Act of 1986; the U.S. Immigration and Nationality Act; the U.S. Illegal

Immigration Reform and Immigrant Responsibility Act of 1996; any successor statutes, laws, rules and regulations; the U.S. federal government’s employment, eligibility verification system known as

E-Verify (where required); U.S. state laws, ordinances, statutes, rules and regulations regarding the use of E-Verify (where applicable); and the wage and hour

regulations related to employment under the H-1B or the H-2B visa program (where applicable), except for noncompliance as has not had and would not reasonably be

expected to have, individually or in the aggregate, a Company Material Adverse Effect.

(d) Except as, individually or in the aggregate,

would not reasonably be expected to have a Company Material Adverse Effect, as of the date hereof, there are no and for the past three (3) years have been no charges, complaints, claims or investigations or audits against such party pending or,

to the Knowledge of the Company, threatened to be brought by or filed with any Governmental Entity based on, arising out of, in connection with, or otherwise relating to the employment of, or termination of employment by, such party of any person

against the Company or any of the Company Subsidiaries.

(e) To the Knowledge of the Company, no Key Employee is in material violation of

any term of any noncompetition agreement, non-solicitation agreement or any restrictive covenant covering such Key Employee.

(f) The Company and the Company Subsidiaries have promptly and reasonably investigated all material sexual harassment, discrimination and

retaliation allegations by or against any director, officer, employee of the Company or any Company Subsidiary made in the past three (3) years of which the Company or any of its Subsidiaries are aware. Neither the Company nor any of the

Company Subsidiaries reasonably expects any material liability with respect to any such allegations and, to the Knowledge of the Company, no allegations are pending as of the date hereof.

3.11 Contracts.

(a)

Section 3.11(a) of the Company Disclosure Schedule sets forth, as of the date hereof, a true and complete list of each Contract (except for purchase or service orders executed in the ordinary course of business of the

Company or any Company Subsidiary, as applicable, and any Company Benefit Plan) to which the Company or any Company Subsidiary is a party or which binds or affects their respective properties, rights or assets, and which falls within any of the

following categories:

(i) any joint venture, partnership, strategic alliance, limited liability or other similar Contract which is

material to the Company and its Subsidiaries, taken as a whole, related to the formation, creation, operation, management or control of any partnership, limited liability company or joint venture in which the Company or any Company Subsidiary owns

any interest;

(ii) any agreement that involves future expenditures or receipts by the Company or any

Company Subsidiary of more than $5,000,000 in any one-year period that cannot be terminated on less than ninety (90) days’ notice without material payment or penalty;

(iii) any Contract that grants any right of first refusal or right of first offer or that limits the ability of the Company, any Company

Subsidiary, or any of their respective affiliates (including Parent and its affiliates after the Effective Time) to own, operate, sell, transfer, pledge or otherwise dispose of any material assets or businesses;

(iv) any Contract that limits, restricts or prohibits, or purports to limit, restrict or prohibit, in any material respect the freedom of the

Company or any Company Subsidiary (A) to engage in any line of business, compete with any Person, (B) to purchase, sell, supply or distribute any product or service, or (C) to develop, sell, supply, license, distribute, offer, support

or service any product or other asset to or for any other Person, in each case, in any geographic area (other than confidentiality or employee non-solicitation agreements entered into in the ordinary course of

business);

(v) any Contract to which the Company or a Company Subsidiary is subject to (A) any “most favored nation” or

similar provision in favor of the other party, (B) any minimum purchase commitment in excess of $5,000,000, (C) a “sole source” or similar relationship or contains any provision that requires the purchase of all or any portion of

requirements from any third party or (D) any exclusivity, call or put option or rights of first or last offer, negotiation or refusal;

(vi) any Contract related to the acquisition, disposition or other merger, reorganization or business combination (A) that was entered

into since January 1, 2023 for aggregate actual or contingent consideration under such Contract in excess of $5,000,000 or (B) that contains “earn-out” provisions or other contingent

payment obligations, or remaining indemnity or similar obligations, in each case, that could reasonably be expected to result in future payments by the Company or a Company Subsidiary in excess of $5,000,000;

(vii) any Contract relating to indebtedness for borrowed money or any guarantee of such indebtedness of the Company or any Company

Subsidiary, in each case, in excess of $5,000,000 other than Contracts solely among the Company and any wholly-owned Subsidiary of the Company;

(viii) is a Contract with respect to any hedging, swap, derivative, ISDA or similar Contract for a value in excess of $5,000,000;

(ix) any Collective Bargaining Agreement;

(x) any Contract with a Significant Supplier;

(xi) any Contract with a Significant Customer;

(xii) any Company Real Property Lease;

(xiii) any Contract pursuant to which (A) the Company or any Company Subsidiary

licenses from a third party or otherwise is granted the right to use or exploit material Intellectual Property, with one-time or annual aggregate license, maintenance, support and other fees of more than

$2,000,000, except for shrink-wrap, click-through or off-the-shelf software licenses or Contracts which include non-exclusive

rights to non-customized pre-installed software, middleware, or firmware or (B) the Company or any Company Subsidiary licenses to a third party or otherwise grants

the right to use or exploit material Company Owned Intellectual Property, except for non-exclusive licenses granted by the Company or the Company Subsidiaries in the ordinary course of business;

(xiv) any Contract that obligates the Company or any Company Subsidiary to make any loans, advances or capital contributions to, or

investments in, any Person (other than with respect to any Company Subsidiary) in excess of $5,000,000;

(xv) any reseller, sales agent,

dealer, joint marketing or distribution Contract that would be reasonably likely to involve commissions or payments by the Company or any Company Subsidiary, in each case, in any twelve (12) month period pursuant to such Contract in excess of

$5,000,000;

(xvi) any Contract providing for indemnification of any officer, director or employee of the Company or any Company

Subsidiary, other than Contracts entered into on substantially the same form as the Company’s or its Subsidiaries’ standard forms previously made available to Parent;

(xvii) any Contract (other than a Contract evidencing any Company Equity Award on the form or forms used by the Company in the ordinary

course of business and made available to Parent): (A) relating to the acquisition, issuance, voting, registration, sale or transfer of any security; (B) providing any Person with any preemptive right, right of participation, right of

maintenance or any similar right with respect to any security; or (C) providing any of the Company or any Company Subsidiary with any right of first refusal or similar right with respect to, or right to repurchase or redeem, any security;

(xviii) any (A) material Contract with a Company Related Party (as defined in Item 404 of Regulation

S-K of the SEC) if such Company Related Party is a natural person, or (B) Contract with a Company Related Party if such Company Related Party is not a natural person;

(xix) any material Contract that is currently in effect to which a Governmental Entity is a party;

(xx) any settlements or conciliations that impose material future monetary or other obligations not yet satisfied upon the Company or any

Company Subsidiary; and

(xxi) any other “material contract” (as such term is defined in Item 601(b)(10) of Regulation S-K of the SEC), other than a Company Benefit Plan.

(b) Each Contract of the type described in Section 3.11(a) is

referred to herein as a “Company Material Contract.” True and complete copies of each Company Material Contract in effect as of the date hereof (including all modifications, amendments, supplements, annexes and schedules thereto

and written waivers thereunder in the Company’s possession) have been made available to Parent (including pursuant to agreed-upon procedures to protect competitively sensitive information) or publicly filed with the SEC as part of the Company

SEC Documents.

Material Adverse Effect: (i) each Company Material Contract is a legally valid and enforceable obligation of the Company or the Company Subsidiary party thereto, in accordance with its terms, subject to applicable Enforceability Limitations;

(ii) each Company Material Contract is in full force and effect, (iii) none of the Company or any Company Subsidiary is in (or to the Knowledge of the Company, is alleged to be in) breach or default under any Company Material Contract to

which it is a party or by which it or any of its properties, rights or assets is bound or affected and (iv) neither the Company, any of the Company Subsidiaries nor, to the Knowledge of the Company, any other party to a Company Material

Contract has terminated or failed to renew any Company Material Contract or given notice of any termination or intent to not renew thereunder, nor, to the Knowledge of the Company, has the other party to a Company Material Contract given any

informal indication that it does not intend to renew that agreement on terms substantially the same as, or more favorable to the Company and Company Subsidiaries than, the current agreement.

3.12 Customers and Suppliers.

(a) Section 3.12(a) of the Company Disclosure Schedule sets forth a list of the ten (10) largest customers of the Company

by total revenue during the year ended December 31, 2025 (each, a “Significant Customer”). Since January 1, 2025, and as of the date hereof, no Significant Customer has stated in writing that it will (i) stop

purchasing products or services from the Company or its Subsidiaries; or (ii) change, materially and adversely, the terms and conditions on which it purchases products from the Company or its Subsidiaries. To the Knowledge of the Company, all

accounts receivable owed by Significant Customers are bona fide, arose in the ordinary course of business, and are valid obligations to the Company. Except as previously disclosed or made available to Parent, as of the date hereof, the Company has

not agreed with any Significant Customer to any material reduction in the prices in a future period paid by such Significant Customer in respect of the products sold to such Significant Customer, that, taken together in the aggregate with similar

reductions with respect to other Significant Customers, would reasonably be likely to result in a material reduction in the revenue of the Company and its Subsidiaries (taken as a whole) with respect to such future period as compared to such sales

revenue for the year ended December 31, 2025.

(b) Section 3.12(b) of the Company Disclosure Schedule sets forth a

list of the ten (10) largest suppliers of the Company by total expenditures during the year ended December 31, 2025 (each, a “Significant Supplier”). Since January 1, 2025, and as of the date hereof, no Significant

Supplier has stated in writing that it will (i) stop supplying the Company or its Subsidiaries; or (ii) change, materially and adversely, the terms and conditions on which it is prepared to supply the Company or its Subsidiaries.

3.13 Permits. (a) The Company and each material Company Subsidiary

(i) holds all authorizations, licenses, permits, certificates, variances, exemptions, approvals, orders, registrations and clearances of any applicable Governmental Entity and (ii) has filed all tariffs, reports, notices and other material

documents with any Governmental Entity, in each case of clauses (i) and (ii), that is required by applicable Law for the Company and each Company Subsidiary to own, lease and operate its properties and assets, and to carry on and

operate its businesses as currently conducted, in all material respects (collectively, the “Company Permits”); (b) is, and since January 1, 2023, has been in compliance with all the terms and conditions of all Company

Permits, except where the failure to hold or to comply with any of the Company Permits has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, and (c) all Company Permits

are valid and in full force and effect, are not subject to any administrative or judicial proceeding that could result in any modification, termination or revocation thereof and, to the Knowledge of the Company, no suspension or cancellation of any

such Company Permit is threatened, except as has not had and would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect.

3.14 Litigation. As of the date hereof, there are no Proceedings pending, or to the Knowledge of the Company, threatened

(a) against the Company or any of the Company Subsidiaries or any of their respective assets or properties or any of the officers or directors of the Company (in their capacities as such), except, in each case, for those that are not and would

not reasonably be expected to be, individually or in the aggregate, material to the Company and the Company Subsidiaries, taken as a whole, or (b) that challenges the validity or propriety of, or that is intended to have the effect of

preventing, hindering, modifying, challenging or delaying the Merger or the other transactions contemplated hereby. Neither the Company nor any of the Company Subsidiaries, nor any of the assets owned or used by any of the Company or its

Subsidiaries is subject to any Order or, to the Knowledge of the Company, investigation, pending or threatened, that is or would reasonably be expected to be, individually or in the aggregate, material to the Company and the Company Subsidiaries,

taken as a whole.

3.15 Environmental Matters. Except as has not had or would not reasonably be expected to have, individually or

in the aggregate, a Company Material Adverse Effect, (a) each of the Company and the Company Subsidiaries is, and since January 1, 2023, has been, in compliance with all Environmental Laws and each has, and since January 1, 2023, has

had, all Environmental Permits necessary for the conduct and operation of their respective businesses, and all such Environmental Permits are in full force and effect; (b) none of the Company or any Company Subsidiary has received any notice,

demand, letter or claim alleging that the Company or any Company Subsidiary is noncompliant with, is in violation of, or is liable under, any Environmental Law or Environmental Permit, in each case, that remains pending or unresolved; (c) there

has been no Release of or exposure of any Person to any Hazardous Substance that has given rise or would reasonably be expected to give rise to any liability of the Company or any Company Subsidiary under Environmental Law at, in, on, under or from

any Company Real Property or, to the Knowledge of the Company, at, in, on, under or from any real property formerly owned, leased or operated by the Company or any Company Subsidiary; (d) none of the Company or any Company Subsidiary has

entered into or agreed to any consent decree or order, or is subject to any judgment, decree or judicial order, relating to noncompliance with Environmental Laws, Environmental Permits or the investigation, sampling, monitoring, treatment,

remediation,

removal or cleanup of Hazardous Substances and no formal investigation, information request, litigation or other proceeding is pending or, to the Knowledge of the Company, threatened with respect

thereto; and (e) none of the Company or any Company Subsidiary has assumed by Contract or, to the Knowledge of the Company, by operation of Law any liabilities or obligations of any other Person under Environmental Law. The Company has made

available to Parent copies of all material and final reports, audits, and assessments in the possession of the Company or any Company Subsidiary with respect to the environmental condition of the Company Real Property or the Company’s or any

Company Subsidiary’s compliance with Environmental Law.

3.16 Intellectual Property.

(a) Section 3.16(a) of the Company Disclosure Schedule sets forth a complete and accurate list of all (i) issued patents and

pending patent applications, (ii) trademark and service mark registrations and applications, (iii) copyright registrations, and (iv) internet domain name registrations, in each case that are owned by the Company or any of the Company

Subsidiaries (collectively, the “Company Registered Intellectual Property”). Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (A) each item of Company

Registered Intellectual Property is subsisting, and, to the Knowledge of the Company, valid and enforceable, and (B) no Proceeding is pending or, to the Knowledge of the Company, is threatened, that challenges the validity, enforceability,

registration, use, ownership or scope of any Company Registered Intellectual Property (other than office actions in connection with applications for the registration or issuance of any Company Registered Intellectual Property).

(b) Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, each item of

Company Owned Intellectual Property is owned exclusively by the Company or a Company Subsidiary, free and clear of all Liens (other than Permitted Liens) and, to the Knowledge of the Company, none of the execution, delivery or performance of this

Agreement by the Company, the consummation by the Company of the Merger or any other transaction contemplated by this Agreement will (with or without notice or lapse of time, or both) result in (A) the loss, forfeiture, termination, or

impairment of, or give rise to the creation of any Lien on, or a right of any Person to limit, terminate, or consent to the continued use of, any rights of the Company or any of the Company Subsidiaries in any Intellectual Property or

(B) trigger any requirement for the Company or any of the Company Subsidiaries to pay any additional consideration for the continued use by the Company or any Company Subsidiary of any Intellectual Property.

(c) Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, since

January 1, 2023 neither the Company nor any of the Company Subsidiaries has infringed, misappropriated, diluted or otherwise violated, and the conduct of the Company and the Company Subsidiaries as currently conducted is not infringing,

misappropriating, diluting, or otherwise violating the Intellectual Property rights of any Person. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, neither the Company nor any

of the Company Subsidiaries has received any charge, complaint, claim, demand, or notice (including invitations to license, cease-and-desist or indemnity claims) since

January 1, 2023 (or earlier, if presently not resolved) alleging that the Company or any Company Subsidiary has infringed, misappropriated, diluted or otherwise

violated the Intellectual Property rights of any Person. To the Knowledge of the Company, no Person is infringing, misappropriating, diluting or otherwise violating any Company Owned Intellectual

Property in any material respect. Neither the Company nor any of the Company Subsidiaries has made or asserted any charge, complaint, claim, demand or notice (including invitations to license, cease-and-desist or indemnity claims) since January 1, 2023 (or earlier, if presently not resolved) alleging any such infringement, misappropriation, dilution, or violation.

(d) Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i) all

trade secrets and confidential information owned or held by the Company or any of the Company Subsidiaries (including any confidential information owned by any Person to whom the Company or the Company Subsidiaries have a confidentiality obligation)

have been maintained in confidence in accordance with commercially reasonable procedures customarily used in the industry to protect rights of like importance, (ii) the Company and the Company Subsidiaries have not disclosed any such trade

secrets or confidential information to any Person other than Persons who are subject to contractual, legal, or legally enforceable ethical or professional obligations to maintain the confidentiality of such information and (iii) to the

Knowledge of the Company, there has been no breach of any such confidentiality obligations.

(e) Except as would not reasonably be

expected to have, individually or in the aggregate, a Company Material Adverse Effect, the software, computer hardware, servers, workstations, routers, hubs, switches, circuits, and all other information technology assets and equipment owned,

leased, or licensed by the Company or any of the Company Subsidiaries and used by them in the conduct of their businesses (“Company IT Assets”) are in good working condition and operate and perform as required by the Company and

the Company Subsidiaries for the conduct of their businesses as currently conducted, and have not malfunctioned or failed since January 1, 2023. The Company and the Company Subsidiaries have taken commercially reasonable measures to protect the

security and integrity of the Company IT Assets and to protect the information and data (including Personal Information) contained or stored therein against unauthorized use, access, modification, corruption, encryption, deletion or loss. Except as

would not reasonably be expected to be material to the Company and the Company Subsidiaries, taken as a whole, the Company IT Assets are free of any “back door,” “time bomb,” “Trojan horse,” “worm,”

“drop dead device,” “virus” or other software routines or hardware components that permit unauthorized access or the unauthorized disablement or erasure of such Company IT Assets or data or other software.

3.17 Data Privacy and Security.

(a) Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the

Company’s and each of the Company Subsidiaries’ Processing of Personal Information by or on behalf of the Company or the Company Subsidiaries complies with (i) their externally published policies relating to privacy, security or the

Processing of Personal Information, (ii) their contractual commitments related to privacy, security or the Processing of Personal Information, and (iii) all Privacy and Security Laws (collectively, “Privacy

Requirements”).

(b) The Company and each of the Company Subsidiaries have implemented and maintained

commercially reasonable measures designed to protect Personal Information against any Security Incident. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company and the

Company Subsidiaries have not experienced a Security Incident in the past three (3) years.

expected to have, individually or in the aggregate, a Company Material Adverse Effect, in the past three (3) years, neither the Company nor any Company Subsidiary has, nor have they been legally required to, (i) notify any Person in

connection with Security Incidents, or (ii) received any written notice, claim, or complaint from any Governmental Entity or Person alleging a violation of a Privacy Requirement.

3.18 Tax Matters.

(a)

Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect:

(i) all Tax Returns required to be filed by or with respect to the Company and the Company Subsidiaries have been timely filed (taking into

account any extension of time within which to file) and all such Tax Returns are true, correct and complete in all respects;

(ii) all

Taxes payable by or with respect to the Company and the Company Subsidiaries (whether or not shown to be due and payable on any Tax Return) have been fully and timely paid to the appropriate Governmental Entity;

(iii) all withholding Tax requirements imposed on or with respect to the Company and the Company Subsidiaries have been satisfied in full and

the Company and Company Subsidiaries have complied with all reporting requirements (including maintenance of required records) with respect to such withholding Taxes;

(iv) no agreements, consents, extensions or waivers of statutes of limitations (or extensions of time to file) have been entered into, given

or requested with respect to any Taxes or Tax Returns of the Company or any Company Subsidiary (other than extension of time to file Tax Returns obtained in the ordinary course of business);

(v) none of the Company or any Company Subsidiary has received any written notice of deficiency for any amount of Taxes from any Governmental

Entity, except for deficiencies being contested in good faith in appropriate Proceedings for which adequate reserves have been established in accordance with GAAP on the financial statements of the Company and the Company Subsidiaries;

(vi) there are no audits, examinations, investigations or other Proceedings in progress pending or, to the Knowledge of the Company,

threatened by any Governmental Entity with respect to any Taxes of the Company or any Company Subsidiary;

(vii) no Governmental Entity

has made an assertion in writing to the Company or any of its Subsidiaries that it believes the Company and/or a Company Subsidiary was required to file a Tax Return that it had not filed, which assertion has not been fully resolved;

(viii) neither the Company nor any Company Subsidiary (A) is a party to any Tax-allocation, Tax-sharing, Tax-indemnity or similar agreement (not including, for the avoidance of doubt (I) any agreement or

arrangement solely between or among the Company and the Company Subsidiaries or (II) any customary commercial contract not primarily related to Taxes and entered into in the ordinary course of business) or (B) has requested or is subject

to any IRS private letter ruling or closing agreement (within the meaning of Section 7121 of the Code) or any comparable ruling from or agreement with any other Governmental Entity;

(ix) neither the Company nor any Company Subsidiary (A) has been a member of an affiliated group of corporations within the meaning of

Section 1504 of the Code (other than a group the common parent of which is or was the Company or any Company Subsidiary) or (B) has any liability for Taxes of any Person (other than the Company or the Company Subsidiaries) under Treasury

Regulations Section 1.1502-6 (or any similar provision of state, local or non-U.S. Tax Law), or as a transferee or successor;

(x) except for Permitted Liens, there are no Liens for Taxes upon any property or assets of the Company or the Company Subsidiaries;

(xi) neither the Company nor any Company Subsidiary has participated in any “reportable transaction” within the meaning of

Treasury Regulations Section 1.6011-4(b) (or under a similar provision of state, local, or non-U.S. Tax Law);

(xii) within the last three (3) years, neither the Company nor any Company Subsidiary has constituted either a “distributing

corporation” or a “controlled corporation” (within the meaning of Section 355(a)(1)(A) of the Code) in a distribution of stock intended to qualify for tax-free treatment under

Section 355 of the Code (or any similar provision of state, local, or non- U.S. Law);

(xiii) each of the Company and the Company Subsidiaries has at all times been a resident for Tax purposes only in the jurisdiction of its

organization and has never been treated as resident in any other jurisdiction for any Tax purpose (including any double taxation arrangement);

(xiv) the Company and Company Subsidiaries are in compliance with all transfer pricing requirements in all jurisdictions in which they do

business and all such transactions between the Company and the Company Subsidiaries have been effected on an arm’s length basis; and

(xv) the Company has not been a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code

during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code.

(b) None of the Company, any Company Subsidiary or,

to the Knowledge of the Company, any of the Company’s affiliates has taken (or failed to take) or agreed to take (or agreed to refrain from taking) any action or is aware of any facts, agreements, plans or other circumstances that it would

reasonably expect would prevent or impede the Merger from qualifying for the Intended Tax Treatment.

3.19 Real Property; Title to Assets.

(a) Section 3.19(a) of the Company Disclosure Schedule sets forth a true and complete list of all material real property that is

owned by the Company or any of the Company Subsidiaries (the “Company Owned Real Property”) and identifies a street address for each Company Owned Real Property. The Company or a Company Subsidiary, as applicable, has good, valid

and marketable fee simple title (or, if outside the United States, the local equivalent) to each Company Owned Real Property, free and clear of all Liens (other than Permitted Liens), except as is not and would not reasonably be expected to be,

individually or in the aggregate, material to the Company and the Company Subsidiaries, taken as a whole. Except for Permitted Liens, neither the Company nor any Company Subsidiary has leased, licensed or otherwise granted any Person the right to

use or occupy such Company Owned Real Property. Neither the Company nor any Company Subsidiary has granted or assigned to any Person other than the Company or a Company Subsidiary any rights of first refusal, options to purchase, purchase

agreements, contracts for deed or installment sale agreements in effect with respect to all or a portion of any Company Owned Real Property.

(b) Section 3.19(b) of the Company Disclosure Schedule sets forth (i) a true and complete list of all real property leased,

subleased or otherwise occupied by the Company or any of the Company Subsidiaries with annual lease payments (excluding common area maintenance charges) exceeding $1,000,000 annually (collectively, the “Company Leased Real

Property” and, together with the Company Owned Real Property, the “Company Real Property”) and (ii) the address for such Company Leased Real Property. The Company has made available to Parent accurate and complete

copies of all leases pertaining to any Company Leased Real Property, and any material amendments, modifications, or extensions thereof (the “Company Real Property Leases”). The Company or a Company Subsidiary holds, and is the

sole holder of, good and valid interests in and to all of the Company Leased Real Property, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

(c) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect,

neither the Company nor any of the Company Subsidiaries has received written notice of any Proceedings in eminent domain, condemnation or other similar Proceedings that are pending, and to the Knowledge of the Company there are no such Proceedings

threatened, affecting any portion of the Company Real Property. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, no casualty event has occurred that has not been

remedied (including as required, if applicable, pursuant to a Company Real Property Lease). The Company Real Property constitutes all the material real property used, held for use, or necessary to be used, in connection with the business of the

Company and the Company Subsidiaries as presently conducted.

(d) Except as has not had and would not reasonably be expected to have,

individually or in the aggregate, a Company Material Adverse Effect, the Company or a Company Subsidiary own, and have good and valid title to, or a valid and binding leasehold or other interest in, all tangible assets owned or purported to be owned

by them free and clear of all Liens (except for Permitted Liens), including: (i) all assets reflected on the Company’s consolidated balance

sheet as of December 31, 2025 (including the notes thereto) included in the Company SEC Documents (other than assets disposed of since such date in the ordinary course of business); and

(ii) all other assets reflected in the books and records of the Company and the Company Subsidiaries as being owned by the Company or any Company Subsidiary (other than assets disposed of since such date in the ordinary course of business).

Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, all items of equipment and other tangible assets owned by or leased to the Company or any Company Subsidiary are

adequate for the uses to which they are being put and are in good and safe condition and repair (ordinary wear and tear excepted). As of the date hereof, there are no planned or required capital expenditure in relation to any such material items of

equipment or other tangible assets.

(e) Except as has not had and would not reasonably be expected to have, individually or in the

aggregate, a Company Material Adverse Effect, (i) the buildings and improvements on the Company Real Property are in good operating condition and in a state of good and working maintenance and repair, ordinary wear and tear excepted, are in

compliance with all applicable building codes and are adequate and suitable for their current uses and purposes; (ii) there are no physical conditions or defects on any part of the Company Real Property that would impair or would be reasonably

expected to impair the continued operation of the business of the Company as presently conducted at each such Company Real Property; and (iii) there are no planned or required expenditure in relation to the Company Real Property.

(f) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect,

each part of the Company Real Property has adequate rights of access to dedicated public ways and is served by water, electric, sewer, sanitary sewer and storm drain facilities, in each case to the extent reasonably necessary for the operation, use

and occupancy of such Company Real Property as currently operated and used.

3.20 Anti-Corruption.

(a) In the last eight (8) years, the Company and each Company Subsidiary, and each of their respective directors, officers, and

employees (when acting within their duties to, or scope of employment with, the Company or a Company Subsidiary, in each case, on behalf of the Company or a Company Subsidiary) have not violated, conspired to violate, or aided and abetted the

violation of any Anti-Corruption Laws. None of the Company or any Company Subsidiary or, in each case, any of its respective officers, managers, directors, employees, nor to the Knowledge of the Company, any of the Company’s or any Company

Subsidiary’s agents, representatives, or other Persons that act for or on behalf of the Company or any Company Subsidiary has made any corrupt payment or corruptly given, offered, promised, or authorized or agreed to give, any money or thing

of value, directly or indirectly, to any Government Official.

(b) Since April 24, 2019, none of the Company or any Company Subsidiary has made any

voluntary or involuntary disclosure to any Governmental Entity under the Anti-Corruption Laws, and there have been no actual or threatened written or, to the Knowledge of the Company, oral inquiries, investigations, or enforcement actions by any

Governmental Entity regarding compliance by the Company or any Company Subsidiary with Anti-Corruption Laws, and no Governmental Entity has assessed any fine or penalty against the Company or any Company Subsidiary, or issued any warning letter to

the Company or any Company Subsidiary, with regard to compliance with Anti-Corruption Laws.

have established and maintain policies and procedures reasonably designed to ensure compliance with the Anti-Corruption Laws applicable to the Company and the Company Subsidiaries.

3.21 International Trade.

(a) None of the Company or any Company Subsidiary or, in each case, any of its respective officers, managers, directors, employees, nor, to

the Knowledge of the Company, any of the Company’s or any Company Subsidiary’s agents, representatives, or other Persons that act for or on behalf of the Company or any Company Subsidiary is currently, or since April 24, 2019, has

been, (i) a Sanctioned Person; (ii) engaged in any dealings or transactions (directly or indirectly), or has otherwise had any other business operations, in, with, involving or for the benefit of any Sanctioned Person or Sanctioned

Country; or (iii) otherwise in violation of applicable Sanctions.

(b) The Company and the Company Subsidiaries, and its and their

officers, managers, directors, employees, and, to the Knowledge of the Company, the Company’s and the Company Subsidiaries’ agents, representatives, and other Persons that act for or on behalf of the Company or the Company Subsidiaries

is and, since April 24, 2019, has been in compliance with applicable Trade Compliance Laws in all material respects.

April 24, 2019, the Company and the Company Subsidiaries have not made any voluntary or involuntary disclosure to any Governmental Entity regarding actual or possible violations of Sanctions or Trade Compliance Laws, and there have been no

actual or, to the Knowledge of the Company, threatened, inquiries, proceedings, allegations, investigations, or enforcement actions regarding compliance by the Company or any Company Subsidiary with Sanctions or Trade Compliance Laws, and no

Governmental Entity has assessed any fine or penalty against, or issued any warning letter to, the Company or any Company Subsidiary with regard to compliance with Sanctions or Trade Compliance Laws.

(d) The Company and the Company Subsidiaries have implemented and maintain policies and procedures reasonably designed to ensure compliance

with Sanctions and Trade Compliance Laws.

(e) None of the products or materials imported by, for or on behalf of the Company or the

Company Subsidiaries, for which final liquidation has not yet occurred is subject to or otherwise covered by an antidumping duty order or countervailing duty order that remains in effect or is subject to or otherwise covered by any pending

antidumping or countervailing duty investigation by any Governmental Entity.

(f) The Company and the Company Subsidiaries are not

importing and have not imported, products or materials mined, produced, or manufactured, wholly or in part, with the use of forced labor or mined, produced, or manufactured, wholly or in part, in the Xinjiang Uyghur Autonomous Region or by an entity

on the Uyghur Forced Labor Prevention Act Entity List.

(g) Since April 24, 2019, each of the Company and the Company Subsidiaries, or any of

their representatives obtained, utilized, maintained or complied in all material respects with all permits, records, licenses, license exceptions, authorizations, approvals, clearances, and classifications required by applicable Sanctions and Trade

Compliance Laws, including any permit required for the lawful importation, acquisition, or ownership of any products, including customs declarations, import permits or certificates of origin, as applicable.

3.22 Opinion of Financial Advisor. The Company Board has received the opinion (the “Company Fairness Opinion”) of

J.P. Morgan Securities LLC (the “Company Financial Advisor”), to the effect that, as of the date of the Company Fairness Opinion, and based upon and subject to the assumptions made, procedures followed, matters considered and

limitations on the review undertaken by the Company Financial Advisor in preparing the Company Fairness Opinion, the Merger Consideration is fair from a financial point of view to the holders of Company Common Stock.

3.23 Information Supplied. The information supplied or to be supplied by the Company in writing expressly for inclusion or

incorporation in the Registration Statement shall not at the time the Registration Statement is filed with the SEC, is amended or supplemented or is declared effective by the SEC contain any untrue statement of a material fact or omit to state any

material fact required to be stated therein or necessary in order to make the statements therein not misleading, except that no representation or warranty is made by the Company with respect to statements made therein based on information supplied

by the Parent Parties or any of their respective Parent Representatives for inclusion therein. The information supplied or to be supplied by the Company in writing expressly for inclusion in the Proxy Statement/Prospectus, which shall be included in

the Registration Statement, shall not, on the date the Proxy Statement/Prospectus or any amendment or supplement thereto, as applicable, is first filed with the SEC and at the time it is first mailed to the shareholders of the Company or at the time

of the Company Shareholders Meeting or at the Effective Time, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the

circumstances under which they were made, not misleading, except that no representation or warranty is made by the Company with respect to statements made therein based on information supplied by the Parent Parties or any of their respective Parent

Representatives for inclusion therein. The Proxy Statement/Prospectus will comply as to form in all material respects with the provisions of the Securities Act and the Exchange Act, and the rules and regulations promulgated thereunder.

3.24 State Takeover Statutes. Assuming the representations and warranties of Parent contained in Section 4.11

are true and correct, no “fair price”, “moratorium”, “business combination”, “control share acquisition” or other similar anti-takeover statute or regulation or any anti-takeover provision in the

Company Charter or Company Bylaws is applicable to the Merger or the other transactions contemplated by this Agreement. There is no shareholder rights plan, “poison pill” or similar agreement or arrangement adopted by the Company

designed to have the effect of delaying, deferring or discouraging any Person from acquiring control of the Company.

3.25 Related Party Transactions. Since January 1, 2023, there have been no

transactions or contracts between the Company or any Company Subsidiaries, on the one hand, and any affiliates (other than Company Subsidiaries) of the Company or other Persons, on the other hand, that would be required to be reported by the Company

pursuant to Item 404 of Regulation S-K promulgated by the SEC that have not been so reported (each a “Company Related Party”).

3.26 Insurance. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse

Effect, (a) all insurance policies and material self-insurance programs maintained by the Company or any Company Subsidiary, are in full force and effect and provide insurance in such amounts and against such risks as the management of such

party reasonably has determined to be prudent in accordance with industry practices or as is required by Law, and all premiums due and payable thereon have been paid; and (b) neither the Company nor any Company Subsidiary is in breach or

default of any of the insurance policies, and neither the Company nor any Company Subsidiary has taken any action or failed to take any action which, with notice or the lapse of time, would constitute such a breach or default or permit termination

or material modification of any of the insurance policies. Neither the Company nor any Company Subsidiary has received any written notice of termination or cancellation or denial of coverage with respect to any material insurance policy.

3.27 Brokers. Except for the Company’s obligations to the Company Financial Advisor, no broker, investment banker, financial

advisor or other Person is entitled to any brokerage, finders’, advisory or similar fee or commission in connection with the transactions contemplated by this Agreement, including the Merger. The Company has made available to Parent a true and

complete copy of such agreement with the Company Financial Advisor.

3.28 Joint Ventures. Except as would not reasonably be

expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i) there is currently no violation of, default or breach under any Company Joint Venture’s organizational documents and the execution and delivery of,

compliance with, performance under or consummation of this Agreement shall not result in any such violation, default or breach, (ii) each Company Joint Venture’s outstanding shares of capital stock or other equity interests (if any) is

duly authorized, validly issued, fully paid and non-assessable, (iii) there are no remaining capital contributions or other payments due to any Company Joint Venture from the Company or any Company

Subsidiary, and (iv) there are no preemptive or other outstanding rights, options, warrants, conversion rights, stock appreciation rights, stock-based units (performance based or otherwise), redemption rights, repurchase rights, agreements,

arrangements, calls, rights of first refusal or first offer, profits interests, commitments or rights of any kind that obligate any Company Joint Venture to issue or sell, or which relate to, any shares of capital stock or other equity interests of

such Company Joint Venture or any securities or obligations convertible or exchangeable into or exercisable for, or giving any person a right to subscribe for or acquire, any shares of capital stock or other equity interests of such Company Joint

Venture, and no securities or obligations evidencing such rights are authorized, issued or outstanding.

3.29 No Other Representations or Warranties.

(a)Except for the representations and warranties expressly set forth in this Article 3, none of the Company, any of its affiliates or

any other Person on behalf of the Company makes any express or implied representation or warranty (and there is and has been no reliance Parent Parties or any of their respective affiliates or Parent Representatives on any such representation or

warranty) with respect to the Company, the Company Subsidiaries or their respective businesses or with respect to any other information provided, or made available, to Parent Parties or their respective Parent Representatives or affiliates in

connection with the transactions contemplated hereby, including the accuracy or completeness thereof. Without limiting the foregoing, neither the Company nor any other Person shall have or be subject to any liability or other obligation to the

Parent Parties or their respective Parent Representatives or affiliates or any other Person resulting from the Parent Parties’ or the Parent Representatives’ or affiliates’ use of any information, documents, projections, estimates,

forecasts or other material made available to the Parent Parties or their respective Parent Representatives or affiliates, including any information made available in the electronic data room maintained by the Company for purposes of the

transactions contemplated by this Agreement, teaser, marketing material, confidential information memorandum, management presentations, functional “break-out” discussions, responses to questions

submitted on behalf of the Parent Parties or their respective Parent Representatives or in any other form in connection with the transactions contemplated by this Agreement, in each case, unless and to the extent any such information is expressly

included in a representation or warranty contained in this Article 3.

(b)The Company has conducted its own independent review and

analysis of the business, operations, assets, intellectual property, technology, liabilities, results of operations, financial condition and prospects of Parent and its Subsidiaries and acknowledges that the Company has received access to such books

and records, facilities, equipment, contracts and other assets of Parent and its Subsidiaries that the Company and the Company Representatives have requested to review, and that it and the Company Representatives have had the opportunity to meet

with the management of Parent and to discuss the business and assets of Parent and its Subsidiaries. The Company acknowledges that neither Parent Parties nor any Person on behalf of the Parent Parties makes, and none of the Company has relied upon,

any express or implied representation or warranty with respect to Parent or any of its Subsidiaries or with respect to any other information provided to the Company in connection with the transactions contemplated hereby including the accuracy or

completeness thereof other than the representations and warranties contained in Article 4. The Company acknowledges and agrees that, to the fullest extent permitted by applicable Law, Parent, Merger Sub and the Subsidiaries of Parent, and

their respective affiliates, shareholders, controlling persons or Parent Representatives shall not have any liability or responsibility whatsoever to the Company, or its affiliates, stockholders, controlling persons or Company Representatives on any

basis (including in contract or tort, under federal or state securities Laws or otherwise) based upon any information (including any statement, document or agreement delivered pursuant to this Agreement and any financial statements and any

projections, estimates or other forward-looking information) provided or made available (including in any data rooms, management presentations, information or descriptive memorandum or supplemental information), or statements made (or any omissions

therefrom), to the Company, or any of its affiliates, stockholders, controlling persons or Company Representatives, except as and only to the extent expressly set forth in Article 4. Notwithstanding anything to the contrary contained in this

Section 3.29 or elsewhere in this Agreement, nothing in this Section 3.29 shall limit any right or remedy of the Company in the event of Fraud by Parent or Merger Sub (regardless of whether or not

such Fraud relates to an express representation or warranty set forth in Article 4 or in any certificate delivered by Parent or Merger Sub to the Company in accordance with the terms hereof).

Article 4

REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

Except (a) as set forth in the disclosure schedule delivered by Parent to the Company (the “Parent Disclosure

Schedule”) concurrent with the execution of this Agreement (with specific reference to the representations and warranties in this Article 4 to which the information in such schedule relate; provided, that, disclosure

in the Parent Disclosure Schedule as to a specific representation or warranty shall qualify one or more other sections of this Agreement to the extent (notwithstanding the absence of a specific cross reference) it is reasonably apparent on its face

that such disclosure relates to such other sections); provided, further, that nothing in the Parent Disclosure Schedule is intended to broaden the scope of any representation, warranty, covenant or agreement of the Parent Parties made

herein and no reference to or disclosure of any item or other matter in the Parent Disclosure Schedule shall be construed as an admission or indication that (i) such item or other matter is material, (ii) such item or other matter is

required to be referred to in the Parent Disclosure Schedule, (iii) any breach or violation of applicable Laws or any contract, agreement, arrangement or understanding to which a Parent Party is a party exists or has actually occurred, or

(iv) such item or other matter constitutes an admission to any third party, and no reference to or disclosure of any item or other matter in the Parent Disclosure Schedule shall give rise to any claim or benefit to any Person who is not a party

to this Agreement, and (b) as otherwise disclosed or identified in the Parent SEC Documents filed, furnished, amended or supplemented at least two (2) Business Days prior to the date hereof (other than forward-looking disclosures contained

in the “Forward Looking Statements” and “Risk Factors” sections of the Parent SEC Documents and any other disclosures included in the Parent SEC Documents to the extent they are primarily predictive, cautionary or

forward-looking in nature, but including any historical or factual matters disclosed in such sections), each Parent Party each hereby jointly and severally represent and warrant to the Company as follows:

4.1 Organization and Qualification; Subsidiaries.

(a) Each Parent Party is a corporation or other legal entity duly organized, validly existing and in good standing (with respect to

jurisdictions which recognize such concept) under the Laws of its jurisdiction of incorporation or organization. Parent has the requisite corporate power and authority to own, lease and operate its properties and assets and to carry on its business

as it is now being conducted in all material respects.

(b) Each Parent Party is duly qualified to do business and is in good standing in

each jurisdiction in which the nature of the business conducted by it or the character or location of the properties, rights and assets owned or leased by it makes such licensing or qualification necessary, except where the failure to be so

qualified or in good standing has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.

complete copies of (i) any amendment to the Amended and Restated Certificate of Incorporation of Parent (as amended, the “Parent Charter”) not filed prior to the date hereof with the SEC, (ii) any amendments to the

Bylaws of Parent (as amended, the “Parent Bylaws”) not filed prior to the date hereof with the SEC, (iii) the articles of incorporation and bylaws of Merger Sub and any amendments to such documents. All such

organizational documents, including the Parent Bylaws and the Parent Charter, are in full force and effect and neither Parent nor Merger Sub is in violation of any of the provisions of their organizational documents in any material respect.

(d) Parent owns, beneficially and of record, directly or indirectly, all Equity Interests of Merger Sub free and clear of any Liens other

than Permitted Liens. Merger Sub is a direct, wholly owned Subsidiary of Parent, has been newly formed solely for the purpose of engaging in the Merger and has not engaged in any activity other than in connection with the Merger and the transactions

contemplated hereby.

4.2 Capitalization.

(a) The authorized capital stock of Parent consists of (i) 500,000,000 shares of Parent Common Stock, par value $0.01 per share, of which, as

of the close of business on April 9, 2026 (the “Parent Capitalization Date”), there were 210,340,624 shares of Parent Common Stock issued and outstanding and (ii) 10,000,000 shares of preferred stock, par value $0.01

per share, of the Parent (“Parent Preferred Stock” and together with the Parent Common Stock, the “Parent Stock”). As of the Parent Capitalization Date no shares of Parent Preferred Stock are issued and

outstanding. No Parent Subsidiary owns any shares of Parent Stock or has any option or warrant to purchase shares of any Parent Stock or any other Equity Interest in Parent. All of the outstanding shares of Parent Common Stock have been duly

authorized and validly issued and are fully paid, non-assessable and free of preemptive rights and have been issued in compliance with all applicable securities Laws.

(b) As of the close of business on the Parent Capitalization Date, Parent has no shares of Parent Stock subject to or reserved for issuance,

except for Parent Common Stock reserved for issuance pursuant to Parent Equity Awards.

were (i) 2,930,904 shares of Parent Common Stock underlying outstanding Parent Options, (ii) 1,157,394 shares of Parent Common Stock underlying outstanding Parent RSU Awards, (iii) 732,939 shares of Parent Common Stock underlying outstanding Parent

PSU Awards, assuming target achievement level of all outstanding performance-based restricted stock unit awards, and (iv) 6,201,237 shares of Parent Common Stock reserved for issuance under the Parent Equity Plan.

(d) All shares of Parent Common Stock subject to issuance under the Parent Equity Plan upon issuance prior to the Effective Time on the terms

and conditions specified in the instruments pursuant to which they are issuable, shall be duly authorized, validly issued, fully paid, non-assessable and free of preemptive rights.

(e) Except as set forth in Section 4.2(c), there are no outstanding Equity Interests

or other options, phantom equity, warrants or other rights, relating to or based on the value of any Equity Interests of Parent or any Parent Subsidiary or obligating Parent or any Parent Subsidiary to issue, acquire or sell any Equity Interests of

Parent or any Parent Subsidiary. From the close of business on the Parent Capitalization Date until the date hereof, Parent has not issued any Parent Common Stock or other Equity Interests other than Parent Common Stock issued upon the exercise or

settlement of Parent Equity Awards outstanding as of the close of business on the Parent Capitalization Date in accordance with their terms.

(f) Except with respect to the Parent Equity Awards, there are no outstanding obligations of Parent or any Parent Subsidiary

sale of or (v) granting any preemptive or anti-dilutive rights with respect to, any Parent Common Stock or other Equity Interests of Parent or any Parent Subsidiary.

4.3 Authority. Each Parent Party has all necessary power and authority to execute and deliver this Agreement, to perform its

obligations hereunder and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement by the Parent Parties and the consummation by the Parent Parties of the transactions contemplated hereby (subject to the

adoption of this Agreement by Parent as the sole stockholder of Merger Sub) have been duly and validly authorized by all necessary corporate action. Each Parent Party has duly and validly executed and delivered this Agreement and, assuming due and

valid authorization, execution and delivery by the other Parent Party and the Company, this Agreement constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms, except as limited by Enforceability

Limitations.

4.4 No Conflict. Subject to receipt of the Required Company Vote and the adoption of this Agreement by Parent as the

sole stockholder of Merger Sub, none of the execution, delivery or performance of this Agreement by each Parent Party, including, the Merger or any other transaction contemplated by this Agreement will (with or without notice or lapse of time, or

both): (a) conflict with, breach or violate any provision of the Parent Charter or the Parent Bylaws or the organizational or governing documents of Merger Sub; (b) assuming that all consents, approvals, authorizations and permits

described in Section 4.5 have been obtained and all filings and notifications described in Section 4.5 have been made and any waiting periods thereunder have terminated or expired, conflict with or

violate, or give any Person the right to challenge the Merger or any of the other transactions contemplated by this Agreement or to exercise any remedy or obtain any relief under any Law applicable to any Parent Party or any of their respective

properties, rights or assets; or (c) require any consent or approval under, violate, conflict with, result in any breach of (with or without the lapse of time, the giving of notice or both) or any loss of any benefit under, or constitute a

change of control or default under, or result in termination or give to others any right of termination, vesting, amendment, modification, acceleration or cancellation of, or result in the creation of a Lien (other than Permitted Liens) upon any of

the respective properties, rights or assets of any Parent Party pursuant to any Contract or permit to which any Parent Party is a party, except, with respect to clauses (b) and (c), for any such conflicts, violations,

consents, breaches, losses, changes of control, defaults, rights, other occurrences or Liens which would not, individually or in the aggregate, reasonably be expected to (i) have a Parent Material Adverse Effect or (ii) prevent, materially

delay or materially impair the ability of Parent to perform its obligations under this Agreement or to consummate the Merger.

4.5 Required Filings and Consents. Assuming the accuracy of the representations and

warranties of the Company in Section 3.4, none of the execution, delivery or performance of this Agreement by the Parent Parties, including the consummation by the Parent Parties of the Merger, or any other transaction

contemplated by this Agreement will require (with or without notice or lapse of time, or both) any consent, approval, authorization or permit of, or filing or registration with or notification to, any Governmental Entity, other than (a) the

filing of the Articles of Merger as required by the GBCLM, (b) compliance with any applicable requirements of any Competition Laws, (c) compliance with the applicable requirements of the Exchange Act, Securities Act and any other

applicable U.S. state or federal securities Laws, (d) filings with the SEC as may be required by Parent in connection with this Agreement and the transactions contemplated hereby, and (e) where the failure to obtain such consents,

approvals, authorizations or permits of, or to make such filings, registrations with or notifications to any Governmental Entity would not reasonably be expected to (i) have a Parent Material Adverse Effect or (ii) prevent, materially

delay or materially impair the ability of Parent to perform its obligations under this Agreement or to consummate the Merger.

4.6

Compliance With Law. Neither Parent nor any Parent Subsidiary is, or since January 1, 2023, has been in conflict with, default under or violation of any Law applicable to Parent or any Parent Subsidiary or by which any property, rights

or asset of Parent or any Parent Subsidiary is bound or affected, except for any conflicts, defaults or violations that have not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.

Neither Parent nor any Parent Subsidiary has received since January 1, 2023 any written notice or, to the Knowledge of Parent, other communication from any Governmental Entity regarding any actual, alleged, potential or possible violation of,

or failure to comply with any Law, except for any violations or failures to comply that have not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. No investigation by any

Governmental Entity with respect to Parent or any Parent Subsidiary is pending, nor has any Governmental Entity indicated to Parent an intention to conduct any such investigation, except for such investigations, the outcomes of which if determined

adversely to Parent or any Parent Subsidiary have not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.

4.7 SEC Filings; Financial Statements.

(a) Parent has filed or furnished all reports, schedules, forms, statements, registration statements, prospectuses and other documents

required to be filed or furnished by Parent with the SEC under the Securities Act or the Exchange Act since January 1, 2024 (the “Parent SEC Documents”). No Parent Subsidiary is required to make any filings with the SEC.

(b) As of its respective filing date, and, if amended, as of the date of the last amendment

prior to the date hereof, each Parent SEC Document complied in all material respects with the requirements of the Exchange Act, the Securities Act or the Sarbanes-Oxley Act, as the case may be, and the rules and regulations of the SEC promulgated

thereunder applicable to such Parent SEC Document, and did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the

circumstances under which they were made, not misleading, except that information set forth in the Parent SEC Documents as of a later date (but before the date of this Agreement) will be deemed to modify information as of an earlier date. As of the

date of this Agreement, there are no unresolved comments issued by the staff of the SEC with respect to any of the Parent SEC Documents. As of the date of this Agreement, to the Knowledge of Parent, none of the Parent SEC Documents is the subject of

any ongoing review by the SEC.

each case, any notes or schedules thereto) (the “Parent Financial Statements”) fairly present, in all material respects, the consolidated financial condition and the consolidated results of operations, cash flows and changes in

stockholders’ equity of Parent and its Subsidiaries (on a consolidated basis) as of the respective dates of and for the periods referred to in the Parent Financial Statements, and were prepared in accordance with GAAP applied on a consistent

basis during the periods involved (except as may be indicated in the notes thereto), subject, in the case of any interim unaudited Parent Financial Statements, to normal year-end adjustments and the absence of

notes and other presentation items. No financial statements of any Person other than Parent and the Parent Subsidiaries are required by GAAP to be included in the consolidated financial statements of Parent.

(d) Parent has established and maintains disclosure controls and procedures and internal control over financial reporting (as such terms are

defined in paragraphs (e) and (f), respectively, of Rule 13a-15 and paragraph (e) of Rule 15d-15 under the Exchange Act) as required by Rules 13a-15 and 15d-15 under the Exchange Act. Parent’s disclosure controls and procedures are designed to ensure that all material information (both financial and

non-financial) required to be disclosed by Parent in the reports that it files or furnishes under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules

and forms of the SEC, and that such material information is accumulated and communicated to Parent’s management as appropriate to allow timely decisions regarding required disclosure and to make the certifications required pursuant to

Sections 302 and 906 of the Sarbanes-Oxley Act. Parent’s management has completed an assessment of the effectiveness of Parent’s disclosure controls and procedures and, to the extent required by applicable Law, presented in any

applicable Parent SEC Document that is a report on Form 10-K or Form 10-Q, or any amendment thereto, its conclusions about the effectiveness of the disclosure controls

and procedures as of the end of the period covered by such report or amendment based on such evaluation. Since January 1, 2024, to the Knowledge of Parent, Parent has not had: (i) any significant deficiency or material weakness in the

design or operation of its internal control over financial reporting that is reasonably likely to adversely affect Parent’s ability to record, process, summarize and report financial information; or (ii) any fraud, whether or not

material, that involves management or any other employee (or former employee) who has (or has had) a significant role in Parent’s internal control over financial reporting.

4.8 Absence of Certain Changes or Events. Since January 1, 2026 through the date

hereof:

(a) Except for the discussion and negotiation of this Agreement, Parent and the Parent Subsidiaries have conducted their

respective businesses in all material respects in the ordinary course of business consistent with past practice.

(b) None of the Parent

Parties have taken any action, or authorized, approved, committed, agreed or offered to take any action, that if taken after the date hereof and prior to the Closing would have required the Company’s consent under Sections 5.2(b)(i),

5.2(b)(iii) and 5.2(b)(iv).

reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.

4.9 Litigation. As of the date

hereof, there are no Proceedings pending, or to the Knowledge of Parent, threatened (a) against Parent or any Parent Subsidiary or any of their respective assets or properties or any of the officers or directors of Parent, except, in each case,

for those that are not and would not reasonably be expected to be, individually or in the aggregate, material to Parent and the Parent Subsidiaries, taken as a whole, or (b) that challenges the validity or propriety of, or that is intended to

have the effect of preventing, hindering, modifying, challenging or delaying the Merger or the other transactions contemplated hereby. Neither Parent nor any Parent Subsidiary, nor any of the assets owned or used by any of Parent or its Subsidiaries

is subject to any Order or, to the Knowledge of Parent, investigation, pending or threatened, that is or would not reasonably be expected to be, individually or in the aggregate, material to Parent and the Parent Subsidiaries, taken as a whole.

4.10 Information Supplied. The information supplied or to be supplied by Parent in writing expressly for inclusion or incorporation in

the Registration Statement shall not at the time the Registration Statement is filed with the SEC, is amended or supplemented or is declared effective by the SEC contain any untrue statement of a material fact or omit to state any material fact

required to be stated therein or necessary in order to make the statements therein not misleading, except that no representation or warranty is made by Parent with respect to statements made therein based on information supplied by the Company or

its Company Representatives for inclusion therein. The information supplied or to be supplied by Parent in writing expressly for inclusion in the Proxy Statement/Prospectus, which shall be included in the Registration Statement, shall not, on the

date the Proxy Statement/Prospectus or any amendment or supplement thereto, as applicable, is first filed with the SEC and at the time it is first mailed to the shareholders of the Company or at the time of the Company Shareholders Meeting or at the

Effective Time, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not

misleading, except that no representation or warranty is made by Parent with respect to statements made therein based on information supplied by the Company or its Company Representatives for inclusion therein. The Proxy Statement/Prospectus will

comply as to form in all material respects with the provisions of the Securities Act and the Exchange Act, and the rules and regulations promulgated thereunder.

4.11 State Takeover Statutes. Neither Parent, any Parent Subsidiary nor any of their

respective affiliates (as such term is defined in Section 351.459 of the GBCLM) is, or has within the last five (5) years been deemed to be, (a) an “interested shareholder” of the Company for purposes of

Section 351.459 of the GBCLM or (b) an “Interested Shareholder” of the Company for purposes of the Company Charter or Company Bylaws. As of the date of this Agreement, none of Parent or any Parent Subsidiary owns any shares of

capital stock of the Company or has any rights to acquire any shares of capital stock of the Company (except pursuant to this Agreement).

4.12 Adequacy of Funds. Parent has, as of the date hereof, and Parent will have, as of the Closing, (a) sufficient Parent Common

Stock authorized to issue the aggregate Merger Consideration and (b) sufficient financial resources to pay all amounts required to consummate and perform its obligations with respect to the Merger and the other transactions contemplated hereby

on the terms and subject to the conditions contemplated hereby.

4.13 Intended Tax Treatment. None of the Parent Parties or, to the

Knowledge of Parent, any of Parent’s affiliates has taken (or failed to take) or agreed to take (or agreed to refrain from taking) any action or is aware of any facts, agreements, plans or other circumstances that it would reasonably expect

would prevent or impede the Merger from qualifying for the Intended Tax Treatment.

4.14 Brokers. No broker, investment banker,

financial advisor or other Person is entitled to any brokerage, finders’, advisory or similar fee in connection with the transactions contemplated by this Agreement, including the Merger, for which the Company or any Company Subsidiary would

be liable.

4.15 No Other Representations or Warranties.

(a) Except for the representations and warranties expressly set forth in this Article 4, none of the Parent Parties, any of their

respective affiliates or any other Person on behalf of Parent makes any express or implied representation or warranty with respect to Parent, the Parent Subsidiaries or their respective businesses or with respect to any other information provided,

or made available, to the Company or the Company Representatives or the Company’s affiliates in connection with the transactions contemplated hereby, including the accuracy or completeness thereof. Without limiting the foregoing, neither

Parent, Merger Sub nor any other Person shall have or be subject to any liability or other obligation to the Company or the Company Representatives or the Company’s affiliates or any other Person resulting from the Company’s or the

Company’s Representatives’ or the Company’s affiliates’ use of any information, documents, projections, estimates, forecasts or other material made available to the Company or the Company’s Representatives or the

Company’s affiliates, including any information made available in the electronic data room maintained by Parent for purposes of the transactions contemplated by this Agreement, teaser, marketing material, confidential information memorandum,

management presentations, functional “break-out” discussions, responses to questions submitted on behalf of the Company or the Company Representatives or in any other form in connection with the

transactions contemplated by this Agreement, in each case, unless and to the extent any such information is expressly included in a representation or warranty contained in this Article 4.

(b) The Parent Parties have conducted their own independent review and analysis of the

business, operations, assets, intellectual property, technology, liabilities, results of operations, financial condition and prospects of the Company and its Subsidiaries and each of them acknowledges that such Parent Party and Parent

Representatives have received access to such books and records, facilities, equipment, contracts and other assets of the Company and its Subsidiaries that such Parent Party and the Parent Representatives have requested to review, and that it and the

Parent Representatives have had the opportunity to meet with the management of the Company and to discuss the business and assets of the Company and its Subsidiaries. Each Parent Party acknowledges that neither the Company nor any Person on behalf

of the Company makes, and none of the Parent Parties has relied upon, any express or implied representation or warranty with respect to the Company or any of its Subsidiaries or with respect to any other information provided to the Parent Parties in

connection with the transactions contemplated hereby including the accuracy or completeness thereof other than the representations and warranties contained in Article 3. The Parent Parties acknowledge and agree that, to the fullest extent

permitted by applicable Law, the Company and its Subsidiaries, and their respective affiliates, shareholders, controlling persons or Company Representatives shall not have any liability or responsibility whatsoever to the Parent Parties or their

respective affiliates, stockholders, controlling persons or Parent Representatives on any basis (including in contract or tort, under federal or state securities Laws or otherwise) based upon any information (including any statement, document or

agreement delivered pursuant to this Agreement and any financial statements and any projections, estimates or other forward-looking information) provided or made available (including in any data rooms, management presentations, information or

descriptive memorandum or supplemental information), or statements made (or any omissions therefrom), to the Parent Parties or any of their respective affiliates, stockholders, controlling persons or Parent Representatives, except as and only to the

extent expressly set forth in Article 3. Notwithstanding anything to the contrary contained in this Section 4.15 or elsewhere in this Agreement, nothing in this Section 4.15 shall limit any

right or remedy of the Parent Parties in the event of Fraud by the Company (regardless of whether or not such Fraud relates to an express representation or warranty set forth in Article 3 or in any certificate delivered by the Company to

Parent or Merger Sub in accordance with the terms hereof).

Article 5

CONDUCT OF THE PARTIES

5.1 Conduct of Business by the Company Pending the Closing.

(a) The Company agrees that, between the date hereof and the earlier of the Effective Time and the valid termination of this Agreement in

accordance with Article 8, except (w) as set forth in Section 5.1(a) of the Company Disclosure Schedule, (x) as required by applicable Law, (y) as expressly required or contemplated by this Agreement

(including declaring and paying the Special Dividend) or (z) otherwise with the prior written consent of Parent (not to be unreasonably withheld, conditioned or delayed), the Company shall, and shall cause each Company Subsidiary to, use

commercially reasonable efforts to (I) conduct its operations only in the ordinary course of business consistent with past practice and (II) maintain and preserve its business and material assets and current organization and to preserve

the rights, franchises, goodwill and relationships with clients, customers, suppliers, distributors, landlords, creditors, lenders, licensors, licensees, employees, regulators and other Persons having significant business relations with the Company

or its Subsidiaries, and comply with all applicable Laws in all material respects.

(b)Except (w) as set forth in Section 5.1(b) of the Company

Disclosure Schedule, (x) as required by applicable Law, (y) as expressly required or contemplated by this Agreement (including declaring and paying the Special Dividend), or (z) otherwise with the prior written consent of Parent (not

to be unreasonably withheld, conditioned or delayed), the Company shall not, and shall not permit any Company Subsidiary to, between the date hereof and the earlier of the Effective Time and the valid termination of this Agreement in accordance with

Article 8, directly or indirectly, take any of the following actions:

(i) amend, adopt, modify, waive, rescind or otherwise change

(whether by merger, consolidation or otherwise) its articles of incorporation or bylaws or equivalent organizational documents, in any manner, except for immaterial or ministerial amendments or amendments required by changes in Law;

(ii) issue, sell, pledge, dispose of, grant, transfer or encumber any shares of capital stock of, or other Equity Interests in, the Company

or any Company Subsidiary, or securities convertible into, or exchangeable or exercisable for, any shares of such capital stock or other Equity Interests, or any options, warrants or other rights of any kind to acquire any shares of such capital

stock or other Equity Interests or such convertible or exchangeable securities, or any other ownership interest (including any such interest represented by Contract right), other than transactions between the Company and any wholly owned Company

Subsidiary or among wholly owned Company Subsidiaries or the issuance of Company Common Stock upon the exercise, vesting or settlement, as applicable, of Company Equity Awards outstanding as of the date hereof, or otherwise permitted to be granted

hereunder in accordance with their terms and pledges of capital stock of any Company Subsidiaries in connection with the incurrence or refinancing of indebtedness permitted under Section 5.1(b)(viii);

(iii) sell, pledge, dispose of (whether by merger, consolidation, disposition of stock or assets or otherwise), transfer, lease, license,

abandon, allow to lapse, guarantee, grant a franchise to, grant a Lien over, or encumber or otherwise transfer any line of business or any material property or assets (not including Intellectual Property) (other than transactions between the Company

and any wholly owned Company Subsidiary or among wholly owned Company Subsidiaries), except (a) pursuant to the Contracts in effect prior to the date hereof (as set forth in Section 5.1(b)(iii) of the Company

Disclosure Schedule), (b) non-exclusive, revocable licenses, (c) Permitted Liens or (d) any such actions with respect to inventory, raw materials, equipment, supplies and surplus, unused or obsolete

assets in the ordinary course of business consistent with past practice;

(iv) declare, set aside, authorize, make or pay any dividend or

other distribution (whether payable in cash, stock, property or a combination thereof) with respect to any of its capital stock or other Equity Interests (other than Permitted Company Dividends, the Special Dividend and dividends paid by a wholly

owned Company Subsidiary to the Company or another wholly owned Company Subsidiary) or enter into any agreement or Contract with respect to the voting or registration of its capital stock or other Equity Interests;

(v) reclassify, combine, split, reverse split, subdivide or amend the terms of, or redeem,

purchase, repurchase or otherwise acquire, directly or indirectly, any of its capital stock, or other Equity Interests, or securities convertible into, or exchangeable or exercisable for, any shares of such capital stock or other Equity Interests,

or any options, warrants or other rights of any kind to acquire any shares of such capital stock or other Equity Interests or such convertible or exchangeable securities, or any other ownership interest (including any such interest represented by

Contract right), except (a) the satisfaction of exercise price and/or Tax withholding obligations in connection with the vesting, exercise and/or settlement of Company Equity Awards in accordance with the terms of such awards as in effect on

the date hereof or (b) upon the forfeiture of outstanding Company Equity Awards pursuant to their terms upon the termination of the employment of the holder thereof or otherwise;

(vi) merge or consolidate the Company or any Company Subsidiary with any Person or engage in, authorize, enter into or adopt a plan of

complete or partial liquidation, dissolution, restructuring, recapitalization or other reorganization or resolutions providing for a complete or partial liquidation, dissolution, restructuring, recapitalization or other reorganization of the Company

or any Company Subsidiary or the filing of a petition in bankruptcy or consent to the filing of any bankruptcy petition against it, other than a merger with and into another wholly owned Company Subsidiary;

(vii) purchase or acquire, directly or indirectly (including by merger, consolidation, or acquisition of stock or assets) whether in a single

transaction or a series of transactions, any corporation, partnership, limited liability company, joint venture, other business organization or division thereof, or any other business or any Equity Interest in any Person, or any assets of any

Person, other than (a) any acquisitions with consideration of less than $10,000,000 individually or with aggregate consideration of less than $25,000,000 (across all such acquisitions), or (b) the purchase of goods, equipment and other

operating assets in the ordinary course of business consistent with past practice;

(viii) (a) incur any indebtedness for borrowed money

(including any borrowings under any revolving credit facility, commercial paper facility or other similar working capital or other facility), in excess of $25,000,000 in the aggregate, or issue any debt securities or assume, guarantee or endorse, or

otherwise as an accommodation become responsible for (whether directly, contingently or otherwise), the obligations of any Person for borrowed money, except, in each case, for (i) corporate guarantees issued in the ordinary course of business

consistent with past practice, (ii) any refinancing of the Company’s existing indebtedness for borrowed money that is not prohibited by clause 5.1(b)(viii)(b) hereof, (iii) intercompany borrowings between the Company

and any wholly owned Company Subsidiary or among wholly owned Company Subsidiaries, (iv) borrowings under the Company’s existing credit facilities, in an aggregate amount (when combined with the amount of commercial paper issued pursuant

to clause (v)) not to exceed, $150,000,000, (v) issuances of commercial paper for working capital or general corporate purposes in the ordinary course of business in an aggregate amount (when combined with the amount of borrowings pursuant to

clause (iv)) not to exceed, $150,000,000, or (vi) the entry into capital leases in the ordinary course of business; and (b) repay or refinance material Company indebtedness (including the Company Notes and the Company Credit

Facilities), unless (i) such refinancing is conducted in the three (3) months prior to the maturity date of the indebtedness being refinanced, (ii) the agreements governing such refinancing

indebtedness (A) explicitly provide that such refinancing indebtedness would be permitted to remain outstanding following the Closing, (B) permit the borrower or issuer of such

refinancing indebtedness to be replaced by the Parent or, at Parent’s option, one of its domestic subsidiaries after the Closing Date without any requirement for consent from the lenders, agents, trustees or holders of such refinancing

indebtedness (other than the satisfaction of reasonable and customary “know your customer” requirements, if any), and (C) permit such refinancing indebtedness to be repaid without any premium or penalty in connection with the

Closing and (iii) the Company has consulted with the Parent prior to conducting such refinancing; provided that the restrictions in this clause (b) shall not apply to any transaction with respect to the Company’s commercial

paper issued under the Company’s commercial paper program repaid or refinanced with new commercial paper issued under the Company’s commercial paper program or by using existing credit facilities, in each case, in the ordinary course of

business;

(ix) make any loans, advances or capital contributions to, or investments in, any other Person (other than contributions to or

investments in any wholly owned Company Subsidiary) or in the case of loans or advances to any directors, officers, employees or other individual service providers (other than loans or advances for travel or reasonable business expenses) in excess

of $100,000 in the aggregate;

(x) except as otherwise required by applicable Law, the terms of this Agreement or a Company Benefit Plan

in existence as of the date of this Agreement, (a) grant any severance or termination pay, (b) increase the annual base salary or target incentive compensation opportunity of any employee of the Company, other than in the ordinary course

of business consistent with past practice; provided, however, that the annual base salary for any Key Employee for any calendar year shall not be increased by a percentage greater than four and

one-tenth percent (4.1%) of such Key Employee’s annual base salary for the prior year (with each Key Employee’s target incentive compensation opportunity adjusted proportionally to reflect such

increase but not otherwise permitted to be increased), (c) establish, modify, enter into, recognize, certify or amend any Collective Bargaining Agreement, (d) terminate the employment or service relationship of any Key Employee (other than for

cause, as determined by the Company acting in good faith) or promote or hire any new Key Employee (other than to replace a former Key Employee who died, resigned, or was demoted or fired for cause), (e) adopt, enter into, terminate or materially

amend any Company Benefit Plan or amend any other benefit or compensation plan, policy, program, agreement or arrangement that would be a Company Benefit Plan if such amendment were in effect on the date hereof (other than changes to any Company

Benefit Plan that is a group health or welfare plan during the plan’s annual renewal or open enrollment process in the ordinary course of business consistent with past practice and to the extent that such changes do not materially increase the

cost of benefits under the applicable Company Benefit Plan), (f) take any action to amend or waive any performance or vesting criteria or accelerate the vesting, funding or time of payment of any compensation or other benefit (including a Company

Equity Award) with respect to any current or former individual service provider or otherwise modify any of the terms of any outstanding Company Equity Award, or (g) change any actuarial or other assumptions used to calculate funding obligations

with respect to any Company Benefit Plan, the manner in which contributions to such plans are made or the basis on which such contributions are determined (other than changes as required by GAAP or that do not materially increase the cost of

benefits under the applicable Company Benefit Plan);

(xi) implement or announce any employee layoffs, plant closings, reductions in force,

furloughs, temporary layoffs, salary or wage reductions, work schedule changes or other such actions, to the extent that any of the forgoing actions would reasonably be expected to trigger the notice requirements of the WARN Act;

(xii) agree to waive or release any material noncompetition, nonsolicitation, nondisclosure or other restrictive covenant obligation of any

Key Employee;

(xiii) except as required by a change in GAAP or by a Governmental Entity, make any material change to accounting

policies, practices, principles, methods or procedures (including with respect to reserves for excess or obsolete inventory, doubtful accounts or other reserves, depreciation or amortization policies or rates, revenue recognition policies and

billing and invoicing policies) or cash management or working capital management procedures (except for changes in cash management or working capital that are otherwise expressly permitted under Section 5.1(b)(viii));

(xiv) (A) waive, release, assign, compromise, settle, pay or agree to settle or pay any material Proceeding (which shall include any

Proceeding against any Significant Customer or Significant Supplier) other than in the ordinary course of business consistent with past practice or compromises, settlements or agreements that involve only the payment of monetary damages by the

Company or any Company Subsidiary in amount that is less than $5,000,000 in the aggregate or (B) initiate or commence any material Proceeding against any Significant Customer (other than Parent or its affiliates) or Significant Supplier;

(xv) make, change or revoke any material Tax election (other than elections consistent with past practice), change any annual Tax accounting

period for purposes of a material Tax, adopt (other than in the ordinary course of business) or change any material method of Tax accounting, file any amended material Tax Return, settle or compromise any audit or other proceeding relating to a

material amount of Taxes, intentionally surrender any right to claim a material refund of Taxes, or enter into any “closing agreement” within the meaning of Section 7121 of the Code (or any corresponding or similar provision of

state, local or non-U.S. Tax Law) with respect to material Taxes;

(xvi) sell, assign, pledge or

otherwise encumber, transfer, license, abandon, permit to lapse or otherwise dispose of any material Company Owned Intellectual Property, except for non-exclusive licenses granted in the ordinary

course of business;

(xvii) make any capital expenditure or expenditures, or enter into any agreement arrangement providing for, or

otherwise commit to providing, any capital expenditure or expenditures that exceed $150,000,000 in the aggregate per calendar year;

(xviii) enter into any “off-balance-sheet-arrangement” within the meaning of Item 303 of

Regulation S-K of the SEC;

(xix) enter into any Contract with any Company Related Party, except

as otherwise permitted pursuant to Section 5.1(b)(x);

(xx) enter into or amend or modify in any material respects, waive or assign any material

rights under, or consent to the termination of, any Company Material Contract or any other Contract or lease that, if in effect as of the date hereof, would constitute a Company Material Contract; except, in each case, (A) with respect to any

extensions of the term of any Company Real Property Leases; provided, that any such extension is on terms no less favorable than market terms in the aggregate and for no more than a five (5) year term, (B) with respect to any

letters of credit issued under any revolving credit facility entered into in the ordinary course of business or (C) in the ordinary course of business consistent with past practice or otherwise with respect to a Contract to which Parent or a

Parent Subsidiary is a party;

(xxi) become a party to or approve or adopt any stockholder rights plan or “poison pill”

agreement or similar takeover protection;

(xxii) enter into a new line of business that are expected to generate at least $15,000,000 of

revenue in any twelve (12) month period or abandon or discontinue any such existing line of business; or

(xxiii) agree, authorize

or enter into any Contract to do any of the foregoing or otherwise make any commitment to do any of the foregoing.

Notwithstanding the

foregoing, nothing contained in this Agreement shall give the Parent Parties, directly or indirectly, the right to control or direct any of the Company’s or the Company Subsidiaries’ operations prior to the Effective Time.

5.2 Conduct of Business by Parent Pending the Closing.

(a) Parent agrees that, between the date hereof and the earlier of the Effective Time and the valid termination of this Agreement in

accordance with Article 8, except (w) as set forth in Section 5.2 of the Parent Disclosure Schedule, (x) as required by applicable Law, (y) as expressly required or contemplated by this Agreement, or

(z) otherwise with the prior written consent of the Company (not to be unreasonably withheld, conditioned or delayed), Parent shall, and shall cause each Parent Subsidiary to use commercially reasonable efforts to (I) conduct its

operations only in the ordinary course of business consistent with past practice and (II) maintain and preserve its business and material assets and current organization and to preserve the rights, franchises, goodwill and relationships with

clients, customers, suppliers, distributors, landlords, creditors, lenders, licensors, licensees, employees, regulators and other Persons having significant business relations with Parent or its Subsidiaries, and comply with all applicable Laws in

all material respects.

(b) Except (w) as set forth in Section 5.2(b) of the Parent Disclosure Schedule,

(x) as required by applicable Law, (y) as expressly required or contemplated by this Agreement, or (z) otherwise with the prior written consent of the Company (not to be unreasonably withheld, conditioned or delayed), Parent shall

not, and shall not permit any Parent Subsidiary to, between the date hereof and the earlier of the Effective Time and the valid termination of this Agreement in accordance with Article 8, directly or indirectly, take any of the following

actions:

(i) amend, modify, waive, rescind or otherwise change Parent’s certificate of incorporation or bylaws in any way that

would be materially adverse to the holders of Company Common Stock or adversely affect the holders of Company Common Stock relative to the other holders of Parent Common Stock;

(ii) declare, set aside, authorize, make or pay any dividend or other distribution (whether

payable in cash, stock, property or a combination thereof) with respect to any of its capital stock or other Equity Interests (other than Permitted Parent Dividends and dividends paid by a wholly owned Parent Subsidiary to Parent or another Parent

Subsidiary);

(iii) unless any such action results in a modification of the Exchange Ratio in accordance with

Section 2.1(b), (A) reclassify, combine, split, reverse split, consolidate, subdivide or otherwise combine the Parent Common Stock, (B) pay a stock dividend or other stock distribution (with a record date during such

period) in the Parent Common Stock, (C) otherwise change the Parent Common Stock into any other securities, or (D) make any other such stock dividend or stock distribution (with a record date during such period) in capital stock of Parent

in respect of the Parent Common Stock;

(iv) adopt a plan or agreement of complete or partial liquidation, dissolution, restructuring,

recapitalization or other reorganization of Parent; or

(v) agree, authorize or enter into any Contract to do any of the foregoing or

otherwise make any commitment to do any of the foregoing.

Notwithstanding the foregoing, nothing contained in this Agreement shall give

the Company, directly or indirectly, the right to control or direct any of Parent’s or the Parent Subsidiaries’ operations prior to the Effective Time.

Article 6

ADDITIONAL

COVENANTS OF THE PARTIES

6.1 Proxy Statement/Prospectus and Registration Statement; Company Shareholders Meeting.

(a) Each of the parties shall cooperate in preparing and shall cause to be filed with the SEC as promptly as reasonably practicable after the

date hereof and in any event within seventy-five (75) days, mutually acceptable proxy materials which shall constitute the proxy statement/prospectus relating to the matters to be submitted to the holders of Company Common Stock at the Company

Shareholders Meeting to adopt this Agreement (the “Company Shareholders Meeting”) (such proxy statement/prospectus, and any amendments or supplements thereto, the “Proxy Statement/Prospectus”), and Parent shall

prepare and file with the SEC a registration statement on Form S-4 (of which the Proxy Statement/Prospectus shall be a part) pursuant to which shares of Parent Common Stock issuable in the Merger shall be

registered with the SEC (such registration statement, and any amendments or supplements thereto, the “Registration Statement”). Each party shall promptly furnish to the other parties all information required or reasonably

requested by the other parties in connection with any such action and the preparation, filing and distribution of the Registration Statement and the Proxy Statement/Prospectus. In addition, the Company shall use its reasonable best efforts to

(i) provide

interim financial statements of the Company and its Subsidiaries (including footnotes) that are required by the Securities Act to be included in the Registration Statement that have been reviewed

by the Company’s independent registered public accounting firm, (ii) provide management’s discussion and analysis of interim and annual consolidated financial statements, (iii) instruct the Company’s independent

registered public accounting firm to consent to the inclusion or incorporation by reference of the audit reports on the annual audited consolidated financial statements of the Company included in the Registration Statement, (iv) provide

information necessary to prepare selected financial data with respect to the Company as required by the Securities Act, and (v) provide information concerning the Company necessary to enable Parent and the Company to prepare required pro forma

financial statements and related footnotes, in each case, to the extent reasonably necessary to permit Parent to prepare the Registration Statement. Parent shall be responsible for all of the fees and expenses incurred in connection with the filing,

printing and mailing of the Proxy Statement/Prospectus and Registration Statement (including applicable SEC filing fees but excluding each party’s legal fees in connection therewith). Each of the parties shall use its reasonable best efforts

to cause the Registration Statement to become effective under the Securities Act as soon after such filing as practicable, to ensure that the Registration Statement complies in all material respects with the applicable provisions of the Securities

Act and the Exchange Act and to keep the Registration Statement effective as long as is necessary to consummate the transactions contemplated hereby. The Proxy Statement/Prospectus shall include the Company Board Recommendation, including to the

holders of Company Common Stock to adopt this Agreement, except to the extent there has been a Change of Board Recommendation permitted by Section 6.3 (in the case of the Company Board Recommendation). The Company shall use

its reasonable best efforts to cause the Proxy Statement/Prospectus to be mailed to its shareholders as promptly as practicable after the Registration Statement becomes effective and to ensure that the Proxy Statement/Prospectus complies in all

material respects with the applicable provisions of the Securities Act and Exchange Act. Each party shall promptly provide the other parties with copies of any written comments received from the SEC with respect to the Registration Statement or

Proxy Statement/Prospectus, as applicable, and promptly advise one another of any oral comments received from the SEC. Prior to filing the Registration Statement (or any amendment or supplement thereto) or mailing the Proxy Statement/Prospectus (or

any amendment or supplement thereto) or responding to any comments of the SEC with respect thereto, each of the Company and Parent shall cooperate and provide the other party a reasonable opportunity to review and comment on such document or

response in advance (including the proposed final version of such document or response) and consider any such comments reasonably requested and timely made in good faith. If at any time prior to the Effective Time any information relating to Parent

or the Company, or any of their respective affiliates, directors or officers, should be discovered by Parent or the Company which should be set forth in an amendment or supplement to either the Registration Statement or the Proxy

Statement/Prospectus, as applicable, so that either such document would not include any misstatement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were

made, not misleading, the party that discovers such information shall promptly notify the other party and an appropriate amendment or supplement describing such information shall be promptly filed with the SEC and, to the extent required by Law,

disseminated to the stockholders of Parent and the shareholders of the Company.

(b) Parent, Merger Sub and the Company, as applicable, shall make all necessary filings

with respect to the Merger and the other transactions contemplated hereby, and the Parent Parties shall make all necessary filings with respect to the issuance of the Merger Consideration in the Merger, in each case, as applicable, under the

Securities Act and the Exchange Act and applicable “blue sky” laws and the rules and regulations thereunder, except that Parent shall not be required to qualify to do business in any jurisdiction in which it is not now so qualified or

file a general consent to service of process in any jurisdiction. Each party shall advise the other, as promptly as practicable after it receives notice thereof, of the time when the Registration Statement has become effective or any supplement or

amendment has been filed, the issuance of any stop order, the suspension of the qualification of the Parent Common Stock issuable in connection with the Merger for offering or sale in any jurisdiction, or any request by the SEC for amendment of the

Proxy Statement/Prospectus or the Registration Statement or comments thereon and responses thereto or requests by the SEC for additional information. No amendment or supplement to the Proxy Statement/Prospectus or the Registration Statement shall be

filed without the approval of the parties, which approval shall not be unreasonably withheld, conditioned or delayed; provided that this right of approval shall not apply with respect to documents filed by a party which are incorporated by

reference in the Proxy Statement/Prospectus or the Registration Statement.

Recommendation as expressly permitted by Section 6.3, the Company, in consultation with Parent, shall duly take all action necessary in accordance with the GBCLM, the Company Charter, and the Company Bylaws to establish a

record date for, duly call, give notice of, convene and hold the Company Shareholders Meeting as promptly as reasonably practicable after the Registration Statement has become effective (but in no event later than seventy-five (75) days thereafter)

for the purpose of obtaining the Required Company Vote and shall not change such record date without the prior written consent of Parent (not to be unreasonably withheld, conditioned or delayed). In connection with such meeting, the Company (i)

shall solicit from the Company shareholders proxies, and use its reasonable best efforts to obtain the Required Company Vote and otherwise comply with all legal requirements applicable to such meeting and proxy solicitation, and (ii) shall not

submit any other proposal (other than matters of procedure and matters required by Law to be voted on by the Company’s shareholders in connection with the adoption of this Agreement and the approval of the transactions contemplated hereby) to

Company shareholders in connection with the Company Shareholders Meeting without the prior written consent of Parent (not to be unreasonably withheld, conditioned or delayed). Notwithstanding the foregoing, if the Company reasonably believes that

(A) after good faith consultation with the Company’s outside counsel and Parent, it is necessary to postpone or adjourn the Company Shareholders Meeting to ensure that any required supplement or amendment to the Proxy Statement/Prospectus is

provided to the shareholders of the Company within a reasonable amount of time in advance of the Company Shareholders Meeting or (B) (I) the Company will not receive proxies representing a sufficient number of shares of Company Common Stock to

obtain the Required Company Vote, whether or not a quorum is present, or (II) the Company will not have a sufficient number of shares of Company Common Stock represented (either in person or by proxy) to constitute a quorum necessary to conduct

the business of the Company Shareholders Meeting; the Company shall have the right to (after consultation with Parent), and shall upon request by Parent, on one or more occasions postpone or adjourn the Company Shareholders Meeting for the minimum

duration necessary to remedy the circumstances giving rise to such adjournment or postponement and not more than an aggregate of 30 days (in the case of clause (B) of this sentence) or 10 days but no longer than 30 days in the aggregate

(in the case of each supplement and amendment subject to clause (A) of this sentence), and the Company shall not, under any other circumstances, postpone or adjourn the Company Shareholders Meeting without the prior written consent of

Parent except as required by Law. The Company shall, upon the reasonable request of Parent, advise Parent prior to the date of the Company Shareholders Meeting as to the aggregate tally of proxies received by the Company with respect to the Required

Company Vote and other matters to be considered at the Company Shareholders Meeting.

6.2 Access to Information; Confidentiality.

(a) From the date hereof to the earlier of the Effective Time and the termination of this Agreement in accordance with Article 8, the

Company shall, and shall cause each Company Subsidiary to: (i) provide to the Parent Parties and the Parent Representatives reasonable access during normal business hours in such a manner as not to interfere unreasonably with the operation of

any business conducted by the Company or any Company Subsidiary upon prior written notice to the Company, to the officers, employees, agents, properties, offices and other facilities of the Company and each Company Subsidiary and to the books and

records thereof, (ii) use commercially reasonable efforts to furnish during normal business hours upon prior notice such documents or information concerning the business, properties, Contracts, assets and liabilities of the Company and each

Company Subsidiary as Parent or any Parent Representative may reasonably request (other than any of the foregoing that relate expressly and solely to any Acquisition Proposal, subject to the disclosure requirements set forth in

Section 6.3); provided, however, that the Company shall not be required to (or to cause any Company Subsidiary to) afford such access or furnish such information to the extent that the Company reasonably

believes that doing so would: (A) result in the loss of attorney-client privilege (but the Company shall use its commercially reasonable efforts to allow for such access or disclosure in a manner that does not result in a loss of

attorney-client privilege), (B) result in the disclosure of any trade secrets of third parties or (C) breach, contravene or violate any Contract or applicable Law (including Competition Laws) (but the Company shall use its commercially

reasonable efforts to allow for such access or disclosure in a manner that does not breach, contravene or violate such Contract or applicable Law). Notwithstanding anything herein to the contrary, nothing in this

Section 6.2(a) shall permit the Parent Parties or any Parent Representatives to perform any invasive or subsurface assessment (including any Phase II environmental site assessment or other invasive or subsurface

testing, sampling, monitoring or analysis) with respect to any property of the Company or the Company Subsidiaries without the Company’s prior written consent. No investigation shall affect the Company’s representations, warranties,

covenants, or agreements contained herein, or limit or otherwise affect the remedies available to the Parent Parties pursuant to this Agreement.

(b) The Confidentiality Agreement, dated January 12, 2026, by and between Parent and the Company (the “Confidentiality

Agreement”) and the Clean Team Addendum to the Confidentiality Agreement, dated April 7, 2026, by and between Parent and the Company (the “Clean Team Agreement”) shall each apply with respect to information

furnished under this Section 6.2 and shall each survive any termination of this Agreement in accordance with the terms of the Confidentiality Agreement and Clean Team Agreement, as applicable. Any information obtained by

any Parent Party or any Parent Representative pursuant to Section 6.2(a) or the Confidentiality Agreement or the Clean Team Agreement shall be treated in accordance with the applicable provisions set forth herein or

therein.

6.3 Non-Solicitation.

(a) Subject to Section 6.3(b), from and after the date hereof until the Effective Time or, if earlier, the valid

termination of this Agreement in accordance with Article 8, the Company shall not, and shall cause the Company Subsidiaries and its and their respective directors and officers and direct its and their other Company Representatives (engaged by

the Company or any Company Subsidiary in connection with the transactions contemplated by this Agreement) not to on behalf of the Company, in each case, directly or indirectly: (i) initiate, solicit or knowingly encourage, knowingly assist,

knowingly induce or take any action to knowingly facilitate the making, submission or announcement of any Acquisition Proposal or any inquiry, proposal, request or offer that could reasonably be expected to result in an Acquisition Proposal, or

conduct or engage in any discussions or negotiations (other than with Parent and the Parent Representatives) with respect thereto (other than informing any third party of the existence of the provisions contained in this

Section 6.3 or clarifying the terms of any inquiry, proposal, request or offer in accordance with the last sentence of Section 6.3(b)), (ii) furnish, disclose or otherwise provide access to

any non-public information regarding the Company or the Company Subsidiaries, or afford access to the business, properties, assets, books or records of the Company or the Company Subsidiaries to any Person

(other than to the Parent Parties and Parent Representatives) in connection with or in response to an Acquisition Proposal or any inquiry, proposal, request or offer that could reasonably be expected to result in an Acquisition Proposal,

(iii) amend or grant any waiver or release under any standstill or similar agreement with respect to any class of Equity Interests of the Company or the Company Subsidiaries unless the Company Board (or a duly authorized committee thereof)

determines in good faith, after consultation with outside counsel, that the failure to amend or grant any such waiver or release would be inconsistent with the Company Board’s fiduciary duties to the shareholders of the Company,

(iv) approve or recommend, or publicly propose to approve or recommend, any Acquisition Proposal, (v) withdraw, change or qualify, in a manner adverse to Parent, the Company Board Recommendation, (vi) enter into any agreement

(including any merger or acquisition agreement), letter of intent, term sheet or other similar agreement relating to any Acquisition Proposal, (vii) if an Acquisition Proposal has been publicly disclosed, fail to publicly recommend against such

Acquisition Proposal within ten (10) Business Days of any written request of Parent or fail to publicly reaffirm the Company Board Recommendation within ten (10) Business Days of any written request of Parent (it being understood and

agreed that the Company shall only be entitled to make one (1) such request per Acquisition Proposal or material modification thereto), (viii) fail to publicly recommend, in a Solicitation/Recommendation Statement on Schedule 14D-9 under the Exchange Act, against any Acquisition Proposal that is a tender offer or exchange offer subject to Regulation 14D promulgated under the Exchange Act, and reaffirm the Company Board

Recommendation, within ten (10) Business Days after the commencement (within the meaning of Rule 14d-2 under the Exchange Act) of such tender offer or exchange offer or (ix) approve, authorize,

resolve or agree or announce any intention to do any of the foregoing (any action set forth in the foregoing clauses (iv) through (viii) or (ix) (to the extent related to the foregoing clauses

(iv) through (viii)), a “Change of Board Recommendation”). The Company agrees that it shall, and shall cause the Company Subsidiaries and its and their respective directors and officers and direct its and

their other Company Representatives to, promptly cease and cause to be terminated any activities, discussions or negotiations existing as of the date hereof with any Persons (other than the Parent Parties and the Parent Representatives) conducted

heretofore with respect to any Acquisition Proposal (or that could reasonably be expected to lead to an Acquisition

Proposal), promptly terminate all data room access previously granted to such Person or its representatives, and to the extent required or permitted pursuant to any confidentiality agreement in

connection with a potential Acquisition Proposal, request that any such Person promptly return and destroy (and confirm destruction of) all non-public information thereunder. Without limiting the foregoing, it

is understood that any violation of Section 6.3 by any Company Representative, to the extent such Company Representative is acting on behalf of the Company or the Company Subsidiaries, shall be deemed to be a breach of

Section 6.3 by the Company.

(b) Notwithstanding anything to the contrary contained in

Section 6.3(a), but subject to Section 6.3(c), if at any time following the date hereof and prior to obtaining the Required Company Vote (i) the Company has received a bona fide

unsolicited written Acquisition Proposal from a third party, (ii) none of the Company, the Company Subsidiaries and none of their respective Company Representatives has materially breached any of the provisions set forth in

Section 6.3(a), (iii) the Company Board (or a duly authorized committee thereof) determines in good faith, after consultation with its financial advisors and outside counsel, based on information then available,

that such Acquisition Proposal constitutes or could reasonably be expected to lead to a Superior Proposal and (iv) the Company Board (or a duly authorized committee thereof) determines in good faith, after consultation with its financial

advisors and outside counsel, that the failure to take such actions would be inconsistent with its fiduciary duties to the shareholders of the Company, then the Company may (A) furnish information with respect to the Company and the Company

Subsidiaries to such third party making such Acquisition Proposal and its financing sources and (B) participate in discussions or negotiations with such third party and its financing sources regarding such Acquisition Proposal; provided,

that the Company (x) shall not, and shall cause the Company Subsidiaries and its and their respective directors and officers and instruct its and their other respective Company Representatives who are then aware of such Acquisition Proposal not

to, disclose any material information to such third party without first entering into an Acceptable Confidentiality Agreement with such third party, a copy of which shall be promptly provided to Parent (and in any event within twenty-four

(24) hours), and (y) shall, except to the extent prohibited under applicable Law (including Competition Law), provide to Parent any information concerning the Company or the Company Subsidiaries provided or made available to such third

party which information was not previously provided or made available to Parent, within twenty-four (24) hours of the furnishing of such information to such third party. Notwithstanding the limitations set forth in

Section 6.3(a) and this Section 6.3(b), if the Company receives, following the date hereof and prior to the Company Shareholders Meeting, an inquiry, proposal, request or offer that did not result

from a material breach of Section 6.3, the Company, its Subsidiaries and the Company Representatives may contact the Person or any of such Person’s Representatives who has made such proposal, request or offer solely

to clarify the terms of such inquiry, proposal, request or offer so that the Company may inform itself about such inquiry, proposal, request or offer.

(c) The Company shall promptly (and in any event within twenty-four (24) hours) notify Parent in writing of the taking of any action

contemplated by Section 6.3(b)(A). If, at any time following the date hereof, the Company, any Company Subsidiary or any of their respective directors, officers or other Company Representatives receives any

(i) Acquisition Proposal or any proposal, inquiry or request that could reasonably be expected to lead to an Acquisition Proposal or (ii) any request for non-public information relating to, or for

access to the business, properties, assets, books, or records of, the Company or any Company Subsidiary from

any Person that informs the Company it is considering making an Acquisition Proposal or relating to, or that could reasonably be expected to lead to, an Acquisition Proposal, the Company shall

promptly (and in any event within twenty-four (24) hours), subject to applicable Law, notify Parent in writing of the receipt of such Acquisition Proposal and/or proposal, inquiry or request. Such notice provided by the Company to Parent

pursuant to this Section 6.3(c) shall include a summary of the material terms and conditions of any such Acquisition Proposal and/or proposal, inquiry or request (which shall include the identity of the party making such

Acquisition Proposal and/or proposal, inquiry or request) and complete and unredacted copies of such written Acquisition Proposal and any significant related documents, including copies of all draft or proposed agreements and financing documents.

The Company shall keep Parent reasonably informed on a current basis with respect to the status of any such Acquisition Proposal and/or proposal, inquiry or request and any modification or proposed modification thereto, and shall promptly (and in no

event later than twenty-four (24) hours after transmittal or receipt) provide Parent with a summary of any material modifications with respect to such Acquisition Proposal. The Company shall provide Parent with twenty-four

(24) hours’ prior written notice (or such lesser prior notice as is provided to the members of the Company Board) of any meeting of the Company Board at which the Company Board is expected to consider any such Acquisition Proposal and/or

proposal, inquiry or request.

(d) Notwithstanding anything to the contrary contained in Section 6.3(a), and

provided that in each case that none of the Company, the Company Subsidiaries and none of their respective Company Representatives has materially breached any of the provisions set forth in Section 6.3(a) with respect to

such Acquisition Proposal, if (i) (A) the Company has received a bona fide unsolicited written Acquisition Proposal that the Company Board (or any duly authorized committee thereof) determines in good faith, after consultation with its

financial advisors and outside counsel, constitutes a Superior Proposal or (B) the Company Board (or any duly authorized committee thereof) determines that a Intervening Event has occurred and is continuing and (ii) the Company Board (or

any duly authorized committee thereof) determines in good faith, after consultation with outside counsel, that the failure to effect a Change of Board Recommendation would be inconsistent with its fiduciary duties to the shareholders of the Company,

then the Company Board may, at any time prior to obtaining the Required Company Vote, (x) effect a Change of Board Recommendation with respect to such Superior Proposal or Intervening Event (as applicable) or fail to include the Company Board

Recommendation in the Proxy Statement/Prospectus or (y) solely with respect to such Superior Proposal, terminate this Agreement in accordance with Section 8.1(e)(i) to accept such Superior Proposal and enter into a

definitive agreement with respect thereto, subject to the requirements of this Section 6.3(d) and Section 6.3(e).

(e) The Company shall not be entitled to effect a Change of Board Recommendation pursuant to Section 6.3(d) unless,

in each case:

(i) the Company shall have provided to Parent at least four (4) Business Days’ prior written notice (the

“Notice Period”) of the Company’s intention to take such action, which notice shall include, (A) with respect to an Acquisition Proposal, the material terms and conditions of such Acquisition Proposal (which shall

include the identity of the party making such Acquisition Proposal), and complete and unredacted copies of the available proposed transaction agreement to be entered into in respect of such Acquisition Proposal and any related documents, including

financing documents (or, in each case, if not provided in writing to the Company, a written summary of the material terms and conditions thereof), or (B) with respect to an Intervening Event, a reasonably detailed summary of the facts and

circumstances related to such Intervening Event that make a Change of Board Recommendation necessary;

(ii) during the Notice Period, if requested by Parent, the Company shall have, and shall

have caused its Subsidiaries, and directed the Company Representatives, and legal and financial advisors to have, engaged in good faith negotiations with Parent regarding any amendment to this Agreement proposed in writing by Parent intended to

(A) with respect to an Acquisition Proposal, cause the relevant Acquisition Proposal to no longer constitute a Superior Proposal or, (B) with respect to an Intervening Event, permit the Company Board (consistent with its fiduciary duties

under applicable Law) to not make a Change of Board Recommendation; and

(iii) the Company Board (or any duly authorized committee

thereof) shall have considered any adjustments and/or proposed amendments to this Agreement (including a change to the price terms hereof) and the other agreements contemplated hereby that may be irrevocably offered in writing by Parent (the

“Proposed Changed Terms”) no later than 11:59 a.m., Eastern Time, on the last day of the Notice Period and shall have determined in good faith that (A) the Acquisition Proposal would continue to constitute a Superior Proposal

or (B) the failure to effect a Change of Board Recommendation in response to such Intervening Event would be inconsistent with its fiduciary duties to the shareholders of the Company, in each case, if such Proposed Changed Terms were to be

given effect, and in each case, the failure to take such action would be inconsistent with its fiduciary duties to the shareholders of the Company.

In the event of any material revisions to such Superior Proposal, including form, amount, mix or timing of consideration (any such change with

respect to the consideration to be deemed material), offered by the party making such Superior Proposal or any material change to the facts and circumstances relating to an Intervening Event, as applicable, the Company shall be required to deliver a

new written notice to Parent and to again comply with the requirements of this Section 6.3(e) with respect to such new written notice, except that the Notice Period shall be two (2) Business Days with respect to any

such revised Superior Proposal (but no such new written notice shall shorten the original Notice Period).

(f) Nothing contained in this

Section 6.3 shall prohibit the Company Board (or any duly authorized committee thereof) from (i) disclosing to the shareholders of the Company a position contemplated by Rule 14e-2(a), Rule 14d-9 and Item 1012(a) of Regulation M-A promulgated under the Exchange Act; or (ii) making any disclosure to the shareholders of the Company if the Company Board

determines in good faith, after consultation with outside counsel, that the failure to make such disclosure would be inconsistent with its fiduciary duties; provided, that (A) any disclosure made under clauses (i) and

(ii) above shall be deemed to be a Change of Board Recommendation unless the Company Board expressly publicly reaffirms the Company Board Recommendation in such disclosure and (B) any Change of Board Recommendation must be made in

accordance with this Section 6.3. The issuance by the Company or the Company Board of a “stop, look and listen” statement pending disclosure of its position, as contemplated by Rules 14d-9 and 14e-2(a) promulgated under the Exchange Act, shall not constitute a Change of Board Recommendation.

6.4 Appropriate Action; Consents; Filings.

(a) The Company and Parent shall use their respective reasonable best efforts to (i) take, or cause to be taken, all appropriate action

and do, or cause to be done, and to assist and cooperate with the parties in doing, all things necessary, proper or advisable under applicable Law or otherwise to consummate and make effective the Merger and the other transactions contemplated by

this Agreement as promptly as practicable after the date hereof, (ii) take such actions as may be required to cause the expiration of the notice periods under Competition Laws with respect to such transactions as promptly as practicable after

the date hereof, (iii) obtain from any Governmental Entities any consents, licenses, permits, waivers, approvals, authorizations or orders required to be obtained by Parent or the Company, or any of their respective Subsidiaries, in order to

effect the Closing by not later than three (3) Business Days prior to the Outside Date, and to avoid any Proceeding by any Governmental Entity (including those in connection with Competition Laws), in connection with the authorization,

execution and delivery of this Agreement and the consummation of the transactions contemplated hereby, including the Merger, (iv) as promptly as practicable, make or cause to be made all necessary applications and filings (and in any event file

all required HSR Act notifications within fifteen (15) Business Days after the date hereof), and thereafter make any other required submissions, and pay any filing fees due in connection therewith, with respect to this Agreement and the Merger

required under any Competition Laws (all such filing fees to be borne by Parent), and (v) as promptly as practicable after the date hereof, make all necessary filings, and thereafter make any other required submissions, and pay any filing fees

due in connection therewith, with respect to this Agreement and the Merger required under any Competition Laws and any other applicable Law. The Company and Parent shall furnish to each other all information required for any application or other

filing under the rules and regulations of any applicable Law in connection with the transactions contemplated by this Agreement. No party shall delay the Closing at the behest of any Governmental Entity without the consent of the other parties to

this Agreement, which consent shall not be unreasonably withheld, conditioned or delayed.

(b) Each of the parties hereto agrees to

cooperate and use its reasonable best efforts to (i) defend and contest any Proceeding seeking to delay, restrain, prevent, enjoin or otherwise prohibit consummation of the Merger and the transactions contemplated by this Agreement, and

(ii) take all necessary or reasonably proper or advisable steps to have vacated, lifted, reversed or overturned any decree, judgment, injunction or other order (whether temporary, preliminary or permanent) entered or issued in any Proceeding

that is in effect and that restricts, prevents or prohibits consummation of the Merger and the transactions contemplated by this Agreement. The parties hereby acknowledge and agree that neither this Section 6.4 nor the

“reasonable best efforts” standard herein nor any other provision set forth in this Agreement shall require, or be construed to require, Parent or any its Subsidiaries or affiliates, in order to effect the expiration of any waiting

periods under applicable Competition Laws or the obtaining from any Governmental Entities of any consent, registration, approval, non-objection, permit or authorization to consummate the transactions

contemplated by this Agreement, or for any other reason, to (1) propose, offer, negotiate, commit to, agree to or effect, by consent decree, hold separate order, or otherwise, (x) the sale, divestiture, long-term license, transfer or other

disposition of any businesses, assets, equity interests, product lines or properties of Parent, the Company or any of their respective affiliates, or (y) the divestment of any Contracts of Parent, the Company or any of their respective

affiliates, or (2) incur (whether due to any remedy,

commitment, undertaking or condition or otherwise, individually or in the aggregate) a material and adverse impact on the business of either Parent or the Company or the anticipated benefits to

Parent of the transactions contemplated by this Agreement. None of the Company, any of the Company Subsidiaries or any of their respective affiliates shall propose, offer, negotiate, commit to, agree to, effect or take any actions set forth in the

immediately preceding sentence without the prior written consent of Parent.

acquire or agree to acquire or pursue the acquisition of (by merging or consolidating with, or by purchasing a substantial portion of the assets of or equity in, or by any other manner) any business, Person or division thereof (through acquisition,

license, joint venture, collaboration or otherwise), if such acquisition, license, joint venture, collaboration or other agreement would reasonably be expected to (i) impose any material delay in the obtaining of, or otherwise materially

increase the risk of not obtaining any applicable clearance, consent, approval or waiver under Competition Laws with respect to the Merger and the other transactions contemplated by this Agreement, (ii) materially increase the risk of any

Governmental Entity entering an Order prohibiting the transactions contemplated by this Agreement, or (iii) materially delay the consummation of the transactions contemplated by this Agreement.

(d) Subject to the requirements of this Section 6.4, and in a manner consistent with its obligations herein, Parent

shall, upon reasonable consultation with the Company, control, lead and direct all actions, decisions and strategy for and, and make all final determinations for obtaining any necessary approval of, or responding to any request from, inquiry by, or

investigation by (including directing the timing, nature and substance of all such responses), any Governmental Entity in connection with this Agreement, including under the HSR Act or other Competition Laws, and the transactions contemplated

hereby, including determining the timing and content of any registrations, filings, agreements, forms, notices, petitions, statements, submissions of information, applications and other documents, communications and correspondence contemplated by,

made in accordance with, or subject to this Section 6.4 as well as responding to any lawsuit, claim, action, or other Proceeding brought by any Governmental Entity relating to the transactions contemplated by this

Agreement.

(e) Without limiting the generality of anything contained in this Section 6.4, and subject to

Section 6.5, Parent and the Company shall: (i) give the other party prompt notice of the making or commencement of any request, inquiry, investigation or Proceeding by or before any Governmental Entity with respect to

the Merger or any of the other transactions contemplated by this Agreement; (ii) keep the other party informed on a current basis as to the status of any such request, inquiry, investigation or Proceeding; (iii) promptly inform the other

party of (and provide the other party with copies of) any communication to or from any Governmental Entity regarding the Merger or any of the other transactions contemplated by this Agreement. Each party shall consult and cooperate with the other

parties, and shall consider in good faith the views of the other parties in connection with any filing, analysis, appearance, presentation, memorandum, brief, argument, opinion or proposal made or submitted in connection with the Merger or any of

the other transactions contemplated by this Agreement. In addition, except as may be prohibited by any Governmental Entity or by any Law, in connection with any such request, inquiry, investigation or Proceeding, each party shall permit authorized

representatives of the other parties to be present at each meeting or conference relating to such request, inquiry, investigation or Proceeding and to have access to and be consulted in connection with any document, opinion or proposal made or

submitted to any Governmental Entity in connection with such request, inquiry, investigation or Proceeding.

(f) The Company and Parent shall give (or shall cause their respective Subsidiaries to

give) any notices to third parties, and use, and cause their respective Subsidiaries to use, commercially reasonable efforts to obtain the third party consents, approvals or waivers identified on Section 3.4 and 3.5

of the Company Disclosure Schedule (with respect to the Company) and requested in writing by Parent and Section 4.4 and 4.5 of the Parent Disclosure Schedule (with respect to Parent) and requested in writing by the

Company, and the Company and Parent shall coordinate and cooperate in seeking any such consents, approvals or waivers; provided, however, that, in no event shall either party be required to make any out-of-pocket payment or any concessions to any third party, or commence any litigation, to obtain any consents, approvals or waivers of third parties contemplated by this

Section 6.4(f). The parties acknowledge and agree that obtaining any such consents, approvals or waivers is not a condition to Closing and that the consummation of the transactions contemplated by this Agreement shall not

be conditioned on, or delayed or postponed as a result of the obtaining of (or the failure to obtain) any such consents, approvals or waivers. Any such notices, consents, approvals or waivers shall be in a form reasonably acceptable to Parent and

the Company.

(g) Nothing contained in this Agreement shall give any party, directly or indirectly, the right to control or direct the

operations of any other party prior to the consummation of the Merger. Prior to the Effective Time, the Company and Parent shall exercise, consistent with the terms and conditions of this Agreement, complete unilateral control and supervision over

their respective business operations.

6.5 Stockholder Litigation.

(a) The Company shall promptly advise Parent, and give Parent the opportunity to consult with the Company regarding the defense, of any

claim, demand, other correspondence related to stockholder litigation against the Company and/or its directors and officers, or any of them, in connection with or relating to the transactions contemplated by this Agreement (collectively,

“Company Transaction Litigation”), including the Merger, and shall, keep Parent reasonably informed regarding any such Company Transaction Litigation. The Company shall not compromise, settle or agree to settle, fully or

partially, any such Company Transaction Litigation without Parent’s prior written consent (not to be unreasonably withheld, conditioned or delayed).

(b) Parent shall promptly advise the Company, and give the Company the opportunity to consult with Parent regarding the defense, of any

claim, demand, other correspondence related to stockholder litigation against Parent and/or its directors and officers, or any of them, in connection with or relating to the transactions contemplated by this Agreement (collectively, “Parent

Transaction Litigation”), including the Merger, and shall keep the Company reasonably informed regarding any such Parent Transaction Litigation.

6.6 Public Announcements. So long as this Agreement is in effect, Parent and the

Parent Subsidiaries, on the one hand, and the Company and the Company Subsidiaries, on the other, shall not issue any press release or make any public statement or disclosure with respect to this Agreement or the transactions contemplated hereby

without the prior written consent of the other party (which consent shall not be unreasonably withheld, conditioned or delayed), except (a) as may be required by applicable Law or the rules or regulations of any applicable United States

securities exchange or regulatory or governmental body to which the relevant party is subject, in which case the party required to make the release or statement or disclosure shall use its commercially reasonable efforts to allow the other party

reasonable time to comment on such release or statement or disclosure in advance of such issuance and shall give due consideration to all reasonable comments suggested thereto, (b) with respect to any press release or other public statement by

the Company expressly permitted by Section 6.3, (c) any releases or public statements or disclosures that are consistent with the final form of joint press release announcing the Merger, (d) any releases or public

statements or disclosures that are consistent in all material respects with any release or other public statements or disclosures previously made in accordance with this Section 6.6, (e) any public statement regarding the

transactions contemplated by this Agreement in response to questions from the press, analysts, investors or those attending industry conferences, and internal announcements to employees, in each case, to the extent that such statements are

consistent in all material respects with previous press releases or public statements or disclosures made jointly by the parties or approved by the parties, and otherwise in compliance with this Section 6.6 or any documents

previously publicly filed with the SEC in accordance with Section 6.1, and provided, that such public statements do not reveal material nonpublic information regarding this Agreement or the transactions contemplated

by this Agreement or (f) any releases or public statements or disclosures related to litigation or arbitration among the parties with respect to this Agreement or the transactions contemplated hereby. The press release announcing the execution

and delivery of this Agreement shall be a joint release of, and shall not be issued prior to the approval of each of, the Company and Parent.

6.7 Employee Benefit Matters.

(a) During the Benefit Continuation Period, unless otherwise required by an applicable Collective Bargaining Agreement, Parent, the Surviving

Corporation or any of their respective affiliates shall provide each Continuing Employee with (i) an annual base salary or hourly wage rate (as applicable) at least equal to the annual base salary or hourly wage rate (as applicable) provided to

such Continuing Employee immediately prior to the Effective Time, (ii) annual or periodic target cash bonus opportunities (other than any retention or transaction bonuses or incentives) that are no less favorable than the corresponding cash

bonus opportunities provided to such Continuing Employee immediately prior to the Effective Time and (iii) employee and fringe benefits which include vacation/leave, tax-qualified defined contribution

retirement benefits, medical, dental and long term disability (and exclude any equity or equity-based compensation, nonqualified deferred compensation benefits, retention, change in control or similar type bonus, severance, defined benefit

pension, and retiree medical) that are substantially comparable, in the aggregate, to those provided to such Continuing Employee immediately prior to the Effective Time. “Benefit Continuation Period” means the period of twelve

(12) months following the Effective Time or if earlier, until the date of termination of employment of the relevant Continuing Employee. In addition, during the Benefit Continuation Period, Parent, the Surviving Corporation or any of their

respective affiliates shall provide each Continuing Employee with severance benefits and protections that are no less favorable than those provided to such Continuing Employee immediately prior to the Effective Time, as set forth on

Section 6.7 of the

Company Disclosure Schedule, taking into account such Continuing Employee’s additional period of service with Parent, the Surviving Corporation or any of their respective affiliates.

Further, during the Benefit Continuation Period, Parent shall either (i) provide to each Continuing Employee with nonqualified deferred compensation benefits (including all credits, discounts and matching contributions provided by the Company,

including under the Company’s Retirement K Excess Program) that are no less favorable than such benefits provided to such Continuing Employee pursuant to the Deferred Compensation Plans and the Company’s Retirement K Excess Program as of

immediately prior to the Effective Time or (ii) pay to such Continuing Employee a one-time cash payment in lieu of the continuation of such benefits (with such payment equal to the total credits,

discounts and matching contributions provided by the Company, including under the Company’s Retirement K Excess Program, if any, to such Continuing Employee pursuant the Deferred Compensation Plans and the Company’s Retirement K Excess

Program for calendar year 2026). Further, during the Benefit Continuation Period, Continuing Employees will be eligible to participate in long-term equity incentive plans maintained by Parent. With respect to any Continuing Employees based outside

of the United States, Parent’s obligations under this Section 6.7 shall be modified to the extent necessary to comply with applicable Laws of the foreign countries and political subdivisions thereof in which such

Continuing Employees are based.

(b) Effective as of the Effective Time and thereafter, Parent and its affiliates shall recognize, or

shall cause the Surviving Corporation to recognize, each Continuing Employee’s employment or service with the Company or any Company Subsidiary (including any current or former affiliates thereof or any predecessor of such Person) prior to the

Closing for purposes of determining, as applicable, eligibility for participation, vesting, and entitlement of the Continuing Employee under all employee benefit plans in which the Continuing Employee participates, whether maintained by the

Surviving Corporation, Parent, or any of their respective affiliates and, for purposes of benefit accrual of or entitlement to benefits, under all such plans that are vacation plans or arrangements, any equity or equity-based awards or plan (solely

for purposes of retirement eligibility and vesting, pursuant to the terms and conditions of the applicable equity programs in which the Continuing Employee is eligible to participate or, with respect to the Assumed RSU Awards and Assumed PSU Awards,

pursuant to the original terms and conditions of the Assumed RSU Award or Assumed PSU Award, as applicable), 401(k) or other defined contribution retirement plans and any severance or welfare plans (but not for purposes of benefit accrual of or

entitlement to pension benefits or post-employment welfare benefits, or to the extent such recognition would result in a duplication of benefits). In addition, and without limiting the generality of the foregoing, effective as of the Effective Time

and thereafter, Parent and its affiliates shall, or shall cause the Surviving Corporation to use commercially reasonable efforts to (i) cause any pre-existing conditions or limitations, eligibility

waiting periods, actively at work requirements, evidence of insurability requirements or required physical examinations under any health or similar plan of the Surviving Corporation, Parent or any of their respective affiliates to be waived with

respect to Continuing Employees and their eligible dependents, except to the extent that any waiting period, exclusions or requirements still applied to such Continuing Employee under the comparable Company Benefit Plan in which such Continuing

Employee participated immediately before the Effective Time and (ii) fully credit each Continuing Employee with all deductible payments, co-payments and other out-of-pocket expenses incurred by such Continuing Employee and his or her covered dependents under the medical, dental, pharmaceutical or vision benefit plans of the Company or any Company Subsidiary prior

to the Closing during the plan year in which the Closing occurs for the purpose of determining the extent to which such Continuing

Employee has satisfied the deductible, co-payments, or maximum

out-of-pocket requirements applicable to such Continuing Employee and his or her covered dependents for such plan year under any medical, dental, pharmaceutical or

vision benefit plan of the Surviving Corporation, Parent or any of their respective affiliates, as if such amounts had been paid in accordance with such plan. For clarity, this Section 6.7(b)(ii) may result in no credits to

Continuing Employees in the event Parent maintains the Company Benefit Plans through the end of the calendar year in which the Closing occurs.

(c) Prior to making any broad-based notices or communications to employees, individual independent contractors, officers or directors of the

Company following the date of this Agreement, the Company shall provide all such notices or communication materials (including website postings) that are intended to be provided to such individuals, including compensation or benefits matters

following the Closing (the “Employee Communications”) to Parent for its prior review and Parent shall have the right to provide timely and reasonable comments to any such notices or communications, which will be considered by the

Company in good faith. The foregoing shall not apply to any Employee Communications to the extent the substance of statements contained therein are consistent in all material respects with (i) previous Employee Communications made by the

Company after prior review by Parent or (ii) this Agreement.

(d) If requested by Parent in writing delivered to the Company not

less than five Business Days prior to the Closing Date, the Company and each of the Company Subsidiaries shall adopt resolutions and take all such corporate action as is necessary to terminate each 401(k) plan maintained, sponsored or contributed to

by the Company or any of the Company Subsidiaries (collectively, the “Company 401(k) Plans”), in each case, effective as of the day immediately prior to the Closing Date. The Company shall provide Parent with evidence that such

Company 401(k) Plans have been properly terminated, and the form of such termination documents shall be subject to the reasonable approval of Parent. In the event of the termination of any Company 401(k) Plan pursuant to this

Section 6.7(d) (each such terminated Company 401(k) Plan, a “Terminated Company 401(k) Plan”), Parent or the applicable Parent Subsidiary shall use commercially reasonable efforts to cause a defined

contribution plan that is qualified under Section 401(a) of the Code, that includes a cash or deferred arrangement within the meaning of Section 401(k) of the Code and that is established or maintained by Parent or the applicable Parent

Subsidiary to accept eligible rollover distributions (as defined in Section 402(c)(4) of the Code) from current and former employees of the Company and the Company Subsidiaries with respect to such individuals’ account balances (excluding

loans) under such Terminated Company 401(k) Plan, if elected by any such individuals.

(e) If the Closing occurs prior to the payment of bonuses to Continuing Employees under the annual incentive program (the

“AIP”) maintained by the Company with respect to the year in which the Closing Date occurs (the “Closing Year”), then, the Company shall pay to each Continuing Employee such employee’s bonus in an amount

equal to the greater of (i) the bonus the employee earns, if any, based on actual achievement of performance goals through the last day of the performance period and (ii) fifty percent (50%) of the employee’s applicable target bonus,

in any case, payable on the date on which annual bonuses are paid to Company Employees generally under the AIP and subject to the Continuing Employee’s continued employment through the final day of the applicable performance period.

Notwithstanding the

generality of the foregoing, if a Continuing Employee’s employment is terminated by the Surviving Corporation (or Parent or any of its Subsidiaries) without “cause” or for

“good reason” (each, as defined in the employee’s Severance Benefit Agreement or, if none, the employee’s most recent award agreement as of the date of this Agreement evidencing an award under the Company Equity Plan), in any

event, prior to the payment date of such bonus, then such employee shall remain entitled to receive such employee’s bonus (calculated as described in this Section 6.7(e) on the date on which annual bonuses are paid to

Company employees generally under the AIP (but in no event later than March 15 of the year following the Closing Year)) and pro-rated for the portion of the performance period during which the Continuing

Employee was employed; provided, however, that if a Continuing Employee is party to a Severance Benefit Agreement with the Company, and if such employee’s employment is terminated after the Closing but prior to the last day of

the calendar year, then the payment described in this Section 6.7(e) shall be in lieu of (and not in addition to) the payment of a pro-rata bonus described in Section 3.3 of the

Severance Benefit Agreement, and the payment timing shall be in accordance with such Section 3.3 of the Severance Benefit Agreement.

(f) Prior to the Closing, the Company shall provide any notice, and comply in all material respects, with any applicable information,

consultation and bargaining obligations, and shall use commercially reasonable efforts to satisfy any applicable consent requirements owed to any labor union, works council, labor organization or employee representative, which is representing any

employee of the Company and its Subsidiaries, or any applicable labor tribunal, or pursuant to any Collective Bargaining Agreement, in connection with the transactions contemplated hereby; provided that, this

Section 6.7(f) shall not require the Company or the Company Subsidiaries to make any payment or provide any other consideration (including increased or accelerated payments) in order to secure the consent of any labor

union, works council, labor organization or employee representative or pursuant to any Collective Bargaining Agreement (it being understood and agreed that any failure to obtain any consent under this Section 6.7(f) shall

not, by itself, have any effect on, or be considered with respect to, whether the condition set forth in Section 7.2(d) has been satisfied). From the date of this Agreement through the Effective Time, Parent shall cooperate

in good faith in respect of consultation obligations and similar notice and bargaining obligations to satisfy any applicable requirements owed to any labor union, works council, labor organization or employee representative, which is representing

any employee of the Company and its Subsidiaries, or any applicable labor tribunal, or pursuant to any Collective Bargaining Agreement, in connection with the transactions contemplated hereby.

(g) Notwithstanding anything to the contrary set forth in this Agreement, no provision of this Agreement shall be deemed to

(i) guarantee employment for any period of time for, or preclude the ability of Parent or the Surviving Corporation to terminate the employment of, any Continuing Employee for any reason; (ii) require the Company, Parent or the Surviving

Corporation to continue any Company Benefit Plan or Parent benefit plan or prevent the amendment, modification or termination thereof; or (iii) amend, terminate, establish or create any Company Benefit Plan or Parent benefit plan or other

employee benefit plans or arrangements. The provisions of this Section 6.7 are solely for the benefit of the parties, and no Continuing Employee (including any beneficiary or dependent thereof) shall be regarded for any

purpose as a third party beneficiary of this Agreement, and no provision of this Section 6.7 shall create such rights in any such persons.

6.8 Indemnification of Directors and Officers.

(a) For a period beginning at the Effective Time and ending six (6) years after the Effective Time, the Parent shall cause the Surviving

Corporation and its Subsidiaries, as applicable, to, indemnify and hold harmless all past and present directors, officers and employees of the Company or any Company Subsidiary (the “Covered Persons”) to the maximum extent

permitted by Law for any Proceedings arising out of acts or omissions in their capacity as directors, officers or employees of the Company or any Company Subsidiary, as applicable, occurring at or prior to the Effective Time. Parent shall cause the

Surviving Corporation and its Subsidiaries, as applicable, to, indemnify and hold harmless the Covered Persons to the fullest extent permitted by Law, for acts or omissions occurring in connection with the adoption and approval of this Agreement and

the consummation of the transactions contemplated hereby. The Surviving Corporation shall, and shall cause its Subsidiaries, as applicable, to, advance expenses (including reasonable legal fees and expenses) incurred in the defense of any Proceeding

or investigation with respect to the matters subject to indemnification pursuant to this Section 6.8(a). Notwithstanding anything herein to the contrary, if any Proceeding (whether arising before, at or after the Effective

Time) is made against such persons with respect to matters subject to indemnification hereunder on or prior to the sixth anniversary of the Effective Time, the provisions of this Section 6.8(a) shall continue in effect

until the final disposition of such Proceeding.

(b) For six (6) years from and after the Effective Time, the articles of

organization of the Surviving Corporation shall contain provisions no less favorable with respect to exculpation, indemnification of and advancement of expenses to Covered Persons for periods at or prior to the Effective Time than are currently set

forth with respect to any Covered Person, in the Company Charter and the Company Bylaws in existence on the date hereof. For six (6) years from and after the Effective Time, the articles or certificate of incorporation and bylaws, or equivalent

organizational documents, of each Subsidiary of the Surviving Corporation that was formerly a Company Subsidiary (each, a “Former Company Subsidiary”), shall contain provisions no less favorable with respect to exculpation,

indemnification of and advancement of expenses to Covered Persons for periods at or prior to the Effective Time than are currently set forth with respect to any Covered Person in the articles or certificate of incorporation and bylaws, or equivalent

organizational documents, of such Former Company Subsidiary. All indemnification agreements of the Company and the Company Subsidiaries in existence on the date hereof, if any, with any Covered Person shall be enforceable against the Surviving

Corporation or Former Company Subsidiary, as applicable, as an additional indemnitor, without any further action, and shall continue in full force and effect in accordance with their terms. For not less than six (6) years from the Effective

Time, the Surviving Corporation shall not amend, repeal or otherwise modify the exculpation, indemnification and advancement of expenses provisions of its or any of the Former Company Subsidiaries’ articles or certificates of incorporation or

bylaws or similar organizational documents as in effect immediately prior to the Effective Time in any manner that would adversely affect the rights thereunder of any Covered Person. In the event that the Surviving Corporation or any of the Former

Company Subsidiaries (i) consolidates with or merges into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger or (ii) transfers or conveys all or substantially all of its properties

and assets to any Person, then, and in each such case, the Surviving Corporation shall cause (and Parent shall cause the Surviving Corporation to cause) proper provision to be made so that the successors and assigns of the Surviving Corporation or

the Former Company Subsidiaries, as applicable, assume the obligations set forth in this Section 6.8, unless such assumption occurs by operation of Law.

Surviving Corporation to, and the Surviving Corporation shall, maintain in effect, the Company’s current directors’ and officers’ liability insurance policies covering acts or omissions occurring (or alleged to occur) prior to or

at the Effective Time with respect to Covered Persons; provided, however, that in no event shall the Surviving Corporation be required to expend pursuant to this Section 6.8(c) more than an aggregate amount

equal to 300% of current annual premiums paid by the Company for such insurance. In the event that, but for the proviso to the immediately preceding sentence, the Surviving Corporation would be required to expend more in aggregate than 300% of

current annual premiums, the Surviving Corporation shall obtain the maximum amount of such insurance obtainable by payment of an aggregate amount equal to 300% of current annual premiums. In lieu of the foregoing obligations set forth in this

Section 6.8(c), the Company may, or at Parent’s request, the Company shall, purchase at or prior to the Effective Time, a six-year “tail” prepaid officers’ and

directors’ liability insurance policy in respect of acts or omissions occurring prior to the Effective Time covering each such Covered Person for an aggregate amount not to exceed 300% of current annual premiums. If such “tail”

policy has been established by the Company, the Surviving Corporation shall not terminate such policy and shall cause all obligations of Parent or the Company thereunder to be honored by the Surviving Corporation.

(d) Following the Effective Time, the obligations under this Section 6.8 shall not be terminated or modified in any

manner that is adverse to the Covered Persons (and their respective successors and assigns) without the consent of such affected Covered Person (or their respective successors and assigns) (it being expressly agreed that the Covered Persons

(including successors and assigns) shall be third party beneficiaries of this Section 6.8).

6.9

Section 16 Matters. Prior to the Effective Time, Parent and the Company shall take all such steps as may be required to cause any dispositions of Company Common Stock (including derivative securities with respect to Company

Common Stock) or acquisitions of Parent Common Stock (including derivative securities with respect to Parent Common Stock) resulting from the transactions contemplated hereby by each individual who is subject to the reporting requirements of

Section 16(a) of the Exchange Act with respect to the Company to be exempt under Rule 16b-3 promulgated under the Exchange Act, to the extent permitted by applicable Law.

6.10 Takeover Statutes. If any state takeover Law or state Law that purports to limit or restrict business combinations or the ability

to vote Company Stock or acquire Parent Common Stock (including any “fair price”, “moratorium”, “business combination”, “control share acquisition” or other similar takeover Law) becomes or is deemed

to be applicable to the Company or the Parent Parties, the Merger or any other transaction contemplated by this Agreement, then the Company and the Company Board or Parent and the Parent Board, as applicable, shall use reasonable best efforts to

take all action reasonably available to it so that the transactions contemplated hereby, including the Merger, may be consummated as promptly as practicable on the terms contemplated hereby and otherwise act to minimize or make inapplicable the

effect of any such Law on this Agreement and the transactions contemplated hereby, including the Merger.

6.11 Existing Indebtedness. Prior to the Closing, solely to the extent the applicable

pay-off letter is not delivered in accordance with the following sentence, the Company shall, and shall cause the Company Subsidiaries to, timely deliver to the applicable counterparty in respect such

indebtedness (with a copy timely provided to the Parent) notices of prepayment (including any calculations to be provided therewith) relating to the prepayment in full of outstanding indebtedness at the Closing under all obligations with respect to

each of the credit agreements with an asterisk on Section 6.11 of the Company Disclosure Schedule. The Company shall use commercially reasonable efforts to (a) obtain customary

pay-off letters, and lien and guarantee terminations (including any termination statements on Form UCC-3, short-form termination and release agreements with respect to

any and all security interests in any intellectual property, real property, accounts and other applicable releases) to the extent necessary for the release of all Liens related to, and the prepayment, payoff, discharge and termination in full of,

all obligations set forth on Section 6.11 of the Company Disclosure Schedule (collectively, the “Debt Payoff Letters”), in form and substance reasonably satisfactory to Parent; (b) (i) provide Parent

with a draft of such Debt Payoff Letters at least four (4) Business Days prior to the Closing Date and (ii) provide Parent with a copy of such fully executed Debt Payoff Letters and related lien and guarantee termination documentation at

least two (2) Business Days on or prior to the Closing Date; and (c) timely give any necessary notices (including notices of prepayment and/or notice of commitment termination) to allow for the prepayment, payoff, discharge and termination

in full of such indebtedness at the Closing.

6.12 Dividends.

(a) It is agreed that the parties shall take such actions as are necessary to ensure that the timing of any regular quarterly dividend paid

to common shareholders by the Company or to common stockholders by Parent, in each case prior to the Closing will be coordinated so that, if either the holders of Company Common Stock or the holders of Parent Common Stock receive a regular dividend

for a particular calendar quarter prior to the Closing Date, then the holders of Parent Common Stock and the holders of Company Common Stock, respectively, shall also receive a regular dividend for such calendar quarter prior to the Closing Date in

order to ensure that the common shareholders of the Company and the common stockholders of Parent receive the same number of such dividends (or partial dividends as applicable) prior to the Effective Time; provided that Parent shall determine

the date of its regular quarterly dividend; provided further that the amount of any such quarterly dividend declared by Company shall be consistent with Permitted Company Dividends and the amount of any such quarterly dividend declared

by Parent shall be consistent with Permitted Parent Dividends.

(b) In the event that a distribution with respect to shares of Company

Common Stock permitted under the terms of this Agreement has (i) a record date prior to the Effective Time and (ii) has not been paid prior to the Effective Time, such distribution shall be paid by the Company immediately prior to the

Effective Time.

greater than $0, the Company shall declare a dividend in the amount equal to the Special Dividend Amount (the “Special Dividend”) which shall be payable to the holders of Company Common Stock as of immediately prior to the

Effective Time.

6.13 Parent Written Consent. As promptly as reasonably practicable following the

execution and delivery of this Agreement, Parent, in its capacity as the sole stockholder of Merger Sub shall execute and deliver, a written consent approving and adopting this Agreement and the transactions contemplated hereby, including the

Merger, and promptly provide evidence thereof to the Company.

6.14 Certain Merger Sub Matters. Parent shall take all actions

necessary to cause (a) the due, prompt and faithful performance and discharge by, and compliance with, all of the obligations, covenants, terms, conditions and undertakings of Merger Sub under this Agreement in accordance with the terms hereof,

including any such obligations, covenants, terms, conditions and undertakings that are required to be performed discharged or complied with following the Effective Time and (b) ensure that, prior to the Effective Time, Merger Sub shall not

conduct any business, or incur or guarantee any indebtedness (other than, in each case, (x) any guarantees required by the terms of any of Parent’s Existing Financings or (y) any guarantees in connection with any Financing

Transaction) or make any investments, other than as specifically contemplated by this Agreement. Any consent or waiver by Parent under this Agreement shall be deemed to also be a consent or waiver by Merger Sub.

6.15 Delisting and Deregistration. Prior to the Closing Date, the Company shall use commercially reasonable efforts to take, or cause

to be taken, all actions, and do or cause to be done all things reasonably necessary or advisable on its part, or as reasonably requested by Parent, under applicable Laws, including, for the avoidance of doubt, the rules and policies of NYSE, to

enable the delisting by the Surviving Corporation of the Company Common Stock from NYSE as of or as promptly as practicable after the Effective Time and to facilitate the deregistration of the Company Common Stock under the Exchange Act as promptly

as practicable after the Effective Time.

6.16 Stock Exchange Listing. Parent shall use its commercially reasonable efforts to

cause the shares of Parent Common Stock to be issued in the Merger to be approved for listing on the NYSE, subject to official notice of issuance.

6.17 Financing Cooperation.

(a) Prior to the Closing, (x) in the event that Parent determines, in its sole discretion to obtain debt financing on or prior to the

Closing for the purpose of (i) paying any amounts required to consummate and perform its obligations with respect to the Merger and the other transactions contemplated hereby (including in respect of any amounts to be paid under the Debt Payoff

Letters) or (ii) refinance, amend, extend or replace any of Parent’s or any of the Parent Subsidiaries’ existing credit facilities or indentures (as amended from time to time, the “Existing Financings”) or any

other existing indebtedness of the Company or any Company Subsidiary, (y) in connection with any actions to be taken under the Company Notes Indentures for the Company Notes to remain outstanding on and after the Closing Date, or

(z) otherwise, as the Parent deems reasonably necessary for it to comply with its obligations under its Existing Financings (the transactions pursuant to clauses (x), (y) and (z) collectively, the “Financing

Transactions”). The Company shall use commercially reasonable efforts, and shall cause the Company Subsidiaries and its and their respective Representatives to use their commercially reasonable efforts, to provide all customary cooperation

reasonably requested by Parent in connection with any Financing Transactions (provided, that such requested cooperation does not unreasonably interfere with the ongoing operations of the Company and the Company Subsidiaries), in each case, at

Parent’s sole cost and expense, including, to the extent so requested, by using commercially reasonable efforts to:

(i) furnish

Parent and the Debt Financing Sources with such customary financial information regarding the Company and the Company Subsidiaries as may be reasonably requested by Parent for the consummation of any Financing Transactions;

(ii) provide customary assistance to Parent with respect to the providing of guarantees by

the Company and the Company Subsidiaries and the granting of security interests in and perfecting any liens on, the assets of the Company and the Company Subsidiaries, in each case, in connection with any Financing Transactions; provided that

any such guarantees, grant of security interests or perfection of liens shall be effective no earlier than as of Closing;

(iii)

cooperate with the marketing efforts of Parent and the Debt Financing Sources, in each case, in connection with any Financing Transactions;

(iv) make appropriate members of senior management of the Company available at reasonable times and locations and upon reasonable prior

notice, to participate in a reasonable number, of meetings (including one-on-one meetings or conference calls with any Debt Financing Sources), sessions with prospective

financing sources and due diligence sessions and other syndication activities; provided that any such meeting or communication may be conducted virtually by videoconference or other media;

(v) cooperate with Parent in taking any steps necessary under the Company Notes Indentures (including delivery of any notices and

officer’s certificates to the trustee under the Company Notes Indentures) in connection with any Financing Transactions;

(vi)

provide, at least three (3) Business Days prior to the Closing Date (to the extent reasonably requested from the Company at least ten (10) Business Days prior to the Closing Date), any information required by applicable “know your

customer”, beneficial ownership and anti-money laundering rules and regulations relating to the Company or the Company Subsidiaries in connection with any Financing Transaction; or

(vii) at the reasonable request of Parent, consent to the reasonable use of the Company’s logos in connection any Financing

Transaction; provided that such logos are used solely in a manner that is not intended to, nor reasonably likely to, harm or disparage the Company’s reputation or goodwill.

For the avoidance of doubt, the parties acknowledge and agree that the provisions contained in this Section 6.17(a)

represent the sole obligation of the Company and the Company Subsidiaries with respect to cooperation in connection with any Financing Transaction. Parent acknowledges and agrees that no Financing Transaction is a condition to Closing and that the

consummation of the transactions contemplated by this Agreement shall not be conditioned on, or delayed or postponed as a result of the obtaining of (or the failure to obtain) any Financing Transaction except as provided for in

Section 6.17(b).

(b) Notwithstanding anything to the contrary in Section 6.17,

none of the Company nor any of the Company Subsidiaries or their respective Representatives shall be required to take or permit the taking of any action pursuant to this Section 6.17 that would:

(i) cause any representation or warranty, covenant or other term in this Agreement to be breached by any of the Company or cause any condition

set forth in Article 7 to fail to be satisfied,

(ii) require the Company to waive or amend any terms of this Agreement or agree

to pay any commitment or other similar fee or incur any other expense, liability or obligation (other than the obligations expressly contemplated by this Section 6.17) in connection with any Financing Transaction or have

any obligation of the Company or any of the Company Subsidiaries or their respective Representatives under any agreement, certificate, document or instrument (other than (x) executing customary bank authorization letters, (y) executing any

notices of repayment or redemption delivered in advance of the Closing, where such redemption or repayment that will occur at the Closing and (z) any agreement, certificate, document or instrument that will be effective at the Closing),

(iii) reasonably be expected to result in any director, officer, employee or shareholders of the Company or any of the Company Subsidiaries

or representatives to incur any personal liability,

(iv) conflict with or violate, or would reasonably be expected to conflict with or

violate, its organizational documents, any applicable Law or Contract of the Company or of the Company Subsidiaries or any confidentiality obligation to which they are subject,

(v) provide access to or disclose information that the Company or the Company Subsidiaries determine would reasonably be likely to result in

loss or waiver of or otherwise jeopardize any attorney-client privilege, attorney work product or other applicable privilege or protection of the Company or the Company Subsidiaries,

(vi) require the Company or the Company Subsidiaries to adopt any resolution or take any similar actions in approving any Financing

Transaction, other than any resolution or action that would be effective on the Closing Date,

(vii) require the Company or the Company

Subsidiaries to deliver or obtain opinions of internal or external counsel (other than any opinion in connection with any Financing Transaction pursuant to clause (y) of the definition thereof, so long as such opinion would be delivered

only on or after the Closing Date), or

(viii) require the Company or the Company Subsidiaries to deliver any financial statements which

are not prepared by the Company or the Company Subsidiaries in the ordinary course of business at the time requested by the Parent.

of the Company Subsidiaries for all reasonable out-of-pocket and documented costs (including but not limited to reasonable attorneys’ and accountants’ fees

and trustee fees) incurred by them or their respective Representatives in connection with any Financing Transaction or with any such cooperation contemplated by this Section 6.17 and shall indemnify, defend and hold

harmless the Company, the Company Subsidiaries and their respective representatives and each of the their respective present and former directors, officers, employees and agents (collectively, the “Financing Indemnified Parties”)

from and against any and all costs, expenses, losses, damages, claims, judgments, fines, penalties, interest, settlements, awards and liabilities suffered or incurred by any of them in connection with the arrangement and consummation of any

Financing Transaction and any information used in connection therewith (other than to the extent arising from fraud by the Company or any of the Company Subsidiaries or its or their Representatives, as determined in a final judgment by a court of

competent jurisdiction). This Section 6.17(c) shall survive the termination of this Agreement.

(d)

Notwithstanding anything to the contrary in this Agreement, the Company and the Company Subsidiaries and its and their Representatives shall be deemed to have performed in all material respects all obligations, and complied in all material respects

with all agreements and covenants, required to be performed by it under this Section 6.17 for the purposes of, and any breach by the Company or its Subsidiaries or its Representatives of any of the covenants required to be

performed by it under this Section 6.17 shall not be considered in, determining the satisfaction of any condition to Closing set forth in this Agreement, including the condition to Closing set forth in

Section 7.2(b), or in determining the entitlement of the Parent Parties to terminate this Agreement, including any entitlement to termination arising from Section 8.1, nor the cause thereof, nor

entitle any Parent Party to damages under this Agreement, other than, for purposes of (x) determining the satisfaction of the condition to Closing set forth in Section 7.2(b), (y) the entitlement of the Parent Parties

to terminate this Agreement, or (z) determining damages under Section 8.2 in each case, as a result of a Willful and Material Breach of this this Section 6.17 by the Company or its

Subsidiaries.

6.18 Resignation of Directors. The Company shall use commercially reasonable efforts to obtain and deliver to Parent

at or prior to the Effective Time the resignation of each individual (as requested by Parent) who is a director of any of the Company or the Company Subsidiaries, effective as of the Effective Time.

Article 7

CONDITIONS TO

CONSUMMATION OF THE MERGER

7.1 Conditions to Obligations of Each Party Under This Agreement. The respective obligations

of each party to consummate the Merger shall be subject to the satisfaction (or waiver, if permissible under applicable Law) at or prior to the Effective Time of each of the following conditions:

(a) Company Shareholder Approval: The Company shall have obtained the Required Company Vote at the Company Shareholders Meeting

(as such meeting may have been adjourned or postponed in accordance with this Agreement);

(b) No Injunctions or Restraints: (i) The consummation of the Merger shall not

then be restrained, enjoined or prohibited by any Order or any other action (whether preliminary or permanent) of a Governmental Entity of competent jurisdiction (in each case, exclusive of any Orders or other actions related to Competition Laws,

other than Competition Laws set forth in Section 3.5(b) of the Company Disclosure Schedule), and (ii) there shall not be in effect any Law promulgated, enacted or enforced by a Governmental Entity of competent

jurisdiction (in each case, exclusive of any Competition Laws, other than Competition Laws set forth in Section 3.5(b) of the Company Disclosure Schedule) that remains in effect and that makes the Merger illegal or

otherwise prevents the consummation of the Merger (each of clauses (i) or (ii), a “Legal Impediment”);

(c) Competition Law: (i) Any waiting period under the HSR Act and any extensions thereof with respect to the Merger and any

commitment to, or agreement with, any Governmental Entity in connection with a Competition Law set forth in Section 3.5(b) of the Company Disclosure Schedule to delay the consummation of, or not to consummate before a

certain date, the Merger shall have expired or been terminated and (ii) any consents, authorizations, approvals, orders, filings and declarations relating to the Merger pursuant to a Competition Law set forth in

Section 3.5(b) of the Company Disclosure Schedule shall have been filed, occurred or been obtained (or any applicable waiting period thereunder shall have expired or been terminated), as applicable;

(d) Exchange Listing: The shares of Parent Common Stock to be issued in the Merger shall have been authorized and approved for listing

on the NYSE, subject to official notice of issuance; and

(e) Registration Statement: The Registration Statement shall have been

declared effective by the SEC under the Securities Act and shall not be the subject of any stop order and no proceeding for that purpose shall have been initiated or be threatened in writing by the SEC with respect to the Registration Statement that

has not been withdrawn.

7.2 Additional Conditions to Obligations of the Parent Parties. The respective obligations of each Parent

Party to consummate the Merger shall be subject to the satisfaction (or waiver, if permissible under applicable Law) at or prior to the Effective Time of each of the following conditions:

(a) Representations and Warranties of the Company: (i) Any representation or warranty of the Company contained in

Section 3.2(a) and Section 3.2(b) shall be true and correct in all respects as of the date of this Agreement and as of the Closing Date with the same force and effect as if made on and as of such

date (or, in the case of such representations and warranties that address matters only as of a particular date or time, as of such date or time), except for de minimis inaccuracies, (ii) any representation or warranty of the Company

contained in Section 3.1(a), Section 3.1(b), the first sentence of Section 3.2(c), Section 3.3, Section 3.4(a),

Section 3.22, Section 3.24 and Section 3.27 shall be true and correct in all material respects (without giving effect to any qualifications as to materiality or Company

Material Adverse Effect or other similar qualifications contained therein) as of the date of this Agreement and as of the Closing Date with the same force and effect as if made on and as of such date (or, in the case of such representations and

warranties that address matters only as of a particular date or time, as of such date or time), (iii) any representation or warranty of the Company contained in Section 3.8(c) shall be true and correct in all respects as of

the date of this Agreement and as of the Closing Date with the same force and effect as if made on and as of such date, and (iv) any other representation

and warranty of the Company contained in Article 3 (except for those representations and warranties set forth in the foregoing clauses (i) through (iii)) shall be true

and correct in all respects (without giving effect to any qualifications as to materiality or Company Material Adverse Effect or other similar qualifications contained therein) as of the date of this Agreement and as of the Closing Date with the

same force and effect as if made on and as of such date (or, in the case of such representations and warranties that address matters only as of a particular date or time, as of such date or time), except to the extent that any failures of such

representations and warranties to be so true and correct, individually or in the aggregate, have not had and would not be expected to have a Company Material Adverse Effect;

(b) Performance of Obligations of the Company: The Company shall have performed or complied in all material respects with all

covenants and agreements to be performed or complied with by it under this Agreement at or prior to the Closing;

Adverse Effect: Since the date of this Agreement, there shall not have occurred any Company Material Adverse Effect or any Effect that would individually or in the aggregate reasonably be expected to have a Company Material Adverse Effect; and

(d) Certificate: The Company shall have delivered to Parent a certificate, dated as of the Closing Date and signed by an

executive officer of the Company, certifying that the conditions provided in Section 7.2(a), Section 7.2(b) and Section 7.2(c) have been satisfied.

7.3 Additional Conditions to Obligations of the Company. The obligations of the Company to consummate the Merger shall be subject to

the satisfaction (or waiver, if permissible under applicable Law) at or prior to the Effective Time of each of the following conditions:

(a) Representations and Warranties of Parent: (i) Any representation or warranty of the Parent Parties contained in

Section 4.2(a), Section 4.2(b) and Section 4.2(c) shall be true and correct in all respects as of the date of this Agreement and as of the Closing Date with the same force

and effect as if made on and as of such date (or, in the case of such representations and warranties that address matters only as of a particular date or time, as of such date or time), except for de minimis inaccuracies, (ii) any

representation or warranty of Parent contained in Section 4.1(a), Section 4.1(b), Section 4.2(d), Section 4.3,

Section 4.4(a), Section 4.11, Section 4.12, and Section 4.14 shall be true and correct in all material respects (without giving effect to any

qualifications as to materiality or Parent Material Adverse Effect or other similar qualifications contained therein) as of the date of this Agreement and as of the Closing Date with the same force and effect as if made on and as of such date (or,

in the case of such representations and warranties that address matters only as of a particular date or time, as of such date or time), (iii) any representation or warranty of Parent contained in Section 4.8(c) shall be

true and correct in all respects as of the date of this Agreement and as of the Closing Date with the same force and effect as if made on and as of such date and (iv) any other representation and warranty of the Parent Parties contained in

Article 4 (except for those representations and warranties set forth in the foregoing clauses (i) and (ii)) shall be true and correct in all respects (without giving effect to any qualifications as to materiality or Parent

Material Adverse Effect or other similar qualifications

contained therein) as of the date of this Agreement and as of the Closing Date with the same force and effect as if made on and as of such date (or, in the case of such representations and

warranties that address matters only as of a particular date or time, as of such date or time), except to the extent that any failures of such representations and warranties to be so true and correct, individually or in the aggregate, have not had

and would not be expected to have a Parent Material Adverse Effect;

(b) Performance of Obligations of the Parent Parties: The

Parent Parties shall have performed or complied in all material respects with all covenants and agreements to be performed or complied with by them under this Agreement at or prior to the Closing;

(c) No Material Adverse Effect: Since the date of this Agreement, there shall not have occurred any Parent Material Adverse Effect or

any Effect that would individually or in the aggregate reasonably be expected to have a Parent Material Adverse Effect;

(d)

Certificate. Parent shall have delivered to Company a certificate, dated as of the Closing Date and signed by an executive officer of Parent, certifying that the conditions provided in Section 7.3(a),

Section 7.3(b) and Section 7.3(c) have been satisfied; and

(e) Company Tax

Opinion. The Company shall have received the Company Tax Opinion.

Article 8

TERMINATION, AMENDMENT AND WAIVER

8.1 Termination. This Agreement may be terminated prior to the Effective Time, and the Merger and the other transactions contemplated

hereby may be abandoned:

(a) Mutual Consent: By mutual written consent of Parent and the Company;

(b) Outside Date: By either the Company or Parent if the Effective Time shall not have occurred on or before January 13, 2027

(the “Initial Outside Date”); provided, that, if (i) on the Initial Outside Date the conditions set forth in Section 7.1(b) (to the extent related to the Competition Laws set forth in

Section 3.5(b) of the Company Disclosure Schedule), or Section 7.1(c) shall not be satisfied but all other conditions to the Closing set forth in Article 7 either have been satisfied (other

than Section 7.1(d), Section 7.1(e) and the other conditions that by their nature can only be satisfied on the Closing Date) or waived by Parent, Merger Sub or the Company, as applicable, then the

Initial Outside Date shall automatically be extended to July 13, 2027 (the “First Extended Outside Date”), (ii) on the First Extended Outside Date the conditions set forth in Section 7.1(b) (to the

extent related to the Competition Laws set forth in Section 3.5(b) of the Company Disclosure Schedule) or Section 7.1(c) shall not be satisfied but all other conditions to the Closing set forth in

Article 7 either have been satisfied (other than Section 7.1(d) or Section 7.1(e) and the other conditions that by their nature can only be satisfied on the Closing Date) or waived by

Parent, Merger Sub or the Company, as applicable, then the First Extended Outside Date shall automatically be extended to January 13, 2028 (the “Second Extended Outside Date”), or (iii) on the Second Extended Outside

Date the conditions set forth in Section 7.1(b) (to the extent related to the Competition Laws set forth in Section 3.5(b) of the Company Disclosure

Schedule) or Section 7.1(c) shall not be satisfied but all other conditions to the Closing set forth in Article 7 either have been satisfied (other than

Section 7.1(d) or Section 7.1(e) and the other conditions that by their nature can only be satisfied on the Closing Date) or waived by Parent, Merger Sub or the Company, as applicable, then the

Second Extended Outside Date shall automatically be extended to April 13, 2028 (the “Third Extended Outside Date” and together with the Initial Outside Date, the First Extended Outside Date and the Second Extended Outside

Date, the “Outside Date”), in each case, unless Parent and the Company mutually agree in writing to an earlier Outside Date; provided, further, that the right to terminate this Agreement under this

Section 8.1(b) shall not be available to any party whose material breach of any of its obligation under this Agreement is the primary cause of the failure of the Effective Time to occur on or before the Initial Outside

Date, the First Extended Outside Date, the Second Extended Outside Date or the Third Extended Outside Date, as the case may be;

(c)

Legal Impediment: By either the Company or Parent, if any Legal Impediment permanently restraining, enjoining or otherwise prohibiting or making illegal either of the Merger or otherwise prohibiting the consummation of the Merger shall

have become final and non-appealable such that the condition specified in Section 7.1(b) would not be satisfied at the Outside Date; provided that the right to terminate this

Agreement pursuant to this Section 8.1(c) shall not be available to any party whose material breach of any of its obligations under this Agreement is the primary cause of, or resulted in, the issuance of such Legal

Impediment;

(d) Required Vote: By either the Company or Parent if the Required Company Vote shall not have been obtained upon a

vote taken thereon at the Company Shareholders Meeting (as such meeting may have been adjourned or postponed);

(e) Change of Board

Recommendation:

(i) By the Company, at any time prior to the time the Required Company Vote is obtained, if (A) the Company

Board shall have effected, and not withdrawn, a Change of Board Recommendation and has authorized the Company to enter into, and the Company substantially concurrently enters into, a definitive agreement with respect to a Superior Proposal,

(B) the Company shall have complied in all material respects with its obligations under Section 6.3, and (C) the Company shall have paid any amounts due pursuant to Section 8.3 in

accordance with the terms, and at the times, specified therein; provided, that this Company’s right to terminate pursuant to this Section 8.1(e)(i) shall expire when the Required Company Vote is obtained; or

(ii) By Parent, at any time prior to the time the Required Company Vote is obtained, if the Company Board shall have effected, and not

withdrawn, a Change of Board Recommendation or the Company shall have approved or adopted, or recommended the approval or adoption of, any definitive agreement with respect to a Superior Proposal;

(f) Company Breach: By Parent, if: (i) there has been a breach by the Company of its representations, warranties, agreements or

covenants contained in this Agreement such that any condition in Section 7.1 or Section 7.2 is not reasonably capable of being satisfied while such breach is continuing, (ii) Parent shall have

delivered to the Company written notice of

such breach and (iii) such breach is not capable of cure in a manner sufficient to allow satisfaction of the conditions set forth in Section 7.1 or

Section 7.2 prior to the Outside Date or otherwise is not cured in a manner sufficient to allow satisfaction of the conditions set forth in Section 7.1 or Section 7.2 by

the earlier of (x) the Business Day prior to the applicable Outside Date or (y) thirty (30) days following the date of delivery of such written notice to Parent; provided that, Parent may not terminate this Agreement pursuant to

this Section 8.1(f) if Parent is then in material breach of any representation, warranty, covenant or agreement set forth in this Agreement that would cause any of the conditions set forth in

Section 7.1 or Section 7.3 not to be satisfied while such breach is continuing; or

(g) Parent Breach: By the Company, if: (i) there has been a breach by any Parent Party of any of their representations,

warranties, agreements or covenants contained in this Agreement such that any condition in Section 7.1 or Section 7.3 is not reasonably capable of being satisfied while such breach is continuing,

(ii) the Company shall have delivered to Parent written notice of such breach and (iii) either such breach is not capable of cure in a manner sufficient to allow satisfaction of the conditions set forth in

Section 7.1 or Section 7.3 prior to the Outside Date or otherwise is not cured in a manner sufficient to allow satisfaction of the conditions set forth in Section 7.1 or

Section 7.3 by the earlier of (x) the Business Day prior to the applicable Outside Date or (y) or at least thirty (30) days following the date of delivery of such written notice to Parent; provided

that, the Company may not terminate this Agreement pursuant to this Section 8.1(g) if the Company is then in material breach of any representation, warranty, covenant or agreement set forth in this Agreement that would

cause any of the conditions set forth in Section 7.1or Section 7.2 not to be satisfied while such breach is continuing.

8.2 Effect of Termination. In the event of the valid termination of this Agreement by either the Company or Parent as provided in

Section 8.1, written notice thereof shall be given by the terminating party to the other parties specifying the provisions hereof pursuant to which such termination is made and the basis therefor described in reasonable

detail, and this Agreement shall become void and there shall be no liability or obligation on the part of any party or their respective Subsidiaries, officers, directors, Parent Representatives or Company Representatives, as applicable, except with

respect to Section 6.2(b), Section 6.6, this Section 8.2, Section 8.3, Section 8.4 and Article 9 which shall, in

each case, survive termination of this Agreement. Subject to Section 8.3 and Section 8.4, nothing herein shall relieve any party for liabilities or damages incurred or suffered (including the loss

to the stockholders of Parent or shareholders of the Company, as applicable, of the benefits of the transactions contemplated by this Agreement) as a result of a Willful and Material Breach or Fraud by the Company, on the one hand, or a Parent

Party, on the other hand. No termination of this Agreement shall affect the obligations of the parties contained in the Confidentiality Agreement or the Clean Team Agreement, all of which obligations shall survive the termination of this

Agreement in accordance with their terms.

8.3 Company Termination Fee.

(a) If this Agreement is terminated by the Company pursuant to Section 8.1(e)(i) (Superior Proposal) or by

Parent pursuant to Section 8.1(e)(ii) (Change of Board Recommendation), then the Company shall pay, or cause to be paid, to Parent prior to or concurrently with such termination a termination fee equal to $64,000,000

(the “Company Termination Fee”).

(b) If this Agreement is terminated by Parent or the Company pursuant to

Section 8.1(b) (Outside Date), or Section 8.1(d) (Required Vote) or by Parent pursuant to Section 8.1(f) (Company Breach), and, in any such case,

(i) an Acquisition Proposal shall have been publicly disclosed or announced, and shall not have been publicly withdrawn, in each case, after the date hereof and prior to the time of the Company Shareholders Meeting (in the case of termination

pursuant to Section 8.1(d) (Required Vote)) or prior to such termination (in the case of termination pursuant to Section 8.1(b) (Outside Date) or

Section 8.1(f) (Company Breach)) and (ii) within twelve (12) months following such termination, the Company or any Company Subsidiary enters into a definitive agreement with respect to, or consummates, an

Acquisition Proposal (in each case, whether or not such Acquisition Proposal is the same as the original Acquisition Proposal publicly disclosed or announced), then the Company shall pay, or caused to be paid, to Parent the Company Termination Fee

immediately prior to and as a condition to the consummation of such transaction. For purposes of this Section 8.3(b), the term “Acquisition Proposal” shall have the meaning assigned to such term in

Section 9.4, except that the references to “20%” shall be deemed to be references to “50%”.

designated in writing by Parent.

(d) Each of the parties acknowledges and agrees (i) that the agreements contained in this

Section 8.3 are an integral part of the transactions contemplated by this Agreement, (ii) that without these agreements the parties would not enter into this Agreement, and (iii) that the Company Termination Fee

is not a penalty, but rather is liquidated damages in a reasonable amount that will compensate the Parent Parties in the circumstances in which such Company Termination Fee is payable. For the avoidance of doubt, in no event shall the Company be

required to pay the Company Termination Fee on more than one occasion.

(e) Notwithstanding anything to the contrary contained herein, in

the event that the Company Termination Fee is actually paid to Parent pursuant to this Agreement, such payment of the Company Termination Fee shall be the sole and exclusive remedy of the Parent Parties and their respective Subsidiaries against the

Company and its Subsidiaries for all losses, damages, costs or expenses in respect of this Agreement (or the termination thereof) or the transactions contemplated by this Agreement, including the Merger (or the failure of such transactions to occur

for any reason or for no reason) or any breach of any covenant or agreement or otherwise in respect of this Agreement or any representation (whether oral or written) made or alleged to be made in connection herewith, and, notwithstanding anything to

the contrary set forth herein (including Section 8.2), upon payment of the Company Termination Fee, neither the Company nor its Subsidiaries shall have any further liability or obligation relating to or arising out of this

Agreement or the transactions contemplated by this Agreement, including the Merger, and Parent or any of its Subsidiaries shall not seek or be entitled to recover any other damages.

(f) If the Company fails to pay the Company Termination Fee when due, and, in order to

obtain such payment, Parent commences a Proceeding that results in a final unappealable judgment against the Company for the Company Termination Fee, the Company shall pay to Parent, together with the Company Termination Fee (A) interest on any

such overdue amount (for the period commencing as of the date such overdue amount was originally required to be paid and ending on the date such overdue amount is actually paid to Parent in full) at a rate per annum equal to the Prime Rate and

(B) Parent’s costs and expenses (including reasonable attorneys’ fees) in connection with such Proceeding (it being understood and agreed that the Company shall not be required to reimburse Parent for any premium, success fee,

contingent fee or other similar fee, commission or payment incurred by Parent in connection with the collection of such overdue amount or the enforcement by Parent of its rights under this Section 8.3).

8.4 Parent Termination Fee.

(a) If this Agreement is terminated by the Company or Parent pursuant to Section 8.1(b) (Outside Date) or

Section 8.1(c) (Legal Impediment), and in either case, at the time of such termination, the condition set forth in Section 7.1(b) (to the extent related to the Competition Laws set forth in

Section 3.5(b) of the Company Disclosure Schedule) or Section 7.1(c) shall not be satisfied, but all other conditions to the Closing set forth in Section 7.1 and

Section 7.2 either have been satisfied (or would be capable of being satisfied if the Closing Date were the date of such termination) or waived (other than Section 7.1(d),

Section 7.1(e) or the other conditions that by their nature can only be satisfied on the Closing Date), then Parent shall pay, or cause to be paid, to the Company prior to or concurrently with such termination a termination

fee equal to $80,000,000 (the “Parent Termination Fee”).

(b) All payments under this

Section 8.4 shall be made by wire transfer of immediately available funds to an account designated in writing by the Company.

integral part of the transactions contemplated by this Agreement, (ii) that without these agreements the parties would not enter into this Agreement, and (iii) that the Parent Termination Fee is not a penalty, but rather is liquidated

damages in a reasonable amount that will compensate Company in the circumstances in which such Parent Termination Fee is payable. For the avoidance of doubt, in no event shall Parent be required to pay the Parent Termination Fee on more than one

occasion.

(d) Notwithstanding anything to the contrary contained herein, in the event that the Parent Termination Fee is actually paid

to the Company pursuant to this Agreement, such payment of the Parent Termination Fee be the sole and exclusive remedy of the Company and its Subsidiaries against the Parent Parties and their respective Subsidiaries for all losses, damages, costs or

expenses in respect of this Agreement (or the termination thereof) or the transactions contemplated by this Agreement, including the Merger (or the failure of such transactions to occur for any reason or for no reason) or any breach of any covenant

or agreement or otherwise in respect of this Agreement or any representation (whether oral or written) made or alleged to be made in connection herewith, and, notwithstanding anything to the contrary set forth herein (including

Section 8.2), upon payment of the Parent Termination Fee, none of the Parent Parties or any of their respective Subsidiaries shall have any further liability or obligation relating to or arising out of this Agreement or the

transactions contemplated by this Agreement, including the Merger, and the Company or any of its Subsidiaries shall not seek or be entitled to recover any other damages.

(e) If Parent fails to pay the Parent Termination Fee when due, and, in order to obtain

such payment, the Company commences a Proceeding that results in a final unappealable judgment against Parent for the Parent Termination Fee, Parent shall pay to the Company, together with the Parent Termination Fee (A) interest on any such

overdue amount (for the period commencing as of the date such overdue amount was originally required to be paid and ending on the date such overdue amount is actually paid to the Company in full) at a rate per annum equal to the Prime Rate and

(B) the Company’s costs and expenses (including reasonable attorneys’ fees) in connection with such Proceeding (it being understood and agreed that Parent shall not be required to reimburse the Company for any premium, success fee,

contingent fee or other similar fee, commission or payment incurred by the Company in connection with the collection of such overdue amount or the enforcement by the Company of its rights under this Section 8.4).

Article 9

GENERAL

PROVISIONS

9.1 Non-Survival of Representations and Warranties. None of the

representations, warranties or covenants in this Agreement (or in any instrument delivered pursuant to this Agreement) shall survive the Effective Time except that this Section 9.1 shall not limit any covenant, obligation

or agreement of the parties or other provision herein which by its terms applies or contemplates performance in whole or in part after the Effective Time, which shall survive in accordance with its terms.

9.2 Fees and Expenses. Except for (a) the expenses in connection with filing, printing and mailing the Proxy

Statement/Prospectus and Registration Statement and any other filings required in connection with the actions specified in Section 6.1, (b) all SEC filing fees relating to the Merger and the transactions contemplated by

this Agreement and (c) the filing fees in connection with the approvals required under Section 7.1(c) related to the Merger and the transactions contemplated by this Agreement (each of which filing fees and expenses

shall be borne, in each case, by Parent), all fees and expenses, including fees and expenses incurred in connection with the preparation, negotiation, execution and performance of this Agreement and the consummation of the transactions contemplated

by this Agreement shall be paid by the party incurring such expenses, whether or not the Merger is consummated.

9.3 Notices. Any

notices or other communications required or permitted under, or otherwise given in connection with, this Agreement shall be in writing and shall be deemed to have been duly given (a) when delivered or sent if delivered in Person (with written

confirmation of receipt), (b) on the next Business Day if transmitted by national overnight courier (with written confirmation of delivery) or (c) on the date delivered if sent by email during normal business hours of the recipient on a

Business Day and otherwise on the next Business Day (to the extent no “bounce back” or similar message indicating non-delivery is received with respect thereto), in each case, as follows (or to

such other Persons or addressees as may be designated in writing by the party to receive such notice in accordance with this Section 9.3):

If to any Parent Party, addressed to it at:

Somnigroup International Inc.

100 Crescent Ct. Suite 700

Dallas, Texas 75201

Attention:

General Counsel, Somnigroup

Email: [***]

with a copy to (for information purposes only):

Cleary Gottlieb Steen & Hamilton LLP

One Liberty Plaza

New York,

New York 10006

Attention: Paul J. Shim

Timothy J. Saviola

Michael

Saliba

Email:

pshim@cgsh.com

tsaviola@cgsh.com

msaliba@cgsh.com

If to the

Company, addressed to it at:

Leggett & Platt, Incorporated

1 Leggett Road

Carthage,

Missouri 64836

Attention: Jennifer Davis

Email: [***]

with a copy to

(for information purposes only):

Latham & Watkins LLP

330 North Wabash Avenue, Suite 2800

Chicago, Illinois 60611

Attention: Bradley Faris

Christopher Drewry

Sean Parish

Email: bradley.faris@lw.com

christopher.drewry@lw.com

sean.parish@lw.com

9.4

Certain Definitions. For purposes of this Agreement, the term:

“Acceptable Confidentiality Agreement” means a

confidentiality agreement entered into by the Company with any Person after the date hereof that contains (a) customary limitations on the use and disclosure of all non-public information furnished to

such Person by or on behalf of the Company and (b) confidentiality, non-use and other provisions that are no less favorable in the aggregate to the Company than those contained in the Confidentiality

Agreement in effect immediately prior to the execution of this Agreement; provided, that any such confidentiality agreement need not contain any standstill provision and shall not include any provision conflicting with or otherwise impairing

the Company’s ability to comply with its obligations under this Agreement.

“Acquisition Proposal” means any inquiry, indication of interest, offer

or proposal from any Person or “group” of Persons (as defined in Section 13(d)(3) of the Exchange Act) (other than Parent and the Parent Subsidiaries) contemplating or otherwise relating to any transaction or a series of related

transactions involving (a) any merger, consolidation, amalgamation, plan or scheme of arrangement, share exchange, business combination, joint venture, reorganization, recapitalization, liquidation, dissolution or other similar transaction

involving the Company; (b) any sale, lease, exchange, transfer, license or disposition of any business or businesses or assets of the Company (including Equity Interests of a Company Subsidiary) or the Company Subsidiaries that constitute or

account for twenty percent (20%) or more of the consolidated assets (measured based on fair market value as of the date of such sale or disposition) or consolidated net revenues or consolidated net income (in each case, measured based on the twelve

(12) full calendar months prior to the date of determination) of the Company and the Company Subsidiaries; (c) any direct or indirect purchase or other acquisition by any Person or “group” of Persons (as defined in

Section 13(d)(3) of the Exchange Act) of twenty percent (20%) or more of the outstanding Company Common Stock or securities of the Company representing twenty percent (20%) or more of the voting power of the Company after giving effect to the

consummation of such purchase or other acquisition, including pursuant to an issuance by the Company or a tender offer or exchange offer by any Person or “group” of Persons (as defined in Section 13(d)(3) of the Exchange Act) that,

if consummated in accordance with its terms, would result in such Person or “group” of Persons (as defined in Section 13(d)(3) of the Exchange Act) beneficially owning twenty percent (20%) or more of the outstanding Company Common

Stock or securities of the Company representing twenty percent (20%) or more of the voting power of the Company after giving effect to the consummation of such tender offer or exchange offer; or (d) any combination of the foregoing (in each

case, other than the Merger or any other transaction involving solely the Company and one or more of the wholly owned Company Subsidiaries or solely among wholly owned Company Subsidiaries).

“affiliate” means, as to any Person, a Person that directly or indirectly, through one or more intermediaries, controls, is

controlled by, or is under common control with, the first-mentioned Person. For purposes of the immediately preceding sentence, the term “control” (including, with correlative meanings, the terms “controlling,”

“controlled by” and “under common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of

such Person, whether through ownership of voting securities, by contract or otherwise. Notwithstanding the foregoing, prior to the Closing, (a) neither Parent nor any Parent Subsidiary shall be deemed to be affiliates of the Company or any

Company Subsidiary and (b) neither the Company nor any Company Subsidiary shall be deemed to be affiliates of Parent or any Parent Subsidiary.

“Anti-Corruption Laws” means all U.S. and non-U.S. Laws relating to the prevention

of corruption and bribery, including, without limitation, the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the UK Bribery Act 2010, as amended.

“beneficial ownership” (and related terms such as “beneficially owned” or “beneficial owner”) has

the meaning set forth in Rule 13d-3 under the Exchange Act.

“Business Day” has the meaning set forth in Rule 14d-1(g)(3) under the Exchange Act.

“Code” means the United States Internal Revenue

Code of 1986, as amended.

“Collective Bargaining Agreement” means any collective bargaining agreement, labor

agreement, works council agreement or other labor related Contract with any Union.

“Commercial Paper Facility” means

that certain Issuing and Paying Agent Agreement, dated as of December 2, 2014, by and between U.S. Bank National Association and the Company regarding the commercial paper program of the Company (the “Issuing and Paying Agent

Agreement”), and the Amended and Restated Commercial Paper Dealer Agreement, concerning notes to be issued pursuant to the Issuing and Paying Agent Agreement.

“Company Benefit Plan” means each (a) “employee benefit plan” as defined in Section 3(3) of ERISA

(whether or not subject to ERISA), (b) bonus, incentive or deferred compensation or equity or equity-based compensation plan, program, policy or arrangement, including employer stock and incentive plans, (c) severance, change in control,

employment, individual consulting, pension, retirement, profit sharing, retention or termination plan, program, agreement, policy or arrangement or (d) other compensation or benefit plan, program, agreement, policy, practice, contract or

arrangement and whether or not subject to ERISA, including all bonus, cash or equity-based incentive, deferred compensation, stock purchase, health, medical, dental, vision, or other health plans, disability, accident, life insurance, or vacation,

paid time off, perquisite, fringe benefit, severance, change of control, retention, employment, separation, retirement, pension, or savings, plans, programs, policies, agreements or arrangements, in any case, whether written or not written, and

other than any statutory plan, program, or arrangement that is required under applicable Laws and maintained by any Governmental Entity and other than any Multiemployer Plan, that is sponsored, maintained, contributed to, or required to be

contributed to, by the Company or any of the Company Subsidiaries for the benefit of or relating to any current or former employee, officer, director, or other individual service provider of the Company or any Company Subsidiary or the beneficiaries

or dependents of any such individual, or with respect to which the Company has any liability.

“Company Credit

Facilities” means the Company’s Revolving Credit Facility and the Company’s Commercial Paper Facility.

“Company DSP” means the Company’s Discount Stock Plan, as amended and restated on November 5, 2024.

“Company Equity Award” means each Company Option, Company RSU Award, Company PSU Award and Company Restricted Share.

“Company Equity Plan” means the Company’s Flexible Stock Plan, as amended and restated, effective as of May 7,

2025.

“Company Joint Venture” means any incorporated (or similarly formed)

joint venture, teaming, partnership, or other similar agreements, arrangements or understandings and all other material joint venture, teaming, partnership, or other similar agreements, arrangements or understandings, in each case, involving a

sharing of profits, losses, costs or liabilities in which the Company or any Company Subsidiary holds at least five percent (5%) of the equity or other participating rights or interests. For the avoidance of doubt, no wholly owned Company Subsidiary

shall be deemed to be Company Joint Venture.

“Company Material Adverse Effect” means any change, event, occurrence,

state of facts, condition or development (an “Effect”) that, individually or in the aggregate with all other Effects, has had or would reasonably be expected to have or result in a material adverse effect on the business,

financial condition, capitalization, assets, operations or results of operations of the Company and the Company Subsidiaries, taken as a whole, Effects to the extent arising out of, or resulting from or attributable to the following shall not

constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that

Effects with respect to clauses (a), (b) or (c) below shall be considered to the extent such Effect disproportionately adversely impacts the Company or the Company Subsidiaries, taken as a whole, relative to the other

companies operating in the same industries (and in which case, only the extent of such disproportionate impact shall be taken into account): (a) changes in Law or other legal or regulatory conditions (or the interpretation or enforcement thereof) or

changes in GAAP or other accounting standards (or the interpretation or enforcement thereof), including the adoption, implementation, repeal or modification of any Law (or the enforcement thereof) by any Governmental Entity, in each case, after the

date hereof, (b) changes in general economic, business, labor or regulatory conditions, or changes in securities, credit or other financial markets, including interests rates or exchange rates or tariffs in the United States or globally, or

changes generally affecting the industries (including seasonal fluctuations) in which the Company or the Company Subsidiaries operate in the United States or globally, in each case, after the date hereof, (c) changes in global or national

political conditions (including the outbreak or escalation of war (whether or not declared), military action, sabotage or acts of terrorism), changes due to natural disasters or changes in the weather or changes due to the outbreak or worsening of

an epidemic, pandemic or other health crisis, in each case, after the date hereof, (d) actions or omissions expressly required of the Company under this Agreement or taken or not taken at the express request of, or with the prior written

consent or prior written approval of, Parent after the date of this Agreement (or, in the case of any action where the consent of Parent was requested in writing in accordance with Section 5.1, where Parent’s consent

was unreasonably withheld, delayed or conditioned), (e) the negotiation, announcement or pendency of this Agreement and the transactions contemplated hereby, including (i) the identity of, or the effect of any fact or circumstance relating to,

Parent and (ii) any termination of, reduction in or similar negative impact on relationships, contractual or otherwise, with any customers, suppliers, distributors, vendors, lenders, employees or partners attributable to, or taken in response

to, the public announcement of this Agreement and the transactions contemplated hereby; provided, that the exception set forth in this clause (e) shall not apply in connection with any breach or inaccuracy of a representation or

warranty set forth in this Agreement expressly addressing the consequences of the announcement or existence of, compliance with or performance under, this Agreement, (f) any Proceeding arising from allegations of breach of fiduciary duty or

violation of Law with respect to this Agreement or the transactions contemplated hereby, (g) changes in the trading price or trading volume of Company Common Stock; provided, that the underlying cause of such change in trading price or

trading volume may be taken into account in determining whether a Company Material Adverse Effect has occurred (to the extent not otherwise excluded from the definition of

Company Material Adverse Effect), (h) any failure by the Company or any of the Company Subsidiaries to meet any revenue, earnings or other financial projections or forecasts, provided,

that the underlying cause of such failure may be taken into account in determining whether a Company Material Adverse Effect has occurred (to the extent not otherwise excluded from the definition of Company Material Adverse Effect), or (i) any

action taken by Parent or its affiliates with respect to the commercial relationship between Parent and the Company and their respective affiliates.

“Company Notes” means each of Company’s $500,000,000 3.50% Senior Notes due 2051, the Company’s $500,000,000

4.40% Senior Notes due 2029 and the Company’s $500,000,000 3.50% Senior Notes due 2027.

“Company Notes

Indentures” means each indenture and supplemental indenture in respect of the Company Notes.

“Company

Option” means an option to acquire shares of Company Common Stock granted under the Company Equity Plan.

“Company

Owned Intellectual Property” means all Intellectual Property that is owned by the Company or any of the Company Subsidiaries, including the Company Registered Intellectual Property.

“Company PSU Award” means an award of performance stock units with respect to shares of Company Common Stock granted under

the Company Equity Plan that is, at the time of determination, subject to performance-based vesting conditions (whether or not in addition to vesting conditions based on continued employment or service).

“Company Representatives” means the Company’s and the Company Subsidiaries’ respective directors, officers,

employees, accountants, consultants, legal counsel, investment bankers, advisors, agents and other representatives.

“Company

Restricted Share” shall mean each share of Company Common Stock granted under the Company Equity Plan that is unvested and subject to vesting or transfer restrictions.

“Company RSU Award” means each (i) award of restricted stock units with respect to shares of Company Common Stock

granted under the Company Equity Plan that is, at the time of determination, subject solely to vesting conditions based on continued employment or service (whether or not fully vested) and (ii) notional account in a Deferred Compensation Plan

containing a Stock Unit (as defined in the applicable Deferred Compensation Plan), which Stock Unit tracks the value of a share of Company Common Stock.

“Company Subsidiary” means any Subsidiary of the Company.

“Company Tax Opinion” means the written opinion of the Company Tax Counsel, in a form reasonably satisfactory to the

Company, dated as of the Closing Date, to the effect that, on the basis of the facts, representations and assumptions described or referred to in such opinion that are consistent with the state of facts existing at the Closing Date, the Merger will

qualify for

the Intended Tax Treatment; provided, that, in rendering the Company Tax Opinion, Company Tax Counsel may require and rely upon supporting certificates or letters (substantially in

the form of Exhibit B-1 and Exhibit B-2 or Exhibit B-3 and Exhibit

B-4, as applicable) duly executed by officers of the Parent Parties and the Company, respectively.

“Competition Laws” means (a) applicable supranational, national, federal, state, provincial or local Law designed or

intended to prohibit, restrict or regulate actions having the purpose or effect of monopolizing or restraining trade or lessening competition in any other country or jurisdiction, including the HSR Act, the Sherman Act, the Clayton Act, the Federal

Trade Commission Act, in each case, as amended and other similar competition or antitrust laws of any jurisdiction other than the United States, and (b) all Laws or administrative processes governing the review, screening, approval, prohibition

or imposition of conditions in relation to foreign or non-domestic investment or ownership in entities, assets, infrastructure or sectors of strategic or sensitive importance (including, for the avoidance of

doubt, any foreign investment control, national security or public order screening regimes.

“Continuing Employee”

means each employee of the Company or any of the Company Subsidiaries who is employed by the Company or any of the Company Subsidiaries as of immediately prior to the Effective Time and who continues to be actively employed by the Surviving

Corporation (or any of its affiliates) on or following the Effective Time.

“Contract” or

“Contracts” means any of the agreements, arrangements, contracts, leases (whether for real or personal property), powers of attorney, notes, bonds, mortgages, indentures, deeds of trust, loans, evidences of indebtedness, letters

of credit, settlement agreements, franchise agreements, undertakings, covenants not to compete, employment agreements, licenses, purchase and sale orders and other legal commitments to which in each case a Person is a party or to which any of the

properties or assets of such Person or its Subsidiaries are subject, whether written or oral.

“Debt Financing Sources”

shall mean the parties acting as lead arrangers or agents for, and prospective lenders and investors with respect to, any Financing Transaction.

“Environmental Laws” means any and all applicable Laws which regulate or relate to pollution, protection or cleanup of the

environment or human health and safety (as it relates to exposure to Hazardous Substances), including Laws related to the disposal, generation, use, treatment, storage, transportation, labeling, management, handling, Release or threatened Release of

Hazardous Substances.

“Environmental Permits” means any permit, certificate, registration, approval, identification

number, waiver, variance, exemption, license, clearance, or other authorization required under any applicable Environmental Law.

“Equity Interest” means any share, capital stock, partnership, limited liability company, member or similar equity or

ownership interest in any Person, and any option, warrant, right or security (including debt securities) convertible, exchangeable or exercisable into or for any such share, capital stock, partnership, limited liability company, member or similar

equity or ownership interest.

“ERISA” means the Employee Retirement Income Security Act of 1974 and the

rules and regulations promulgated thereunder.

“ERISA Affiliate” means, with respect to any entity, trade or business,

any other entity, trade or business that is a member of a group described in Section 414(b), (c), (m) or (o) of the Code or Section 4001(b)(1) of ERISA that includes the first entity, trade or business, or that is a member of the same

“controlled group” as the first entity, trade or business pursuant to Section 4001(a)(14) of ERISA.

“Exchange

Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“Exchange Ratio” means 0.1455.

“Existing Financing” has the meaning assigned to such term in Section 6.17(a).

“Financing Transaction” has the meaning assigned to such term in Section 6.17(a).

“Fraud” means, with respect to any Person, common law fraud under the Laws of the State of Delaware, by such Person in the

making of the representations and warranties in this Agreement or any certificate executed and delivered by such Person pursuant to the terms of this Agreement.

“GAAP” means generally accepted accounting principles, as applied in the United States.

“Government Official” means (a) any officer or employee of a Governmental Entity or any department, agency or

instrumentality thereof, including state-owned entities, or of a public organization; (b) any political party, political party official or candidate for political office; or political campaign; or (c) any person acting in an official

capacity for or on behalf of any such government, department, agency, or instrumentality or on behalf of any such public organization.

“Governmental Entity” means any supranational, national, federal, state, county, municipal, local or foreign government, or

other political subdivision thereof, and any entity (including any professional or self-regulatory association or organization or private body) exercising executive, legislative, judicial, regulatory, taxing, administrative, prosecutorial or

arbitral functions of or pertaining to government, or any stock exchange or self-regulatory organization.

“Hazardous

Substances” means any material, substance, chemical or waste that is listed, defined or regulated as “hazardous,” “toxic,” a “pollutant,” or a “contaminant”, or words of similar regulatory

meaning or effect, or for which liability or standards of care or a requirement for investigation or remediation are imposed (if a Release occurs), under any Environmental Law, including asbestos or asbestos-containing materials, petroleum or

petroleum by-products, radioactive materials, per- and polyfluoroalkyl substances or polychlorinated biphenyls.

“HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the rules and regulations thereunder.

“Intellectual Property” means all intellectual property rights, whether

registered or unregistered, throughout the world, including all: (a) patents and patent applications, utility models and other intellectual property rights in inventions (whether or not patentable); (b) trademarks, service marks, trade dress,

logos, slogans, brand names, trade names, Internet domain names, corporate names, and other indicia of source or origin, and all applications and registrations in connection therewith; (c) all copyrights, mask works, designs and other

intellectual property rights in works of authorship and all applications and registrations in connection therewith; (d) intellectual property rights in software, data, databases, and technology; (e) internet domain names, (f) trade

secrets, and other intellectual property rights in know-how and confidential or proprietary information and (g) any registrations of or applications to register any of the foregoing.

“Intervening Event” means any Effect that relates to and is material to the Company and the Company Subsidiaries, taken as

a whole, that occurs or arising after the date hereof and that (a) was not known or reasonably foreseeable to the Company Board as of or prior to the date hereof (or, if known or reasonably foreseeable, the magnitude or consequences of which

were not known or reasonably foreseeable by the Company Board as of or prior to the date hereof), and (b) does not involve or relate to (i) an Acquisition Proposal or the expected receipt, existence or terms of an Acquisition Proposal,

(ii) the fact that the Company meets or exceeds any internal or published projections or forecasts or estimates of revenues, earnings or other financial results for any period ending on or after the date of this Agreement, (iii) changes

after the date of this Agreement in the market price or trading volume of the Company Common Stock or (iv) changes in the market price or trading volume of Parent Common Stock or any other securities of Parent or the failure of Parent to meet

internal or securities analysts’ published projections of earnings, revenues or other financial results for any period ending on or after the date hereof (provided, however, that the underlying causes of such fact or change shall

not be excluded by clauses (ii), (iii) or (iv) in determining whether an “Intervening Event” has occurred if not otherwise falling into the foregoing clauses (a) and (b) of this definition).

“IRS” means the United States Internal Revenue Service.

“Key Employee” means any employee of the Company holding the title of executive vice president or a more senior title.

“Knowledge” means (a) when used with respect to the Company, the actual knowledge, after reasonable inquiry of their

direct reports, of the individuals listed in Section 9.4(a) of the Company Disclosure Schedule; and (b) when used with respect to Parent, the actual knowledge, after reasonable inquiry of their direct reports, of the

individuals listed in Section 9.4(b) of the Parent Disclosure Schedule.

“Law” means any

applicable international, national, provincial, state, municipal, local and common laws, statutes, ordinances, bylaws, rules, constitutional provisions, treaties, conventions, mandates, codes, edicts, regulations, ordinances or other requirements,

legally binding guidance, consent permits, policies, restrictions or licenses of any Governmental Entity and any Orders, in each case, having the force of law.

“Lien” means any lien, mortgage, pledge, conditional or installment sale

(or lease in the nature thereof) agreement, encumbrance, defect in title, covenant, condition, restriction, charge, option, right of first refusal, right of first offer, lease, sublease, easement, security interest, deed of trust, right-of-way, encroachment, community property interest or other claim or restriction of any nature, whether voluntarily incurred or arising by operation of Law (including any

restriction on the voting of any security, any restriction on the transfer of any security or other asset, and any restriction on the possession, exercise or transfer of any other attribute of ownership of any asset).

“Multiemployer Plan” means a “multiemployer plan” (as defined in or within the meaning of

Section 3(37) or Section 4001(a)(3) of ERISA or Section 414(f) of the Code).

“NYSE” means the New York

Stock Exchange (provided, that if NYSE is no longer the principal U.S. trading market for either the Parent Common Stock or the Company Common Stock, then “NYSE” shall be deemed to mean the principal U.S. national securities

exchange registered under the Exchange Act on which the Parent Common Stock or the Company Common Stock, as the context requires, is then traded).

“Order” means any judgment, order, decision, writ, injunction, temporary restraining order, verdict, ruling, stipulation,

rule, settlement, determination, decree or arbitration award issued or entered by or with any Governmental Entity.

“Parent

Equity Awards” means each Parent Option, Parent RSU Award and Parent PSU Award.

“Parent Equity Plan” means

Parent’s Amended and Restated 2013 Equity Incentive Plan, as amended and restated on May 5, 2025, as the same may be further amended or restated from time to time.

“Parent Material Adverse Effect” means any Effect that, individually or in the aggregate with all other Effects, has had or

would reasonably be expected to have or result in a material adverse effect on the business, financial condition, capitalization, assets, operations or results of operations of Parent and the Parent Subsidiaries, taken as a whole, Effects to the

extent arising out of, or resulting from or attributable to the following shall not constitute or be deemed to contribute to a Parent Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Parent Material

Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) or (c) below shall be considered to the extent such Effect disproportionately adversely impacts

Parent or the Parent Subsidiaries, taken as a whole, relative to the other companies operating in the same industries (and in which case, only the extent of such disproportionate impact shall be taken into account): (a) changes in Law or other legal

or regulatory conditions (or the interpretation or enforcement thereof) or changes in GAAP or other accounting standards (or the interpretation or enforcement thereof), including the adoption, implementation, repeal or modification of any Law (or

the enforcement thereof) by any Governmental Entity, in each case, after the date hereof, (b) changes in general economic, business, labor or regulatory conditions, or changes in securities, credit or other financial markets, including

interests rates or exchange rates or tariffs in the United States or globally, or changes generally affecting the industries (including seasonal fluctuations) in which Parent or the Parent Subsidiaries operate in the United States or globally, in

each case, after the date hereof, (c) changes in global or national political conditions (including the outbreak or

escalation of war (whether or not declared), military action, sabotage or acts of terrorism), changes due to natural disasters or changes in the weather or changes due to the outbreak or

worsening of an epidemic, pandemic or other health crisis, in each case, after the date hereof, (d) actions or omissions expressly required of any of the Parent Parties under this Agreement or taken or not taken at the express request of, or

with the prior written consent or prior written approval of, the Company after the date of this Agreement (or, in the case of any action where the consent of the Company was requested in writing in accordance with

Section 5.1, where the Company’s consent was unreasonably withheld, delayed or conditioned), (e) the negotiation, announcement or pendency of this Agreement and the transactions contemplated hereby, including

(i) the identity of, or the effect of any fact or circumstance relating to, the Company and (ii) any termination of, reduction in or similar negative impact on relationships, contractual or otherwise, with any customers, suppliers,

distributors, vendors, lenders, employees or partners attributable to, or taken in response to, the public announcement of this Agreement and the transactions contemplated hereby; provided, that the exception set forth in this clause

(e) shall not apply in connection with any breach or inaccuracy of a representation or warranty set forth in this Agreement expressly addressing the consequences of the announcement or existence of, compliance with or performance under,

this Agreement, (f) any Proceeding arising from allegations of breach of fiduciary duty or violation of Law with respect to this Agreement or the transactions contemplated hereby, (g) changes in the trading price or trading volume of

Parent Common Stock; provided, that the underlying cause of such change in trading price or trading volume may be taken into account in determining whether a Parent Material Adverse Effect has occurred (to the extent not otherwise excluded

from the definition of Parent Material Adverse Effect), (h) any failure by Parent or any of the Parent Subsidiaries to meet any revenue, earnings or other financial projections or forecasts, provided, that the underlying cause of such failure

may be taken into account in determining whether a Parent Material Adverse Effect has occurred (to the extent not otherwise excluded from the definition of Parent Material Adverse Effect), or (i) any action taken by the Company or its

affiliates with respect to the commercial relationship between Parent and the Company and their respective affiliates.

“Parent

Option” means an option to acquire shares of Parent Common Stock granted by Parent pursuant to the Parent Equity Plan.

“Parent PSU Award” means an award of restricted stock units with respect to shares of Parent Common Stock granted under the

Parent Equity Plan that is, at the time of determination, subject to performance-based vesting conditions (whether or not in addition to vesting conditions based on continued employment or service).

“Parent Representatives” means Parent’s and the Parent Subsidiaries’ respective directors, officers, employees,

accountants, consultants, legal counsel, investment bankers, advisors, agents and other representatives.

“Parent RSU

Award” means an award of restricted stock units with respect to shares of Parent Common Stock granted by Parent pursuant to the Parent Equity Plan that is, at the time of determination, either vested in full or subject solely to vesting

conditions based on continued employment or service.

“Parent Subsidiary” means any Subsidiary of Parent.

“Permitted Company Dividends” means regular quarterly dividends on shares

of Company Common Stock, in an amount not in excess of $0.05 per share per calendar quarter, declared and paid in accordance with past practice with respect to timing of declaration and the amount thereof and made out of the Company’s

available liquidity sources prior to the Effective Time, provided that the Company may increase the Permitted Company Dividend by up to $0.01 per share per calendar year.

“Permitted Liens” means (a) Liens for Taxes not yet due and payable or for the amount or validity of which is being

timely contested in good faith by appropriate Proceedings and for which adequate reserves have been established in accordance with GAAP on the financial statements of the applicable Person, (b) Liens in favor of vendors, carriers, warehousemen,

repairmen, mechanics, workmen, materialmen, construction or similar liens or encumbrances arising by operation of Law in the ordinary course of business for amounts not yet due and payable or for the amount or validity of which is being timely

contested in good faith by appropriate Proceedings and for which adequate reserves have been established in accordance with GAAP on the financial statements of the applicable Person, (c) Liens arising from transfer restrictions under securities

Laws or related Laws of any jurisdiction, (d) nonexclusive licenses of Intellectual Property granted by the Company or the Company Subsidiaries in the ordinary course of business, and (e) (i) matters and other easements, rights of way,

encroachments, encumbrances and other real property Liens disclosed in public records that, individually or in the aggregate, do not interfere in any material respect with or otherwise impair in any material respect the use, occupancy, or

insurability of title of the Company Real Property subject thereto, (ii) Liens that would be disclosed by a current, accurate survey or physical inspection of the Company Real Property that, individually or in the aggregate, do not interfere in

any material respect with or otherwise impair in any material respect the use, occupancy or insurability of title of the Company Real Property subject thereto, (iii) applicable building, zoning and land use regulations, that are not violated by

any current use, occupancy or activity conducted at any Company Real Property in any material respect, (iv) Liens encumbering the fee interest in the property constituting Company Leased Real Property (as applicable) and Liens of landlord and

sublandlords pursuant to the leases and subleases of the Company Leased Real Property (as applicable) that, individually or in the aggregate, do not interfere in any material respect with or otherwise impair in any material respect the use or

occupancy of the Company Real Property subject thereto, and (v) other Liens, encumbrances, imperfections or other irregularities in title, restrictions and other encumbrances disclosed in public records that, individually or in the aggregate,

do not interfere in any material respect with or otherwise impair in any material respect the use or occupancy of title of the Company Real Property to which they relate.

“Permitted Parent Dividends” means regular quarterly dividends on shares of Parent Common Stock, in an amount not in excess

of (i) $0.17 per share for the first calendar quarter of fiscal year 2026 and (ii) for each subsequent calendar quarter thereafter, an amount per share not in excess of the cap applicable to the immediately preceding calendar quarter plus $0.02

per share, in each case, declared and paid in accordance with past practice with respect to timing of declaration and made out of Parent’s available liquidity sources prior to the Effective Time.

“Person” means an individual, corporation, limited liability company, partnership, association, trust, unincorporated

organization, other entity or group (as defined in Section 13(d) of the Exchange Act).

“Personal Information” means information that identifies relates to,

describes or is reasonably capable of being associated with, or could reasonably be linked, directly or indirectly, with a particular individual or household or is otherwise considered “personally identifiable information,”

“personal information,” “personal data,” or any similar term by any applicable Laws and Privacy Requirements.

“Prime Rate” means the rate per annum published in The Wall Street Journal from time to time as the prime lending

rate prevailing during any relevant period.

“Privacy and Security Laws” means all applicable Laws relating to privacy,

data security, data breach notification, or the Processing, storage, transmission, transfer, disclosure, use or retention of data, including Personal Information.

“Proceeding” means any action, suit, claim, hearing, arbitration, litigation, mediation, grievance, audit, examination or

other proceeding, in each case, by or before any Governmental Entity.

“Processing” means any operation or set of

operations which is performed on Personal Information, by any means, such as the use, collection, processing, storage, disclosure, dissemination, combination or disposal of such information.

“Release” means any release, spill, emission, leaking, pumping, pouring, injection, escaping, abandonment, deposit,

disposal, discharge, dispersal, dumping, or leaching into or through the environment.

“Revolving Credit Facility”

means that certain Fifth Amended and Restated Credit Agreement, dated as of July 24, 2025, by and among the Company, JPMorgan Chase Bank, N.A. and lender parties thereto.

“Sanctioned Country” means any country or territory that is the subject of comprehensive country-wide, territory-wide, or

region-wide Sanctions (currently, Cuba, Iran, North Korea, and the Crimea, so-called Donetsk People’s Republic, so-called Luhansk People’s Republic regions

of Ukraine, and the non-Ukrainian government-controlled regions of Kherson and Zaporizhzhia).

“Sanctioned Person” means any person with whom dealings are restricted or prohibited by Sanctions, including as a result of

being (a) listed on any Sanctions-related list; (b) organized under the Laws of, located in, or a resident of a Sanctioned Country; or (c) the government of a Sanctioned Country or the Government of Venezuela; (d) directly or

indirectly owned or controlled by, or acting or purporting to act on behalf of, a Person or Persons described in clauses (a), (b) or (c); or (e) any Person who is otherwise the subject or target of Sanctions.

“Sanctions” means all Laws relating to economic or financial sanctions, trade embargoes, or similar laws and regulations

imposed, administered or enforced by the United States (including by the Office of Foreign Assets Control of the U.S. Department of the Treasury’s (OFAC) or the U.S. Department of State), the United Nations Security Council, Canada, the United

Kingdom, the European Union, any European Union member state, or any other applicable Governmental Entity.

“SEC” means the United States Securities and Exchange Commission.

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Security Incident” means any unauthorized intrusion, cyberattack or breach of security of the Company IT Assets and any

unlawful or unauthorized access, use, loss, disclosure, theft, modification, corruption, destruction, compromise or the rendering unavailable or inaccessible (including through a ransomware attack) or Processing of data, including Personal

Information stored on the Company IT Assets or otherwise stored, maintained, owned or Processed by or on behalf of the Company or the Company Subsidiaries.

“Special Dividend Amount” means an amount in cash equal to (i) the product of (A) six percent (6%) and

(B) (1) the volume-weighted average price of Company Common Stock for the thirty (30) Trading Day period ending on (and including) the Trading Day immediately prior to the Closing Date, multiplied by (2) the number of shares of

Company Common Stock outstanding as of immediately prior to the Effective Time, multiplied by (ii) a fraction, the numerator of which is the number of calendar days elapsed after the Special Dividend Date to and including the Closing

Date and the denominator of which is three hundred sixty-five (365); provided, however, that the “Special Dividend Amount” means $0 if the Closing Date occurs on or prior to the Special Dividend Date (if any).

“Special Dividend Date” means the commencement date of any Proceeding (excluding an audit, investigation or examination)

brought by the Department of Justice or Federal Trade Commission, under any applicable U.S. federal Competition Law, seeking to delay, restrain, prevent, enjoin or otherwise prohibit consummation of the Merger and the transactions contemplated by

this Agreement.

“Subsidiary” means, with respect to any Person, any corporation, partnership, limited liability

company, joint venture, business trust or other organization, whether incorporated or unincorporated, or other legal entity of which (a) such Person directly or indirectly owns or controls at least a majority of the capital stock or other

equity interests having by their terms ordinary voting power to elect a majority of the board of directors or others performing similar functions, (b) such Person and/or any Person that is a Subsidiary of such Person by reason of the

application of clause (a) or clause (c) of this definition of “Subsidiary” is a general partner, manager, managing member, trustee, director or the equivalent or otherwise manages or controls such other Person

(disregarding major decision and veto rights of other investors), or (c) such Person, directly or indirectly, holds a majority of the beneficial, equity, capital, profits or other economic interest.

“Superior Proposal” means a bona fide, unsolicited written Acquisition Proposal (except the references therein to

“20%” shall be replaced by “50%”) made by a third party after the date of this Agreement, on terms and conditions which, in the good faith judgment of the Company Board (after consultation with its financial advisors and

outside counsel), taking into account the timing and likelihood of consummation relative to the Merger, (a) is reasonably likely to be consummated in accordance with its terms (taking into account all financial, regulatory, financing,

conditionality, legal and other terms and conditions) and (b) if consummated, would

reasonably be expected to result in a transaction that is more favorable, from a financial point of view, to the Company’s shareholders (in their capacity as such) than the Merger, taking

into account all of the terms and conditions of such Acquisition Proposal and this Agreement (in each case, including all financial, regulatory, financing, conditionality, legal and other terms and conditions, and any proposal by Parent to amend or

modify the terms of this Agreement made in accordance with Section 6.3(e)).

“Supply Agreement

Amendment” means that certain Second Amendment to the Manufacturing and Product Supply Agreement, dated as of the date of this Agreement, between the Company, on the one hand, and Tempur Production USA, LLC, Sealy Mattress Manufacturing

Company, LLC, Tempur Sherwood, LLC, Sealy Canada, Ltd., 1390658 Ontario Inc. d/b/a Tempur Canada and Comfort Revolution, LLC.

“Tax Return” means any report, return (including information return), claim for refund, election, estimated tax filing or

declaration filed or required to be filed with a Governmental Entity responsible for the administration of Taxes, including any schedule or attachment thereto, and including any amendments thereof.

“Taxes” means (a) all taxes, fees, levies, duties, tariffs, imposts and other charges in the nature of a tax or any

other similar payment imposed by any Governmental Entity, including income, franchise, windfall or other profits, gross receipts, personal property, real property, sales, use, net worth, capital stock, alternative or

add-on minimum, environmental, use, payroll, employment, social security, workers’ compensation, unemployment compensation, excise, withholding, ad valorem, stamp, transfer, value-added, gains tax and

estimated taxes, and (b) any interest, penalty, or additional amounts imposed with respect to any of the foregoing.

“Trade

Compliance Laws” means any Laws relating to the regulation of customs, anti-boycott, imports, exports, re-exports, transfers, releases, shipments, transmissions or any other provision of goods,

technology, software or services, including (a) the International Traffic in Arms Regulations (ITAR), 22 C.F.R. Parts 120 et seq., (b) the Export Administration Regulations (EAR), 15 C.F.R. Parts 730 et seq., (c) the Arms Export Control Act (22

U.S.C. § 1778), (d) the International Emergency Economic Powers Act (50 U.S.C. §§ 1701–1706), (e) Section 999 of the Internal Revenue Code, (f) the Export Control Reform Act of 2018 (50 U.S.C. §§ 4801-4861)

(g) Foreign Trade Regulations (15 C.F.R. Part 30) (h) all applicable customs and import Laws, including the customs regulations set forth in Title 19 of the Code of Federal Regulations and 19 C.F.R. Chapter 1, the Tariff Act of 1930, the Trade Act

of 1974, Uyghur Forced Labor Prevention Act, and the Laws, regulations and programs administered or enforced by the U.S. Department of Commerce, U.S. International Trade Commission, U.S. Customs and Border Protection, U.S. Immigration and Customs

Enforcement and their respective predecessor agencies, (i) the antiboycott Laws administered by the U.S. Department of Commerce and U.S. Department of the Treasury’s Internal Revenue Service and (j) all similar or related Laws

imposed, administered or enforced in any other applicable jurisdictions.

“Trading Day” shall mean with respect to

Parent Common Stock, a day on which shares of Parent Common Stock are traded on the NYSE.

“Treasury Regulations” means the United States Treasury Regulations

promulgated under the Code.

“Union” means any union, labor organization, works council or other bargaining unit

representative.

“WARN Act” means the U.S. federal Worker Adjustment and Retraining Notification Act of 1988, as

amended, and similar state, local and foreign Laws related to plant closings, relocations and mass layoffs.

“Willful and

Material Breach” means a material breach of a representation, warranty or covenant set forth in this Agreement that is the consequence of an intentional act, or intentional failure to act, of the breaching party, undertaken with the actual

knowledge that the taking of such act, or failure to act, would reasonably be expected to cause a material breach of this Agreement.

9.5

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below:

Term

Section

Agreement

Preamble

AIP

6.7(e)

Assumed Option

2.7(a)

Assumed PSU Award

2.7(c)

Assumed RSU Award

2.7(b)

Benefit Continuation Period

6.7(a)

Change of Board Recommendation

6.3(a)

Clean Team Agreement

6.2(b)

Closing

1.2(a)

Closing Date

1.2(a)

Closing Year

6.7(e)

COBRA

3.9(e)

Company

Preamble

Company 401(k) Plans

6.7(d)

Company Board

Recitals

Company Board Recommendation

Recitals

Company Book-Entry Shares

2.2(b)(ii)

Company Bylaws

3.1(d)

Company Cancelled Shares

2.1(a)(iii)

Company Capitalization Date

3.2(a)

Company Certificated Shares

2.2(b)(i)

Company Charter

3.1(d)

Company Common Stock

Recitals

Company Disclosure Schedule

Article 3

Company Fairness Opinion

3.22

Company Financial Advisor

3.22

Company Financial Statements

3.7(c)

Company IT Assets

3.16(e)

Company Leased Real Property

3.19(b)

Company Material Contract

3.11(b)

Company Owned Real Property

3.19(a)

Company Permits

3.13

Company Preferred Stock

3.2(a)

Company Real Property

3.19(b)

Company Real Property Leases

3.19(b)

Company Registered Intellectual Property

3.16(a)

Company Related Party

3.25

Company SEC Documents

3.7(a)

Company Shareholders

6.1(a)

Company Stock

3.2(a)

Company Tax Counsel

2.9(a)

Company Termination Fee

8.3(a)

Company Transaction Litigation

6.5(a)

Confidentiality Agreement

6.2(b)

Covered Persons

6.8(a)

Debt Payoff Letters

6.11

Deferred Compensation Plans

2.7(f)

Dissenting Shares

2.3

Effective Time

1.2(b)

Employee Communications

6.7(c)

Enforceability Limitations

3.3

ESUP

2.7(f)

Excess Shares

2.5

Exchange Agent

2.2(a)

Existing Financings

6.17(a)

Final Exercise Date

2.7(f)

Financing Indemnified Parties

6.17(a)

Financing Transactions

6.17(a)

First Articles of Merger

1.2(b)

First Extended Outside Date

8.1(b)

First Merger

Recitals

Former Company Subsidiary

6.8(b)

Fractional Shares Cash Amount

2.5

GBCLM

Recitals

Initial Outside Date

8.1(b)

Intended Tax Treatment

2.9(a)

Legal Impediment

7.1(b)

Merger Consideration

2.1(a)(i)

Merger Sub

Preamble

Non-U.S. Company Benefit Plan

3.9(j)

Notice Period

6.3(e)(i)

Outside Date

8.1(b)

Parent

Preamble

Parent Board

Recitals

Parent Bylaws

4.1(c)

Parent Capitalization Date

4.2(a)

Parent Charter

4.1(c)

Parent Common Stock

1.1(b)

Parent Disclosure Schedule

Article 4

Parent Financial Statements

4.7(c)

Parent Parties

Preamble

Parent Preferred Stock

4.2(a)

Parent SEC Documents

4.7(a)

Parent Stock

4.2(a)

Parent Tax Counsel

2.9(e)

Parent Termination Fee

8.4(a)

Parent Transaction Litigation

6.5(b)

Privacy Requirements

3.17(a)

Proposed Changed Terms

6.3(e)(iii)

Proxy Statement/Prospectus

6.1(a)

Registration Statement

6.1(a)

Required Company Vote

3.3

Second Extended Outside Date

8.1(b)

Significant Customer

3.12(a)

Significant Supplier

3.12(b)

Special Dividend

6.12(c)

Surviving Corporation

Recitals

Terminated Company 401(k) Plan

6.7(d)

Third Extended Outside Date

8.1(b)

Transfer Taxes

2.9(f)

9.6 Headings. The headings contained in this Agreement are for reference purposes only and shall not

affect in any way the meaning or interpretation of this Agreement.

9.7 Entire Agreement. This Agreement (together with the

Exhibits, Parent Disclosure Schedule and Company Disclosure Schedule and the other documents delivered pursuant hereto), the Confidentiality Agreement and the Clean Team Agreement constitute the entire agreement of the parties and supersede all

prior agreements and undertakings, both written and oral, among the parties, or any of them, with respect to the subject matter hereof and thereof and, except as otherwise expressly provided herein or therein, are not intended to confer upon any

other Person any rights or remedies hereunder or thereunder.

9.8 Assignment. Neither this Agreement nor any of the rights,

interests or obligations under this Agreement shall be assigned, in whole or in part, by any of the parties hereto without the prior written consent of the other parties. Any attempted or purported assignment in violation of the preceding sentence

shall be null and void and of no effect whatsoever. Subject to the preceding two (2) sentences, this Agreement shall be binding upon, inure to the benefit of, and be enforceable by, the parties and their respective successors and permitted

assigns.

9.9 Severability. If any term or other provision of this Agreement or its applicable

thereof to any Person or circumstance is held by a court of competent jurisdiction or other authority to be invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other conditions and provisions of this Agreement

shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to Parent or the Company. Upon such determination that any term or

other provision is invalid, illegal or incapable of being enforced, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that

the transactions contemplated hereby are fulfilled to the extent possible.

9.10 No Third Party Beneficiaries. This

Agreement shall be binding upon and inure solely to the benefit of the parties and their respective successors and permitted assigns. Nothing in this Agreement is intended to or shall confer upon any other Person any right, benefit or remedy of any

nature whatsoever under or by reason of this Agreement, except for (a) the right of the Covered Persons to enforce the provisions of Section 6.8, (b) the right of the Financing Indemnified Parties to enforce the

provisions of Section 6.17(c), (c) if the Effective Time occurs, the right of the holders of Company Common Stock to receive the Merger Consideration as provided in Article 1 and Article 2 and the right of the

holders of Company Equity Awards as provided in Section 2.7 and (d) that the right of the Company, on behalf of the holders of Company Common Stock and the holders of Company Equity Awards (each of which are third

party beneficiaries of this Agreement solely to the extent required for this provision to be enforceable by the Company), to pursue specific performance as set forth in Section 9.14 or, if specific performance is not sought

or granted as a remedy, damages in accordance with this Agreement (which may include the benefit of the bargain lost by the holders of Company Common Stock and the holders of Company Equity Awards) in the event of a Willful and Material Breach or

Fraud by any Parent Party of this Agreement, it being agreed that in no event shall any such holder be entitled to enforce any of their rights, or any of the Parent Parties’ obligations, under this Agreement in the event of any such Willful

and Material Breach or Fraud, but rather the Company shall have the sole and exclusive right to do so as agent for such holders. The representations and warranties in this Agreement are the product of negotiations among the parties and are for the

sole benefit of the parties. Any inaccuracies in such representations and warranties are subject to waiver by the parties without notice or liability to any other Person. In some instances, the representations and warranties in this Agreement may

represent an allocation among the parties of risks associated with particular matters regardless of the knowledge of any of the parties, and consequently, may not accurately characterize actual facts or circumstances.

9.11 Mutual Drafting; Interpretation. Each party has participated in the drafting of this Agreement, which each party acknowledges is

the result of extensive negotiations between the parties. If an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise

favoring or disfavoring any party by virtue of the authorship of any provision. For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the

feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders. As used in this Agreement, the words “include” and

“including” and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed

100

by the words “without limitation.” As used in this Agreement, references to a “party” or the “parties” are intended to refer to a party to this Agreement or

the parties to this Agreement. Except as otherwise indicated, all references in this Agreement to “Sections,” “Exhibits,” and “Schedules” are intended to refer to Sections of this Agreement, Exhibits of this

Agreement, and Schedules to this Agreement, respectively. The exhibits and schedules attached to this Agreement constitute a part of this Agreement and are incorporated herein for all purposes. The words “hereof,” “hereto,”

“hereby,” “herein,” “hereunder” and words of similar import, when used in this Agreement, shall refer to this Agreement as a whole and not to any particular section or article in which such words appear. All

references in this Agreement to “dollars” or “$” are intended to refer to U.S. dollars. Unless otherwise specifically provided for herein, the use of the words “either,” “or,” “neither,”

“nor” and “any” shall not be exclusive. The word “extent” in the phrase “to the extent” shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply

“if.” Any Contract or Law defined or referred to herein means any such Contract or Law as from time to time amended, modified or supplemented, unless otherwise specifically indicated (provided that for purposes of any

representations and warranties contained in this Agreement that are made as of a specific date or dates, references to any Contract or Law shall be deemed to refer to such Contract or Law, as amended, and to any rules or regulations promulgated

thereunder, as applicable, in each case, as of such date). All provisions herein qualified by the term “domestic” or “foreign” shall be construed on the basis that the United States is the relevant domestic country. Any

reference to “days” means calendar days unless Business Days are expressly specified. When calculating the period of time before which, within which or following which any act is to be done or step taken pursuant to this Agreement, the

date that is the reference date in calculating such period shall be excluded; and, if the last day of such period is not a Business Day, the period shall end on the next succeeding Business Day. The measure of a period of one month or year for

purposes of this Agreement will be the date of the following month or year corresponding to the starting date; and, if no corresponding date exists, then the end date of such period being measured will be the next actual date of the following month

or year (for example, one month following February 18 is March 18 and one month following March 31 is May 1). Any statement in this Agreement to the effect that any information, document or other material has been

“furnished,” “delivered” or “made available” to a party or its representatives means that such information, document or other material (a) with respect to Parent, was provided to the Company or its

representatives, or (b) with respect to the Company, was posted to the electronic data room hosted by or on behalf of the Company at Intralinks, in each case, in connection with the transactions contemplated hereby no later than 10:00 p.m.

Eastern Time on the calendar day prior to the date hereof.

9.12 Governing Law; Consent to Jurisdiction; Waiver of Trial

by Jury.

(a) This Agreement and all claims and causes of action arising in connection herewith shall be governed by, and construed

in accordance with, the Laws of the State of Delaware, without regard to Laws that may be applicable under conflicts of laws principles (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any

jurisdiction other than the State of Delaware, except that matters relating to the fiduciary duties of the Company Board or the internal affairs of the Company shall be subject to the internal Laws of the State of Missouri.

101

(b) Each of the parties hereby irrevocably and unconditionally submits, for itself and its

property, to the exclusive jurisdiction of the Court of Chancery of the State of Delaware or, solely if such court does not have subject matter jurisdiction, the Superior Court of the State of Delaware (Complex Commercial Division), or if subject

matter jurisdiction over the matter that is the subject of the Proceeding is vested exclusively in the federal courts of the United States of America, the Federal court of the United States of America sitting in the district of Delaware, and any

appellate court from any thereof, in any Proceeding arising out of or relating to this Agreement or the transactions contemplated hereby or thereby or for recognition or enforcement of any judgment relating thereto, and each of the parties hereby

irrevocably and unconditionally (i) agrees not to commence any such Proceeding except in such courts, (ii) agrees that any claim in respect of any such Proceeding may be heard and determined in such court, (iii) waives, to the fullest

extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such Proceeding in any such court, and (iv) waives, to the fullest extent permitted by Law, the defense of an

inconvenient forum to the maintenance of such Proceeding in any such court. Each of the parties agrees that a final and non-appealable judgment in any such Proceeding shall be conclusive and may be enforced in

other jurisdictions by suit on the judgment or in any other manner provided by Law. Each party to this Agreement, to the fullest extent permitted by Law, irrevocably consents to service of process in the manner provided for notices in

Section 9.3. Nothing in this Agreement shall affect the right of any party to this Agreement to serve process in any other manner permitted by Law.

(c) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND

DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS

DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER

PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE EITHER OF SUCH WAIVERS, (II) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (III) IT MAKES SUCH WAIVERS VOLUNTARILY AND (IV) IT HAS BEEN INDUCED TO

ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9.12(c).

9.13 Counterparts. This Agreement may be signed in any number of counterparts, including by facsimile or other electronic transmission,

each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement shall become effective when each party shall have received a counterpart hereof signed by all of the other

parties. Until and unless each party has received a counterpart hereof signed by the other parties, this Agreement shall have no effect and no party shall have any right or obligation hereunder (whether by virtue of any other oral or written

agreement or other communication). The words “execution,” “execute”, “signed,” “signature,” and words of like import in or related to Agreement or any document to be signed in connection with this

Agreement

102

and the transactions contemplated hereby shall be deemed to include signatures transmitted by electronic mail in “portable document format” (“.pdf”) form, or by any other

electronic means, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable

Law, including the Federal Electronic Signatures in Global and National Commerce Act, or any other similar state Laws based on the Uniform Electronic Transactions Act.

9.14 Specific Performance. The parties acknowledge and agree that if any of the provisions of this Agreement are not performed in

accordance with their specific terms or are otherwise breached (including failing to take such actions as are required by each party hereunder to consummate the transactions contemplated hereby), irreparable damage would occur, no adequate remedy at

Law would exist and damages would be difficult to determine, and accordingly, subject to the limitations set forth in this Section 9.14, prior to the valid termination of this Agreement (a) the parties shall be

entitled to an injunction or injunctions or other equitable relief to prevent breaches of this Agreement and to specific performance of the terms hereof, this being in addition to any other remedy to which they are entitled at Law or in equity,

(b) the parties waive any requirement for the securing or posting of any bond in connection with the obtaining of any specific performance or injunctive or equitable relief and (c) the parties shall waive, in any action for specific

performance, the defense of adequacy of a remedy at Law. The Company’s or Parent’s pursuit of specific performance or equitable relief at any time shall not be deemed an election of remedies or waiver of the right to pursue any other

right or remedy to which such party may be entitled, including the right to pursue remedies for liabilities or damages incurred or suffered by the other party in the case of a breach of this Agreement involving a Willful and Material Breach. It is

accordingly agreed that, prior to the valid termination of this Agreement in accordance with Article 9, the parties shall be entitled to an injunction or injunctions or other equitable remedy to prevent breaches of this Agreement and to

enforce specifically the terms and provisions of this Agreement (without necessity of posting bond or other security (any requirements therefor being expressly waived)) in accordance with Section 9.12, this being in

addition to any other remedy to which they are entitled at Law or in equity. Notwithstanding anything to the contrary contained herein, if this Agreement is validly terminated in accordance with Section 8.1, this

Section 9.14 is not intended and shall not be construed to limit in any way, and shall be subject in all respect to, the provisions of Sections 8.3(e) and 8.4(d).

9.15 Modification or Amendment. This Agreement may be amended, modified or supplemented by the parties at any time prior to the

Effective Time, whether before or after Company has obtained the Required Company Vote; provided, that after the Required Company Vote has been obtained, no amendment shall be made that, pursuant to the GBCLM, requires further approval or

adoption by the shareholders of the Company, without such further approval or adoption. This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise, except by an instrument in writing

specifically designated as an amendment hereto, signed on behalf of each of the parties in interest at the time of the amendment.

103

9.16 Extension; Waiver. At any time prior to the Effective Time, each of the parties

may, to the extent permitted by applicable Law, (a) extend the time for the performance of any of the obligations or acts of the other parties, (b) waive any inaccuracies in the representations and warranties of the other parties set forth

in this Agreement or any document delivered pursuant hereto, or (c) waive compliance with any of the agreements or conditions of the other parties contained herein; provided, that after the Required Company Vote has been obtained, no

waiver may be made that, pursuant to the GBCLM, requires further approval or adoption by the shareholders of the Company, without such further approval or adoption. Any agreement on the part of a party to any such waiver shall be valid only if set

forth in a written instrument executed and delivered by a duly authorized officer on behalf of such party. No failure or delay of any party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or

partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right or power. The

rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights or remedies which they would otherwise have hereunder.

[Signature pages follow]

104

IN WITNESS WHEREOF, the Parent Parties and the Company have caused this Agreement to be

executed as of the date first written above by their respective officers thereunto duly authorized.

Parent:

SOMNIGROUP INTERNATIONAL INC.

By:

/s/ Scott L. Thompson

Name:

Scott L. Thompson

Title:

Chairman, President and Chief Executive Officer

Merger Sub:

SPARROW UNITY CORPORATION

By:

/s/ Scott L. Thompson

Name:

Scott L. Thompson

Title:

President

[Signature Page to Merger

Agreement]

The Company:

LEGGETT & PLATT, INCORPORATED

By:

/s/ Karl G. Glassman

Name:

Karl G. Glassman

Title:

President and Chief Executive Officer

[Signature Page to Merger

Agreement]

EXHIBIT A

FORM OF ARTICLES OF MERGER

EXHIBIT B-1

FORM OF PARENT PARTIES TAX REPRESENTATION LETTER

EXHIBIT B-2

FORM OF COMPANY TAX SUPPORTING LETTER

EXHIBIT B-3

ALTERNATIVE FORM OF PARENT PARTIES TAX REPRESENTATION LETTER

EXHIBIT B-4

ALTERNATIVE FORM OF COMPANY TAX REPRESENTATION LETTER

EX-99.1

Filename: d38467dex991.htm · Sequence: 3

EX-99.1

Exhibit 99.1

Somnigroup International, the World’s Leading Bedding Company, to Acquire Leggett & Platt, A Diversified Component

Manufacturer and Key Somnigroup Supplier, in an All-Stock Transaction

– Continues

vertical integration strategy, enhancing consumer-centric innovation

– Expands addressable market in bedding and into non-bedding industries

– Reduces financial leverage and drives operating cash flow

– Drives immediate adjusted EPS accretion before synergies

– Creates meaningful synergy opportunities

DALLAS, TX and CARTHAGE, MO, April 13, 2026 – Somnigroup International Inc. (NYSE: SGI, “Somnigroup”) and

Leggett & Platt, Incorporated (NYSE: LEG, “Leggett & Platt”) today announced that the companies have signed a definitive agreement pursuant to which Somnigroup will acquire Leggett & Platt in an all-stock transaction valued at approximately $2.5 billion based on Somnigroup’s closing share price on April 10, 2026.

Under the terms of the agreement, Leggett & Platt shareholders will receive 0.1455 shares of Somnigroup common stock in exchange for each share of

Leggett & Platt common stock they own. As a result of the transaction, Leggett & Platt’s shareholders will own approximately 9% of the combined company on a fully diluted basis. The agreement has been unanimously approved by

the Boards of Directors of Somnigroup and Leggett & Platt.

The transaction is currently anticipated to close by

year-end 2026, subject to the satisfaction of customary closing conditions, including approval by Leggett & Platt’s shareholders and receipt of applicable regulatory approvals. The transaction

does not require Somnigroup shareholder approval.

Following the close of the transaction, Leggett & Platt is expected to operate as a separate

business unit within Somnigroup, similar to Tempur Sealy, Mattress Firm, and Dreams, and to maintain its offices in Carthage, Missouri. Leggett & Platt’s Chairman and CEO, Karl Glassman, will continue to lead Leggett & Platt

following the closing date and will assist with a seamless transition to a new CEO of the Leggett & Platt business unit within twelve months of the closing date.

Somnigroup and Leggett & Platt have collaborated for nearly 50 years to drive innovation in the

bedding market. With a deep, longstanding partnership and strong cultural alignment, the companies know each other well, and the combination is expected to further strengthen their ability to deliver innovative bedding products. Together, after

giving effect to the transaction, including elimination of intercompany sales, the combined company generated 2025 net sales of approximately $11.2 billion, approximately $1.7 billion of adjusted EBITDA, and $1.1 billion of

operating cash flow. The combined company is expected to operate 175 manufacturing facilities across 36 countries worldwide, supported by a global workforce of more than 36,000 colleagues. The combined company will continue to honor

Leggett & Platt’s existing supply agreements with customers in the bedding industry.

Leggett & Platt is a diversified

manufacturer that designs and produces a broad variety of engineered components and products that can be found in many homes and automobiles. It is a leading supplier of bedding components and solutions; automotive seat comfort and convenience

systems; home and work furniture components; geo components; flooring underlayment; and hydraulic cylinders for material handling and heavy construction applications.

Somnigroup Chairman and CEO Scott Thompson said, “We are proud to have Leggett & Platt join Somnigroup. Leggett & Platt’s strong

engineering capabilities, diversified end users and cash-generating financial profile meaningfully enhance our global platform. This combination is consistent with our vertical integration strategy, which

drives innovation and value for customers while also enhancing shareholder value. By bringing a successful supply partner into our group, we accelerate our ability to deliver differentiated, consumer-centric

innovation. This combination is evidence of our commitment to disciplined capital allocation centered on long-term shareholder value creation.”

Leggett & Platt Chairman and CEO Karl Glassman said, “We are pleased to reach this agreement with Somnigroup, a valued long-standing customer and partner. This transaction provides Leggett & Platt shareholders with the opportunity to participate in the future growth and value creation of a leading global company on a tax

deferred basis. On behalf of our Board of Directors and management team, I would like to thank the Leggett & Platt team for their hard work and dedication. For more than 140 years, we have provided our customers with innovation and quality.

I believe this combination positions us to continue that track record and deliver compelling strategic and financial value for our customers, employees and shareholders.”

Strategic Rationale

The companies expect the combination to leverage the individual strengths of Somnigroup and Leggett & Platt to realize five strategic benefits.

Continues Vertical Integration Strategy, Enhancing Consumer-Centric Innovation.

The combination enables closer collaboration between component engineering, mattress design, and consumer trends, supporting accelerated

innovation cycles and more cost effective consumer-centric product constructions.

Expands Addressable Markets in Bedding and Into Non-Bedding

Industries.

The combination provides access to incremental addressable markets beyond bedding, expanding long-term

growth opportunities and cash flow generation. Additionally, Leggett & Platt’s diversified sales streams and geographic presence lessen reliance on any single category, product or geographic market, reducing overall volatility.

Reduces Financial Leverage and Drives Operating Cash Flow.

The combination is expected to lower Somnigroup’s net financial leverage and increases financial flexibility. Enhanced balance sheet

capacity supports an expanded capital allocation strategy, which we, in turn, expect will drive shareholder value and enhance the combined company’s competitive position.

Drives Immediate Adjusted EPS Accretion Before Synergies.

The combination is expected to be accretive to adjusted EPS before synergies in the first year post close*.

Creates Meaningful Synergy Opportunities.

The combination presents cost synergy opportunities with an expected net positive impact on adjusted EBITDA of $50 million on a fully

implemented annual run-rate basis. The main categories of anticipated synergies are sourcing, operations and product innovation. We expect that these synergies will be fully realized over a three-year period,

with approximately $10 million benefiting adjusted EBITDA in the first twelve months post-closing.

Post closing, Somnigroup expects Leggett & Platt’s financial results will be presented as a

new reporting segment within the Somnigroup business. Leggett & Platt’s sales to Somnigroup’s other reporting segments will be eliminated, with no impact to reported Leggett & Platt segment profits. In 2025, Somnigroup

represented 7% of Leggett & Platt’s net sales. Additionally, in accordance with GAAP, Somnigroup expects to incur approximately $50 million of annualized non-cash expense from the

adjustment to fair value of the acquired Leggett & Platt business, which will primarily impact cost of goods sold, and Somnigroup expects to incur approximately $10 million of annualized non-cash

expense from the adjustment to fair value of the acquired Leggett & Platt bonds, which will impact interest expense.

Financial Impact

As of December 31, 2025, Leggett & Platt’s net leverage under its credit agreement was 2.4 times adjusted EBITDA. Somnigroup expects to

leave Leggett & Platt’s existing long-term bond debt in place following the transaction.

Advisors

Goldman Sachs & Co. LLC is serving as exclusive financial advisor and Cleary Gottlieb Steen & Hamilton LLP is serving as legal counsel to

Somnigroup. J.P. Morgan Securities LLC is serving as exclusive financial advisor and Latham & Watkins LLP is serving as legal counsel to Leggett & Platt.

Forward-Looking Statements

This press release contains

statements that may be characterized as “forward-looking” within the meaning of the federal securities laws. Such statements might include information concerning one or more of Somnigroup’s and Leggett & Platt’s

plans, guidance, objectives, goals, strategies, and other information that is not historical information. When used in this release, the words “will,” “targets,” “expects,” “anticipates,”

“plans,” “proposed,” “intends,” “outlook,” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements include, without

limitation, statements relating to Somnigroup’s expectations regarding the impact of the proposed transaction on Somnigroup’s brands, products, customer base, results of operations, or financial position, its share repurchases, adjusted

EPS, net leverage, operating cash flow, net income, future performance, cost and run-rate synergies, funding sources, expected capital structure, the financial impact of Leggett & Platt’s

existing long-term debt, ability to deleverage after the proposed transaction, the expected timing and likelihood of completion of the proposed transaction, the integration of Leggett & Platt with Somnigroup’s business and personnel

and Somnigroup’s and Leggett & Platt’s post-acquisition financial reporting. Any forward-looking statements contained herein are based upon current expectations and beliefs and various assumptions. There can be no assurance that

these expectations or beliefs will prove correct.

Numerous factors, many of which are beyond Somnigroup’s and Leggett & Platt’s control,

could cause actual results to differ materially from any that may be expressed herein as forward-looking statements. These potential risks include risks associated with Leggett & Platt’s ongoing operations; the ability to obtain the

requisite Leggett & Platt shareholder approval; the risk that Somnigroup or Leggett & Platt may be unable to obtain governmental and regulatory approvals required for the proposed transaction (and the risk that such approvals may

result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the proposed transaction); the risk that an event, change or other circumstance could give rise to the termination of the proposed

transaction; the risk of delays in completing the proposed transaction; the ability to successfully integrate Leggett & Platt into Somnigroup’s operations and realize synergies from the proposed transaction and the expected run-rate of such synergies; the possibility that the expected benefits of the acquisition are not realized when expected or at all; the risk that any announcement relating to the proposed transaction could have

adverse effects on the market price of Somnigroup’s or Leggett & Platt’s common stock; the risk of litigation related to the proposed transaction; the diversion of management time from ongoing business operations and

opportunities as a result of the proposed transaction; the risk of adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction; general economic,

financial and industry conditions, particularly conditions relating to the financial performance and related credit issues present in the retail sector, as well as consumer confidence and the availability of consumer financing; the impact of the

macroeconomic environment in both the U.S. and internationally on Somnigroup and Leggett & Platt; uncertainties arising from national and global events; industry competition; the effects of consolidation of retailers on revenues and costs;

consumer acceptance and changes in demand for Somnigroup’s and Leggett & Platt’s products; and other risks inherent in Somnigroup’s and Leggett & Platt’s businesses.

All such factors are difficult to predict, are beyond Somnigroup’s and Leggett & Platt’s control, and are subject to additional risks and

uncertainties, including those detailed in Somnigroup’s annual report on Form 10-K for the year ended December 31, 2025 and those detailed in Leggett & Platt’s annual report

on Form 10-K for the year ended December 31, 2025. These risks, as well as other risks related to the proposed transaction, will be included in the Form

S-4 and proxy statement/prospectus (each as defined below) that Somnigroup and Leggett & Platt intend to file with the United States Securities and Exchange Commission (the “SEC”) in

connection with the proposed transaction. There may be other factors that may cause Somnigroup’s and Leggett & Platt’s actual results to differ materially from the forward-looking statements. Neither Somnigroup nor

Leggett & Platt undertakes any obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

No Offer or Solicitation

This press release is not intended to be, and shall not constitute, an offer to sell, buy or exchange or the solicitation of an offer to sell, buy or exchange

any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of

any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Additional Information and Where to Find It

connection with the proposed transaction, Somnigroup intends to file with the SEC a registration statement on Form S-4 (the “Form S-4”) that will include a

proxy statement of Leggett & Platt and that will also constitute a prospectus of Somnigroup with respect to the shares of Somnigroup common stock to be issued in the proposed transaction (the “proxy statement/prospectus”). The

definitive proxy statement/prospectus (if and when available) will be filed with the SEC by, and mailed to shareholders of, Leggett & Platt. Each of Somnigroup and Leggett & Platt may also file other relevant documents with the SEC

regarding the proposed transaction.

This press release is not a substitute for the Form S-4, the proxy

statement/prospectus or any other document that Somnigroup or Leggett & Platt may file with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS OF SOMNIGROUP AND LEGGETT & PLATT ARE URGED TO READ THE

FORM S-4, THE PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, CAREFULLY IN THEIR ENTIRETY IF AND WHEN THEY BECOME

AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain copies of these documents (if and when available), as well as other filings containing information about

Somnigroup and Leggett & Platt, free of charge on the SEC’s website at www.sec.gov. Copies of the documents filed with, or furnished to, the SEC by Somnigroup will be available free of charge on Somnigroup’s website at

https://somnigroup.com/investor-resources/financials/sec-filings/default.aspx. Copies of the documents filed with, or furnished to, the SEC by Leggett & Platt will be available free of charge

on Leggett & Platt’s website at https://leggett.gcs-web.com/financials/sec-filings. The information included on, or accessible through,

Somnigroup’s or Leggett & Platt’s website is not incorporated by reference into this communication.

Participants in Solicitation

Somnigroup, Leggett & Platt and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of

proxies with respect to the proposed transaction under the rules of the SEC. You can find information about Somnigroup’s executive officers and directors in Somnigroup’s definitive proxy statement filed with the SEC on March 31,

2026, under the section entitled “Proposal No. 1 — Election of Directors—Executive Officers,” “Proposal No. 1 — Election of Directors—Nominees to Board of Directors,” “Stock Ownership

– Stock Ownership of Certain Beneficial Owners and Directors and Executive Officers,” “Executive Compensation and Related Information—Compensation of Executive Officers” and “Director Compensation.” You can

find information about Leggett & Platt’s executive officers and directors in Leggett & Platt’s Annual Report on Form 10-K for the year ended December 31, 2025, under the

section entitled “Supplemental Information: Information about our Executive Officers,” and “Directors, Executive Officers and Corporate Governance,” and in Leggett & Platt’s definitive proxy statement filed

with the SEC on April 7, 2026, under the sections entitled “Corporate Governance and Board Matters—Director Compensation,” “Proposals to be Voted On at the Annual Meeting—Proposal One: Election of Directors,”

“Executive Compensation and Related Matters—Compensation Discussion & Analysis” and “Security Ownership—Security Ownership of Directors and Executive Officers.” Additional information regarding the

interests of the participants in the solicitation of proxies will be included in the Form S-4, the proxy statement/prospectus and other relevant materials to be filed with the SEC if and when they become

available. You should read the Form S-4 and the proxy statement/prospectus carefully when available before making any voting or investment decisions. You may obtain free copies of these documents using the

sources indicated above.

About Somnigroup International

Somnigroup is the world’s leading bedding company, dedicated to transforming how the world sleeps. With superior capabilities in design, manufacturing,

distribution and retail, we deliver breakthrough sleep solutions and serve the evolving needs of consumers in more than 100 countries worldwide, through our fully-owned businesses, Tempur Sealy, Mattress Firm and Dreams. Our portfolio includes the

most highly recognized brands in the industry, including Tempur-Pedic®, Sealy®, Stearns & Foster®, and Sleepy’s®, and our global omni-channel platform enables us to meet consumers wherever they shop, offering a personal connection

and innovation to provide a unique retail experience and tailored sleep solutions.

We seek to deliver long-term value for our shareholders through

prudent capital allocation, including managing investments in our businesses. We are guided by our core value of Doing the Right Thing and committed to our global responsibility to protect the environment and the communities in which we operate. For

more information, please visit www.somnigroup.com.

About Leggett & Platt

Leggett & Platt is a diversified manufacturer that designs and produces a broad variety of engineered components and products that can be found

in many homes and automobiles. The 143-year-old company is a leading supplier of bedding components and solutions; automotive seat comfort and convenience systems; home

and work furniture components; geo components; flooring underlayment; and hydraulic cylinders for material handling and heavy construction applications.

Investor Relations Contacts

For Somnigroup:

Lauren Avritt

Investor Relations

Somnigroup International Inc.

800-805-3635

Investor.relations@somnigroup.com

For Leggett & Platt:

Ryan M. Kleiboeker

Investor Relations

Leggett & Platt, Incorporated

417-358-8131

invest@leggett.com

Media Contacts

For Somnigroup:

FGS Global

Somnigroup@fgsglobal.com

For Leggett & Platt:

Joele Frank, Wilkinson Brimmer Katcher

Tim Lynch /

Leigh Parrish / Eliza Rothstein / Lyle Weston

(212) 355-4449

EX-99.2

Filename: d38467dex992.htm · Sequence: 4

EX-99.2

Exhibit 99.2 Somnigroup to Acquire Leggett & Platt A pr i l 13, 2026

Transaction Summary • Total purchase price of approximately $2.5B,

based on Somnigroup’s closing share price on April 10, 2026 • 100% stock consideration Consideration • Leggett & Platt shareholders will receive 0.1455 shares of Somnigroup common stock in exchange for each share of Leggett

& Platt stock they own Expected Post- • Leggett & Platt’s shareholders will own approximately 9% of the combined company on a fully diluted basis Closing Ownership¹ • Expected to be accretive to adjusted EPS²

before synergies in the first year post close • Expected to lower Somnigroup’s net financial leverage² and increase financial flexibility Financial Impact • Combination presents meaningful cost synergy opportunities with an

expected net positive impact on adjusted EBITDA² of $50 million on a fully implemented annual run-rate basis, with approximately $10 million benefiting adjusted EBITDA² in the first twelve months post-closing • Leggett & Platt is

expected to operate as a separate business unit within Somnigroup, similar to Tempur Sealy, Mattress Firm and Dreams • Leggett & Platt’s Chairman and CEO, Karl Glassman, will continue to lead Leggett & Platt following the

Management & closing date and will assist with a seamless transition to a new CEO of the Leggett & Platt business unit Governance within twelve months of closing • Leggett & Platt to maintain its offices in Carthage, MO, and the

combined company will continue to honor Leggett & Platt’s existing supply agreements with customers in the bedding industry • Anticipated to close by year-end 2026 Timing & Approvals • Subject to the satisfaction of

customary closing conditions, including approval by Leggett & Platt’s shareholders and receipt of applicable regulatory approvals 2 2

The Somnigroup Investment Thesis: “The Stage Is Set – the

Best Is Yet to Come” Global Scale, Vertical Integration: A leading international bedding company with leading, end-to-end capabilities from design and manufacturing to retail Omnichannel Reach & Iconic Brands: Portfolio of trusted brands

and products, reaching consumers wherever they shop – online, in 2,800+ stores, and through a robust wholesale network Relentless Innovation & Consumer Insight: Industry-leading R&D, marketing investment and consumer access fuel

product differentiation and demand as sleep becomes ever more central to health and wellness Operational Excellence & Leverage: Structural advantages drive superior efficiency and cash flow Resilient Cash Generation & Disciplined Capital

Allocation: Robust free cash flow and strong balance sheet supports business reinvestment, acquisitions and shareholder returns Connected, Proven Leadership: Seasoned management team with track record of driving execution and growth across all

business units Poised for Industry Recovery: 3 Uniquely positioned to drive value as the $120 billion global bedding market rebounds 3

High-level Strategic Direction | Corporate Governance | Capital

Allocation Leading global Leading U.S. Leading U.K. Leading global bedding manufacturer bedding retailer bedding retailer components designer & manufacturer Tactical Go-to-market Strategy | Operational Excellence | Passionate Customer Service

Leggett & Platt Overview Leggett & Platt: • Leggett &

Platt is an international diversified manufacturer that conceives, Facts and Figures⁴ designs, and produces a wide range of engineered components and products found in many homes and automobiles $4.1B • Innovative proprietary products

and efficient vertical integration have made Leggett one of the largest U.S.-based bedding component 2025 sales manufacturers: • Leggett is a supplier of innersprings, specialty foam, adjustable beds, and other bedding components and services,

with global manufacturing and distribution $385M • Leggett also produces machinery for internal production and assembly 2 2025 Adj. EBITDA of its bedding products • Diverse manufacturing expertise, proprietary capabilities, and global

scale have enabled Leggett to become a leading supplier of automotive seat comfort and convenience systems, home and work furniture components, geo $338M components, flooring underlayment, and hydraulic cylinders 2025 Operating Cash Flow 5 2025

Sales Bedding Products 143 Year Specialized Products 38% 28% 34% Heritage Furniture, Flooring & Textiles 5

Leggett & Platt Business Highlights Strong Competitive •

Trusted supplier to customers across varied, large addressable end markets Positions in Core • Diverse customer base with low concentration Markets • Supports bedding customers’ product needs from raw materials to components to

finished mattresses and foundations Heritage as an • Pioneer of the steel coil innerspring with a track record of innovative, proprietary products Innovator supporting the global bedding industry • Drives innovation across Specialized

Products and Furniture, Flooring and Textile segments to improve product quality, increase efficiency, and support ongoing growth Significant Operating • Track record of strong cash generation Cash Flow Deeply Experienced • Deep company

knowledge and understanding of Leggett’s diverse capabilities Management • Driven to succeed through people, product and innovation Team A diversified manufacturer that designs and produces a broad variety of engineered components and

products 6 6

Transaction Rationale 1 Continues Vertical Integration Strategy,

Enhancing Consumer-Centric Innovation 2 Expands Addressable Market in Bedding and into Non-Bedding Industries 2 3 Reduces Financial Leverage and Drives Operating Cash Flow 2 Drives Immediate Adjusted EPS Accretion Before Synergies 4 Creates

Meaningful Synergy Opportunities 5 7

1 Continues Vertical Integration Strategy Bedding Products 01 4

industry-leading lab sites Innovation 110,000+ square feet of R&D + 5 development & 70+ strategically located plants globally, 02 innovation centers supported by resilient supply chains Production + 250,000+ incremental 03 $700M+ annual

advertising spend square feet of R&D Marketing 04 + 28 global manufacturing 20,000+ third-party retail doors Wholesale facilities, including 2 wire Distribution mills and 1 rod mill 2,800+ retail stores globally 05 40+ e-commerce platforms DTC

Retail 8

1 Enhances Consumer-Centric Innovation Bedding Products Deployment of

Innovation Pipeline driven by Innovation Pipeline driven by proprietary technologies Engineering Expertise and Consumer Insights across Somnigroup’s Collaboration portfolio of leading products Key Innovation Areas Key Innovation Areas Enables

end-to-end ü Quality & Durabilityü Industry-Leading development of Co-Development integrated sleep systems ü Support Capabilities ü Comfort ü Ability to Serve Customers Accelerates Anywhere in the Value Chain

advancements in smart ü Climate bed technologies ü Innerspring Innovation and ü Sleep Tracking Production Efficiency ü Snoring Improves ability to serve ü Enhanced Foam consumers across Performance segments Combination

advances Somnigroup’s mission to transform how the world sleeps 9

2 Expands Addressable Market in Bedding ROD & WIRE AND SPECIALTY

ADJUSTABLE INTERNATIONAL U.S. SPRING FOAM BED BEDDING ü Experienced workforce ü Strong business in ü North American ü Strategically supporting quality and hybrid and foam footprint with positioned physical consistent production

mattresses established customer manufacturing relationships presence in or near target geographies ü Vertical integration ü Large U.S. ensures availability of manufacturing and ü Vertical integration in key raw materials distribution

footprint steel and wood ü Consistent quality and fabrication drives cost efficient production efficiency ü Operational scale ü Advanced foam creates durable cost engineering drives advantages product differentiation ü

Engineering, operational and commercial expertise 10

2 Expands Addressable Market into Non-Bedding Industries 6 Combined

Company FY ‘25 FY ‘25 üExpands and fortifies bedding operation and 12% provides opportunity for diversified long-term 100% 10% growth and cash flow generation üIntegrating Leggett & Platt’s innerspring and 78% Product

specialty foam components generates Mix efficiencies üLessens reliance on any single category, product or geographic market, reducing overall volatility Bedding Specialized Products Furniture, Flooring and Textile üStrengthens North

American business by leveraging L&P’s established manufacturing 17% 22% 83% 78% and distribution infrastructure in Canada and Mexico Geographic üReduces U.S. concentration, creating a more Mix balanced international profile with

expanded footprints in Europe and China üProvides a broader global foundation to facilitate long-term growth North America International 11

3 Reduces Financial Leverage and Drives Operating Cash Flow Cost

Accelerated Synergies Deleveraging 2 Leverage Target Range: 2.0x – 3.0x End-Market Operational Expansion Efficiency Capital Return Value to Maintenance Capex and Opportunistic M&A Allocation Shareholders Strategic Reinvestment Priorities

12 12

4 Drives Immediate Adjusted EPS Accretion Before Synergies 4 6 FY

‘25 FY ‘25 FY ‘25 Consolidated Sales $7.5B $4.1B $11.2B 2 Adjusted EBITDA $1.3B $385M $1.7B Capex $167M $57M $224M 2 Acquisition expected to be accretive to adjusted EPS 3 before synergies in the first year post-close 13

5 Creates Meaningful Synergy Opportunities Preliminary Expected

Sourcing: Creates a platform to further increase 3 Run-Rate Synergies internal sourcing and supply integration Operations: Leverages the combined scale and $10M vertically integrated infrastructure across $20M manufacturing and logistics to drive

operational efficiencies $20M Innovation: Enables tighter integration of component engineering, mattress design, and consumer insights, enabling more cost-effective, Sourcing Operations Innovation consumer-centric product development We expect that

these synergies will be fully realized over a three-year period, with approximately $10M benefiting adjusted 2 3 EBITDA in the first year post-close 14 14

Transaction Valuation Pre-Synergies Post-Synergies FY ‘25 FY

‘25 Purchase Price $2.5B $2.5B 2,7 Adjusted EBITDA $380M $380M 3 Expected Run-Rate Synergies $0M $50M 2 Adjusted EBITDA After Synergies $380M $430M 3 Expected Multiple 6.6x 5.8x We expect attractive cost synergies to drive value creation for

the combined shareholder base 15 15

The Somnigroup Investment Thesis: “The Stage Is Set – the

business units Poised for Industry Recovery: 3 Uniquely positioned to drive value as the $120 billion global bedding market rebounds 16

APPENDIX 17

Forward Looking Statements This investor presentation contains

(“Somnigroup”) and Leggett & Platt, Incorporated’s (“Leggett”) plans, guidance, objectives, goals, strategies, and other information that is not historical information. When used in this communication, the words

“will,” “targets,” “expects,” “anticipates,” “plans,” “proposed,” “intends,” “outlook,” and variations of such words or similar expressions are intended

to identify forward-looking statements. These forward-looking statements include, without limitation, statements relating to Somnigroup’s expectations regarding the impact of the proposed transaction on Somnigroup's brands, products, customer

base, results of operations, or financial position, its share repurchases, adjusted EPS, net leverage, operating cash flow, net income, future performance, cost and run-rate synergies, funding sources, expected capital structure, the financial

impact of Leggett’s existing long-term debt, ability to deleverage after the proposed transaction, the expected timing and likelihood of completion of the proposed transaction, the integration of Leggett with Somnigroup’s business and

personnel and Somnigroup's and Leggett's post-acquisition financial reporting. Any forward-looking statements contained herein are based upon current expectations and beliefs and various assumptions. There can be no assurance that these expectations

and these beliefs will prove correct. Numerous factors, many of which are beyond Somnigroup’s and Leggett's control, could cause actual results to differ materially from any that may be expressed herein as forward-looking statements. These

potential risks include risks associated with Leggett’s ongoing operations; the ability to obtain the requisite Leggett shareholder approval; the risk that Somnigroup or Leggett may be unable to obtain governmental and regulatory approvals

required for the proposed transaction (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the proposed transaction); the risk that an event, change

or other circumstance could give rise to the termination of the proposed transaction; the risk of delays in completing the proposed transaction; the ability to successfully integrate Leggett into Somnigroup's operations and realize synergies from

the proposed transaction and the expected run-rate of such synergies; the possibility that the expected benefits of the acquisition are not realized when expected or at all; the risk that any announcement relating to the proposed transaction could

have adverse effects on the market price of Somnigroup’s or Leggett’s common stock; the risk of litigation related to the proposed transaction; the diversion of management time from ongoing business operations and opportunities as a

result of the proposed transaction; the risk of adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction; general economic, financial and industry

conditions, particularly conditions relating to the financial performance and related credit issues present in the retail sector, as well as consumer confidence and the availability of consumer financing; the impact of the macroeconomic environment

in both the U.S. and internationally on Somnigroup and Leggett; uncertainties arising from national and global events; industry competition; the effects of consolidation of retailers on revenues and costs; consumer acceptance and changes in demand

for Somnigroup’s and Leggett's products; and other risks inherent in Somnigroup’s and Leggett’s businesses. All such factors are difficult to predict, are beyond Somnigroup’s and Leggett’s control, and are subject to

additional risks and uncertainties, including those detailed in Somnigroup’s annual report on Form 10-K for the year ended December 31, 2025, and those detailed in Leggett’s annual report on Form 10-K for the year ended December 31,

2025. These risks, as well as other risks related to the proposed transaction, will be included in the Form S-4 and proxy statement/prospectus (as defined below) that Somnigroup and Leggett intend to file with the United States Securities and

Exchange Commission (the “SEC”) in connection with the proposed transaction. There may be other factors that may cause Somnigroup’s and Leggett's actual results to differ materially from the forward-looking statements. Neither

Somnigroup nor Leggett undertakes any obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. 18

Forward Looking Statements Note Regarding Historical Financial

Information: In this investor presentation we provide or refer to certain historical information for Somnigroup and Leggett. For a more detailed discussion of Somnigroup’s and Leggett’s financial performance, please refer to

Somnigroup’s and Leggett’s SEC filings. Note Regarding Trademarks, Trade Names, and Service Marks: TEMPUR®, Tempur-Pedic®, the Tempur-Pedic & Reclining Figure Design®, Tempur Breeze, ActiveBreeze®,

TEMPUR-Adapt®, TEMPUR-ProAdapt®, TEMPUR-LuxeAdapt®, TEMPUR-ProBreeze®, TEMPURLuxeBreeze®, TEMPUR-Cloud®, TEMPUR-Contour , TEMPUR-Rhapsody , TEMPUR-Flex®, THE GRANDBED BY Tempur-Pedic®, TEMPUR- Ergo®,

TEMPUR-UP , TEMPUR-Neck , TEMPUR-Symphony, TEMPUR-Comfort , TEMPUR-Traditional , TEMPUR-Home , Sealy®, Sealy Posturepedic®, Stearns & Foster®, Intellicoil , PrecisionFit , COCOON by Sealy , SealyChill , Mattress Firm®, and

Sleepy’s® are trademarks, trade names, or service marks of Somnigroup International Inc., and/or its subsidiaries. All other trademarks, trade names, and service marks in this presentation are the property of the respective owners.

Legends No Offer or Solicitation This investor presentation is not

intended to be, and shall not constitute, an offer to sell, buy or exchange or the solicitation of an offer to sell, buy or exchange any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any

jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the

requirements of Section 10 of the Securities Act of 1933, as amended. Additional Information and Where to Find It In connection with the proposed transaction, Somnigroup intends to file with the SEC a registration statement on Form S-4 (the

“Form S-4”) that will include a proxy statement of Leggett and that will also constitute a prospectus of Somnigroup with respect to the shares of Somnigroup common stock to be issued in the proposed transaction (the “proxy

statement/prospectus”). The definitive proxy statement/prospectus (if and when available) will be filed with the SEC by, and mailed to shareholders of, Leggett. Each of Somnigroup and Leggett may also file other relevant documents with the SEC

regarding the proposed transaction. This investor presentation is not a substitute for the Form S-4, the proxy statement/prospectus or any other document that Somnigroup or Leggett may file with the SEC in connection with the proposed transaction.

INVESTORS AND SECURITY HOLDERS OF SOMNIGROUP AND LEGGETT ARE URGED TO READ THE FORM S-4, THE PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, CAREFULLY IN

THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain copies of these documents (if and when available), as well as

other filings containing information about Somnigroup and Leggett, free of charge on the SEC's website at www.sec.gov. Copies of the documents filed with, or furnished to, the SEC by Somnigroup will be available free of charge on Somnigroup's

website at https://somnigroup.com/investor-resources/financials/sec-filings/default.aspx. Copies of the documents filed with, or furnished to, the SEC by Leggett will be available free of charge on Leggett’s website at

https://leggett.gcs-web.com/financials/sec-filings. The information included on, or accessible through, Somnigroup’s or Leggett’s website is not incorporated by reference into this investor presentation. Participants in Solicitation

Somnigroup, Leggett and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies with respect to the proposed transaction under the rules of the SEC. You can find information about

Somnigroup's executive officers and directors in Somnigroup's definitive proxy statement filed with the SEC on March 31, 2026, under the section entitled “Proposal No. 1 — Election of Directors – Executive Officers,”

“Proposal No. 1 — Election of Directors - Nominees to Board of Directors,” “Stock Ownership – Stock Ownership of Certain Beneficial Owners and Directors and Executive Officers,” “Executive Compensation and

Related Information - Compensation of Executive Officers” and “Director Compensation.” You can find information about Leggett’s executive officers and directors in Leggett’s Annual Report on Form 10-K for the year ended

December 31, 2025, under the sections entitled “Supplemental Information: Information about our Executive Officers” and “Directors, Executive Officers and Corporate Governance,” and in Leggett’s definitive proxy

statement filed with the SEC on April 7, 2026, under the sections entitled “Corporate Governance and Board Matters - Director Compensation,” “Proposals to be Voted On at the Annual Meeting - Proposal One: Election of

Directors,” “Executive Compensation and Related Matters - Compensation Discussion & Analysis” and “Security Ownership - Security Ownership of Directors and Executive Officers.” Additional information regarding the

the proxy statement/prospectus carefully when available before making any voting or investment decisions. You may obtain free copies of these documents using the sources indicated above. 20

Use of Non-GAAP Financial Measures Information In this investor

presentation and certain of its press releases and SEC filings, Somnigroup provides information regarding EBITDA, adjusted EBITDA, and leverage, which are not recognized terms under U.S. Generally Accepted Accounting Principles (“GAAP”)

and do not purport to be alternatives to net income and earnings per share as a measure of operating performance, an alternative to cash provided by operating activities as a measure of liquidity, or an alternative to total debt. Also, Leggett

provides information regarding Adjusted EBITDA, which is not recognized term under GAAP and does not purport to be an alternative to net income. Somnigroup and Leggett believe these non-GAAP measures provide investors with performance measures that

better reflect Somnigroup’s and Leggett’s underlying operations and trends, including trends in changes in margin and operating expenses, providing a perspective not immediately apparent from net income and operating income. The

adjustments each company’s management makes to derive the non-GAAP measures include adjustments to exclude items that may cause short-term fluctuations in the nearest GAAP measure, but which management does not consider to be the fundamental

attributes or primary drivers of Somnigroup’s or Leggett’s businesses, as applicable. Somnigroup and Leggett believe that exclusion of these items assists in providing a more complete understanding of their respective underlying results

from continuing operations and trends, and each company’s management uses these measures along with the corresponding GAAP financial measures to manage their respective businesses, to evaluate its consolidated and business segment performance

compared to prior periods and the marketplace, to establish operational goals and management incentive goals, and to provide continuity to investors for comparability purposes. Limitations associated with the use of these non-GAAP measures include

that these measures do not present all the amounts associated with Somnigroup’s or Leggett’s results as determined in accordance with GAAP. These non-GAAP measures should be considered supplemental in nature and should not be construed

as more significant than comparable measures defined by GAAP. Because not all companies use identical calculations, these presentations may not be comparable to other similarly titled measures of other companies. For more information regarding the

use of these non-GAAP financial measures, please refer to the reconciliations on the following pages and Somnigroup’s and Leggett’s SEC filings. EBITDA and Adjusted EBITDA A reconciliation of Somnigroup’s GAAP net income to EBITDA

and adjusted EBITDA per credit facility is provided on the subsequent slides. Somnigroup management believes that the use of EBITDA and adjusted EBITDA per credit facility provides investors with useful information with respect to Somnigroup’s

operating performance and comparisons from period to period as well as Somnigroup’s compliance with requirements under its credit agreement. A reconciliation of Leggett’s GAAP net income to EBITDA and adjusted EBITDA is provided on the

subsequent slides. Leggett management believes that the use of EBITDA and adjusted EBITDA provides investors with useful information with respect to Leggett’s operating performance and comparisons from period to period. Leverage Consolidated

indebtedness less netted cash to adjusted EBITDA per credit facility, which Somnigroup may refer to as leverage, is provided on a subsequent slide and is calculated by dividing consolidated indebtedness less netted cash, as defined by

Somnigroup’s senior secured credit facility, by adjusted EBITDA per credit facility. Somnigroup provides this as supplemental information to investors regarding Somnigroup’s operating performance and comparisons from period to period, as

well as general information about Somnigroup 's progress in managing its leverage. 21

Somnigroup – 2025 Adjusted EBITDA Twelve Months Ended (in

millions) December 31, 2025 Net income $ 384.1 Interest expense, net 261.1 (1) Transaction related interest expense, net 6.8 Income tax provision 95.7 Depreciation and amortization 291.6 EBITDA $ 1,039.3 Adjustments for financial covenant purposes:

(2) Acquisition-related costs 114.2 (3) Transaction costs 56.0 (4) Business combination charges 53.8 (5) Loss on disposal of business 13.9 (6) Supply chain transition costs 12.1 (7) Disposition-related costs 10.5 (8) Cloud-based computing

arrangements impairment 6.2 Adjusted EBITDA $ 1,306.0 Adjustments for financial covenant purposes: (9) Loss from unrestricted subsidiary 3.1 (10) Earnings from Mattress Firm prior to acquisition 18.7 (11) Future cost synergies to be realized from

Mattress Firm acquisition 100.0 Adjusted EBITDA per credit facility $ 1,427.8 Consolidated indebtedness less netted cash $ 4,582.4 Ratio of consolidated indebtedness less netted cash to adjusted EBITDA 3.21 times 22

Somnigroup – 2025 Adjusted EBITDA (1) In the year ended 2025, the

Company incurred $6.8 million of transaction related interest expense, net of interest income, related to the Term B Loan drawn and held in escrow. The proceeds of the Term B Loan were released upon the closing of the acquisition of Mattress Firm on

February 5, 2025. (2) In the year ended 2025, the Company recognized $114.2 million of acquisition-related costs following the Mattress Firm Acquisition, primarily related to one- time business combination accounting and purchase price allocation

adjustments. (3) In the year ended 2025, the Company recorded $56.0 million of transaction costs primarily related to the Mattress Firm acquisition and related divestitures. (4) In the year ended 2025, the Company recorded $53.8 million of business

combination charges primarily related to the floor model transition associated with the refinement of Mattress Firm's multi-branded merchandising plan, professional fees and restructuring costs. (5) In the year ended 2025, the Company recorded a

$13.9 million loss on disposal of business, net of proceeds of $9.0 million, associated with the divestiture of 73 Mattress Firm stores and the Sleep Outfitters subsidiary. (6) In the year ended 2025, the Company recorded $12.1 million of supply

chain transition costs associated with the consolidation of certain manufacturing facilities. (7) In the year ended 2025, the Company recorded $10.5 million of disposition-related costs, primarily related to retail store transition costs incurred

for the divestiture to Mattress Warehouse. (8) In the year ended 2025, the Company recorded $6.2 million of impairment charges related to certain cloud-based computing arrangements. (9) A subsidiary in the Tempur Sealy North America business segment

was accounted for as held for sale and designated as an unrestricted subsidiary under the 2023 Credit Agreement. Therefore, this subsidiary's financial results were excluded from the Company’s adjusted financial measures for covenant

compliance purposes. (10) The Company completed the Mattress Firm acquisition on February 5, 2025 and designated this subsidiary as restricted under the 2023 Credit Agreement. For covenant compliance purposes, the Company included $18.7 million of

Mattress Firm adjusted EBITDA for the period prior to acquisition in the Company's calculation of adjusted EBITDA per credit facility for the year ended December 31, 2025. (11) For the year ended 2025, the Company is permitted to include $100.0

million of future cost synergies expected to be realized in connection with acquisitions for the purpose of calculating adjusted EBITDA in accordance with the 2023 Credit Agreement. 23

Somnigroup – 2025 Leverage Reconciliation (in millions) December

31, 2025 Total debt, net $ 4,685.7 (1) Plus: Deferred financing costs 31.6 Total debt 4,717.3 (2) Less: Netted cash 134.9 Consolidated indebtedness less netted cash $ 4,582.4 (1) The Company presents deferred financing costs as a direct reduction

from the carrying amount of the related debt in the Condensed Consolidated Balance Sheets. For purposes of determining total debt for financial covenant purposes, the Company has added these costs back to total debt, net as calculated per the

Condensed Consolidated Balance Sheets. (2) Netted cash includes cash and cash equivalents for domestic and foreign subsidiaries designated as restricted subsidiaries in the 2023 Credit Agreement. 24

Leggett & Platt – 2025 Adjusted EBITDA Twelve Months Ended

(in millions) December 31, 2025 Net earnings $ 235.4 Net interest expense 66.3 Income taxes 54.3 Depreciation and amortization 122.4 EBITDA $ 478.4 Adjustments for reported Adjusted EBITDA Gain on sale of Aerospace Products Group (90.9) Net gain

from insurance proceeds (34.7) Gain on sale of real estate (29.1) (1) Restructuring, restructuring-related, and impairment charges 36.2 (2) Pension settlement 22.0 Somnigroup unsolicited offer evaluation costs 3.4 Adjusted EBITDA $ 385.3 (1) 2025

includes $6 million of other restructuring activities not associated with the restructuring plan. (2) Impact from a non-cash settlement charge related to the termination of a pension plan. 25

Footnotes (1) Expected post-closing ownership is based on fully diluted

shares outstanding as of April 9, 2026. (2) EBITDA, adjusted EBITDA, adjusted EPS, and leverage are non-GAAP financial measures. Please refer to the “Use of Non-GAAP Financial Measures Information” on a previous slide for more

information regarding the definitions of EBITDA, adjusted EBITDA, adjusted EPS, and leverage, including the adjustments (as applicable) from the corresponding GAAP information. (3) Somnigroup management estimates. Addressable market estimates are

informed by equity research notes and other industry reports. (4) Leggett & Platt's 2025 results include $132M of sales and $22M of adjusted EBITDA from the Aerospace business unit, which was divested in August 2025. Prior to the divestiture,

the Aerospace business unit's financial results were included in the Specialized Products reporting segment. (5) The Specialized Products segment includes the Automotive and Hydraulic Cylinder businesses, and the partial impact of the divested

Aerospace business and the Furniture, Flooring & Textile Products Segments includes the Home Furniture, Work Furniture, Flooring Products and Textile Products businesses. (6) The combined financials have been adjusted for the elimination of

$293M of FY25 sales between Leggett & Platt and Somnigroup. (7) Leggett & Platt’s adjusted EBITDA has been adjusted to remove $22M of adjusted EBITDA from the Aerospace business unit, which was divested in August 2025. Leggett &

Platt's adjusted EBITDA has also been adjusted to add back $17M of stock-based compensation amortization to conform to Somnigroup’s definition of adjusted EBITDA in its credit facility. 26

GRAPHIC

Filename: g38467ex99_2p10g1.jpg · Sequence: 8

Binary file (248939 bytes)

Download g38467ex99_2p10g1.jpg

GRAPHIC

Filename: g38467ex99_2p11g1.jpg · Sequence: 9

Binary file (259018 bytes)

Download g38467ex99_2p11g1.jpg

GRAPHIC

Filename: g38467ex99_2p12g1.jpg · Sequence: 10

Binary file (180885 bytes)

Download g38467ex99_2p12g1.jpg

GRAPHIC

Filename: g38467ex99_2p13g1.jpg · Sequence: 11

Binary file (169460 bytes)

Download g38467ex99_2p13g1.jpg

GRAPHIC

Filename: g38467ex99_2p14g1.jpg · Sequence: 12

Binary file (249670 bytes)

Download g38467ex99_2p14g1.jpg

GRAPHIC

Filename: g38467ex99_2p15g1.jpg · Sequence: 13

Binary file (166612 bytes)

Download g38467ex99_2p15g1.jpg

GRAPHIC

Filename: g38467ex99_2p16g1.jpg · Sequence: 14

Binary file (337286 bytes)

Download g38467ex99_2p16g1.jpg

GRAPHIC

Filename: g38467ex99_2p17g1.jpg · Sequence: 15

Binary file (234006 bytes)

Download g38467ex99_2p17g1.jpg

GRAPHIC

Filename: g38467ex99_2p18g1.jpg · Sequence: 16

Binary file (550481 bytes)

Download g38467ex99_2p18g1.jpg

GRAPHIC

Filename: g38467ex99_2p19g1.jpg · Sequence: 17

Binary file (165170 bytes)

Download g38467ex99_2p19g1.jpg

GRAPHIC

Filename: g38467ex99_2p1g1.jpg · Sequence: 18

Binary file (232586 bytes)

Download g38467ex99_2p1g1.jpg

GRAPHIC

Filename: g38467ex99_2p20g1.jpg · Sequence: 19

Binary file (499295 bytes)

Download g38467ex99_2p20g1.jpg

GRAPHIC

Filename: g38467ex99_2p21g1.jpg · Sequence: 20

Binary file (443019 bytes)

Download g38467ex99_2p21g1.jpg

GRAPHIC

Filename: g38467ex99_2p22g1.jpg · Sequence: 21

Binary file (194098 bytes)

Download g38467ex99_2p22g1.jpg

GRAPHIC

Filename: g38467ex99_2p23g1.jpg · Sequence: 22

Binary file (310277 bytes)

Download g38467ex99_2p23g1.jpg

GRAPHIC

Filename: g38467ex99_2p24g1.jpg · Sequence: 23

Binary file (137073 bytes)

Download g38467ex99_2p24g1.jpg

GRAPHIC

Filename: g38467ex99_2p25g1.jpg · Sequence: 24

Binary file (151183 bytes)

Download g38467ex99_2p25g1.jpg

GRAPHIC

Filename: g38467ex99_2p26g1.jpg · Sequence: 25

Binary file (208784 bytes)

Download g38467ex99_2p26g1.jpg

GRAPHIC

Filename: g38467ex99_2p2g1.jpg · Sequence: 26

Binary file (316816 bytes)

Download g38467ex99_2p2g1.jpg

GRAPHIC

Filename: g38467ex99_2p3g1.jpg · Sequence: 27

Binary file (337918 bytes)

Download g38467ex99_2p3g1.jpg

GRAPHIC

Filename: g38467ex99_2p4g1.jpg · Sequence: 28

Binary file (167908 bytes)

Download g38467ex99_2p4g1.jpg

GRAPHIC

Filename: g38467ex99_2p5g1.jpg · Sequence: 29

Binary file (285326 bytes)

Download g38467ex99_2p5g1.jpg

GRAPHIC

Filename: g38467ex99_2p6g1.jpg · Sequence: 30

Binary file (258677 bytes)

Download g38467ex99_2p6g1.jpg

GRAPHIC

Filename: g38467ex99_2p7g1.jpg · Sequence: 31

Binary file (207110 bytes)

Download g38467ex99_2p7g1.jpg

GRAPHIC

Filename: g38467ex99_2p8g1.jpg · Sequence: 32

Binary file (197644 bytes)

Download g38467ex99_2p8g1.jpg

GRAPHIC

Filename: g38467ex99_2p9g1.jpg · Sequence: 33

Binary file (251604 bytes)

Download g38467ex99_2p9g1.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 35

v3.26.1

Document and Entity Information

Apr. 13, 2026

Cover [Abstract]

Entity Registrant Name

LEGGETT & PLATT INC

Amendment Flag

false

Entity Central Index Key

0000058492

Document Type

8-K

Document Period End Date

Apr. 13, 2026

Entity Incorporation State Country Code

Entity File Number

001-07845

Entity Tax Identification Number

44-0324630

Entity Address, Address Line One

1 Leggett Road

Entity Address, City or Town

Carthage

Entity Address, State or Province

Entity Address, Postal Zip Code

64836

City Area Code

417

Local Phone Number

358-8131

Written Communications

true

Soliciting Material

false

Pre Commencement Tender Offer

false

Pre Commencement Issuer Tender Offer

false

Security 12b Title

Common Stock, par value $.01 per share

Trading Symbol

LEG

Security Exchange Name

NYSE

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration